Brief Introduction of Prof. Dr. Alireza Heidari

Name: Prof. Dr. Alireza Heidari

Affiliation: Ph.D., D.Sc., Faculty of Chemistry, California South University (CSU), Irvine, California, USA

Email: scholar.researcher.scientist@gmail.com / alireza.heidari@calsu.us

Institutional Profile: Visit Profile Here

Google Scholar Profile: Visit Profile Here

Prof. Dr. Alireza Heidari is Ph.D., D.Sc., Faculty of Chemistry, California South University (CSU), Irvine, California, USA.

Educational Qualifications:

Faculty of Chemistry, California South University (CSU), Irvine, California, USA
Participate in “Modern Molecular Electronic–Structure Computations Theory” and also “Nanochemistry” as postdoctoral research fellow
School of Chemistry, Faculty of Science, Monash University, Melbourne, Victoria, Australia
Participate in “Project Management” and also “Oncology, Human Cancer Tissues and Synchrotron Radiation” as postdoctoral research fellow
Faculty of Chemistry, California South University (CSU), Irvine, California, USA
Ph.D., D.Sc. Chemistry (Biophysical Chemistry) – GPA: 3.95/4.00 (19.75/20)
Faculty of Chemistry, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran
M.Sc. Chemistry (Physical Chemistry) – GPA: 19.08/20
Faculty of Chemistry, Islamic Azad University (IAU), North Tehran Branch, Tehran, Iran
B.Sc. Chemistry (Pure Chemistry) – GPA: 19.08/20

Work Experiences:

2001 – 2010: Industrial, Investigate & International LARA Company, Tehran, Iran. o FGI Industrial Company, Tehran, Iran
2007– 2011: Pishtaz Tak Chemi Company, Qazvin, Iran. o NASR ASIA PETRO GOSTAR Company, Tehran, Iran
2012– Present: President of American International Standards Institute (AISI), Irvine, California, USA
2015– 2019: Board of Directors Member at Pishtaz Lian Chemi Company, Qazvin, Iran

1. Academic & Research Experiences:

Dr. G. Reza Karimi, Ph.D. Assistant Professor and Head of Biotechnology, Department of Mineral & Petroleum Engineering
Dr. Masoud Rajabi, Ph.D. Assistant Professor, Department of Materials Engineering, Faculty of Engineering and Technology. Babol Noshirvani University of Technology, Babol, Iran
Prof. Dr. Hossein Eisazadeh, Ph.D. Full Professor & Head of Faculty of Chemical Engineering, Department of Chemical Engineering
Dr. Ali Akbar Ranjbar, Ph.D. Associate Professor & Dean of School of Mechanical Engineering, Department of Mechanical Engineering
Volunteer Visitor, Department of Mathematical Sciences, Delaware State University, Dover, Delaware, USA, 2010
Volunteer Visitor, Department of Industrial Engineering, Universidad Politécnica De Cartagena, Cartagena, Spain, 2010
Volunteer Visitor, Department of Engineering and Mathematics, Sheffield Hallam University, Sheffield, UK, 2010
Volunteer Visitor, Department of Mathematics, Ege University, Izmir, Turkey, 2011
Postdoctoral Research Fellow, School of Chemistry, Faculty of Science, Monash University, Melbourne, Victoria, Australia, 2013 – 2014
Postdoctoral Research Fellow, Faculty of Chemistry, California South University (CSU), Irvine, California, USA, 2014

2. Teaching Experiences:

Teacher at the laboratory for Physics I & II for undergraduate students studying Mechanics Engineering, Industrial Engineering, Computer Engineering, IT Engineering, Medical Engineering, and Electrical & Electronic Engineering
Scientific member and instructor at the departments of Electrical & Electronic Engineering, Faculty of Electrical, IT, Computer & Biomedical Sciences
Scientific member and instructor at the department of ICT & Hardware Engineering
Teacher at the laboratory for Physics I & II for Associates Degree students studying Industrial Engineering and Software Engineering, in addition to B.Sc. Industrial Engineering Students
Teaching Applied Mathematics/Engineering, Mathematics/Numerical Analysis and Computation for B.Sc. ICT Engineering Students
Teaching General Mathematics/Differential Equations and Engineering Mathematics for B.Sc. Hardware Engineering Students
Teaching Physics I (Mechanics) and Physics II (Electromagnetic Physics) to B.Sc. Industrial Engineering Students

Academic Association History Publications:

a) Research Articles:

B. Adib, A. Heidari, P. Zarshekan Zamanpour, “Calculation of Bose–Einstein condensation of gases in a harmonic potential trap using a macro canonical ensemble by use of the mathematical and Hermitian functions”, Asian Journal of Chemistry, Volume 21, Number 4, Pages 2593–2609, 2009
Heidari, A. Biswas, “Dynamics of relativistic solitons due to pseudo Sine– Gordon equation”, International Journal of Theoretical Physics, Volume 49, Issue 5, Pages 1096–1105, 2010
R. Sassaman, A. Heidari, F. Majid, E. Zerrad, A. Biswas, “Topological and non– topological solitons of the generalized Klein–Gordon equations in 1+2 dimensions”, Dynamics of Continuous, Discrete and Impulsive Systems Series A: Mathematical Analysis, Volume 17, Number 2, Pages 275–286, 2010
R. Sassaman, A. Heidari, A. Biswas, “Topological and non–topological solitons of nonlinear Klein–Gordon equations by He’s semi–inverse variational principle”, Journal of The Franklin Institute, Volume 347, Issue 7, Pages 1148–1157, 2010
O. Anwar Bég, J. Zueco, S. K. Ghosh, A. Heidari, “Unsteady magneto hydrodynamic heat transfer in a semi–infinite porous medium with thermal radiation flux: Analytical and numerical study”, Advances in Numerical Analysis, Volume 2011, Article ID 304124, 17 Pages, 2011
Heidari, O. Anwar Bég, “An analytical and numerical investigation of the dissipative chaos in superconductor super lattices”, International Journal of Applied Mathematics and Mechanics, Volume 7, Issue 18, Pages 22–37, 2011
Heidari, O. Anwar Bég, “Numerical solution of the heteronuclear diatomic Schrödinger equation using various empirical potential functions via the Numerov method”, International Journal of Applied Mathematics and Mechanics, Volume 7, Issue 18, Pages 38–55, 2011
Heidari, N. Heidari, M. Ghorbani, “Study and investigation of interaction and association of water molecules in carbon nanotubes and calculation of their thermodynamics properties using molecular dynamics simulation: A mathematical approach”, Journal of Computational and Theoretical Nanoscience, Volume 9, Number 10, Pages 1647–1657, 2012
M. A. Balcı, A. Yıldırım, S. T. Mohyud–Din, A. Heidari, “Construction of solitary solutions and periodic solutions of coupled higher–dimensional Burgers equations using the homotopy perturbation method”, World Applied Sciences Journal, Volume 16, Issue 3, Pages 329–330, 2012
Heidari, N. Heidari, M. Godarzvand Chegini, R. Amiri, F. Khademi Jahromi, M. Ghorbani, “A new method for synthesis of nanocomposite membranes for separation of gases”, Advanced Science Letters, Volume 11, Number 1, Pages 126–134, 2012
Heidari, N. Heidari, M. Ghorbani, “A new method for synthesis of single–wall carbon nanotubes using single metallic and bimetallic nanocatalysts”, Journal of Computational and Theoretical Nanoscience, Volume 10, Number 1, Pages 37–47, 2013
Heidari, S. Vedad, M. Ghorbani, “A new approach to utilizing two–state approximation in hydrogen formation through landing proton on positronium: A computational investigation and study”, Fundamental Journal of Modern Physics, Volume 2, Issue 2, Pages 89–104, 2011
Heidari, S. Vedad, O. Anwar Bég, M. Ghorbani, “An analytical and numerical investigation of the quarkonium spectroscopy using the generalized Klein–Gordon equation: A computational study”, Fundamental Journal of Mathematical Physics, Volume 1, Issue 2, Pages 57–68, 2011
Heidari, S. Vedad, O. Anwar Bég, M. Ghorbani, “Simulation of muonic catalyzed fusion using the Monte–Carlo method”, Fundamental Journal of Mathematical Physics, Volume 1, Issue 2, Pages 69–98, 2011
S. Ahmed, O. Anwar Bég, S. Vedad, N. Heidari, M. Zeinalkhani, M. Ghorbani, A. Heidari, “Perturbation analysis of dissipation and thermal radiation effects on hydro magnetic transient mixed convective heat and mass transfer with transpiration”, Fundamental Journal of Thermal Science and Engineering, Volume 2, Issue 1, Pages 13– 36, 2012
J. Zueco, S. Vedad, M. Ghorbani, N. Heidari, M. Zeinalkhani, A. Heidari, “Performance analysis of shell and tube heat exchangers using an educational application”, Fundamental Journal of Thermal Science and Engineering, Volume 2, Issue 1, Pages 37–52, 2012
Heidari, S. Vedad, O. Anwar Bég, M. Ghorbani, “An analytical approach to the non–commutative space effect in the Bethe–Salpeter equation for two particles’ bound state: Quantum electrodynamic modelling”, Fundamental Journal of Modern Physics, Volume 2, Issue 2, Pages 105–117, 2011
Heidari, S. Vedad, O. Anwar Bég, M. Ghorbani, “A numerical method for solving the Lippmann–Schwinger integral equation with the radial interaction potentials”, Fundamental Journal of Modern Physics, Volume 2, Issue 2, Pages 119– 138, 2011
E. Hosseini Nezhad, N. Heidari, M. Ghorbani, A. Heidari, “A new approach to mechanochemically synthesizing Al2O3/Cu–Cr nanocomposites”, International Journal of Scientific & Engineering Research, Volume 3, Issue 4, 2012
S. Afsharmehr, M. Zeinalkhani, M. Ghorbani, A. Heidari, “Stability analysis for carbon nanotube based field effect transistors”, International Journal of Scientific & Engineering Research, Volume 3, Issue 5, 2012
R. Bhargava, O. Anwar Bég, S. Vedad, M. Zeinalkhani, A. Heidari, “Finite element analysis of multi–physical slip flow and heat transfer from a porous rotating disk”, Int. J. Pure Appl. Sci. Technol., Volume 11, Number 1, Pages 8–33, 2012
S. Ahmed, O. Anwar Bég, S. Vedad, M. Zeinalkhani, A. Heidari, “Mathematical modelling of magnetohydrodynamic transient free and forced convective flow with induced magnetic field effects”, Int. J. Pure Appl. Sci. Technol., Volume 11, Number 1, Pages 109–125, 2012
Heidari, N. Heidari, M. Ghorbani, “Investigating the effects of nanosized aluminum oxide powder addition on Bi1.6Pb0.4Sr2Ca2Cu3O10 superconductor using XRD patterns”, Advanced Science, Engineering and Medicine, Volume 4, Number 5, Pages 405–407, 2012
Heidari, M. Ghorbani, “Coherent quantum transport in ferromagnet– superconductor–ferromagnet grapheme–based junctions”, Advanced Science, Engineering and Medicine, Volume 4, Number 5, Pages 401–404, 2012
Heidari, S. Vedad, “Analytical and numerical investigation of soliton solutions of coupled equations in quadratic media: A novel approach”, Studies in Mathematical Sciences, Volume 4, Number 2, Pages 54–69, 2012
Heidari, O. Anwar Bég, M. Ghorbani, “Study of the vibrational characteristics of the homonuclear diatomic nuclear Schrödinger equation with a Numerov method using a number of empirical potential functions”, Russian Journal of Physical Chemistry A, Volume 87, Number 2, Pages 216–224, 2013
E. Hosseini Nezhad, M. Ghorbani, M. Zeinalkhani, A. Heidari, “A new technique to absorb yellow GX anionic pigments”, American Journal of Chemistry, Volume 3, Number 1, Pages 6–9, 2013
E.Hosseini Nezhad, M. Ghorbani, M. Zeinalkhani, A. Heidari, “DNA encapsulation in an anionic reverse micellar solution of dioctyl sodium sulfosuccinate”, Physical Chemistry, Volume 3, Number 1, Pages 7–10, 2013
Heidari, S. Vedad, F. Ghorbani, M. Ghorbani, “Particle–in–cell simulations of Raman forward scattering instability in low–density plasmas: A computational study”, International Journal of Theoretical and Mathematical Physics, Volume 2, Number 6, Pages 215–220, 2012
Heidari, “An investigation of the role of DNA as molecular computers: A computational study on the Hamiltonian path problem”, International Journal of Scientific & Engineering Research, Volume 5, Issue 1, Pages 1884–1889, 2014
Heidari, “Writing method of a research paper”, International Journal of Recent and Futuristic Chemistry, 2015
Miller, A. Heidari, “Review on manufacturing and fabrication nanoparticles methods for processing cadmium oxide (CdO) nanoparticles colloidal solution”, International Journal of Theoretical, Computational and Mathematical Chemistry, Volume 1, Number 1, Pages 1–3, 2015
Brown, A. Heidari, “Experimental and computational investigation of catalytic effect of aluminum nitride nanocrystal (AlN) on the polymerization of benzene, naphthalene, anthracene, phenanthrene, chrysene and tetracene”, International Journal of Theoretical, Computational and Mathematical Chemistry, Volume 1, Number 1, Pages 4–6, 2015
Thomson, A. Heidari, “A novel experimental and computational study of Michaelis–Menten kinetics for catalyst processes innovation, characterization and carrier applications”, International Journal of Theoretical, Computational and Mathematical Chemistry, Volume 1, Number 1, Pages 7–10, 2015
Heidari, C. Brown, “Study of surface morphological, phytochemical and structural characteristics of rhodium (III) oxide (Rh2O3) nanoparticles”, International Journal of Pharmacology, Phytochemistry and Ethnomedicine, Volume 1, Issue 1, Pages 15–19, 2015
Heidari, C. Brown, “Study of composition and morphology of cadmium oxide (CdO) nanoparticles for eliminating cancer cells”, J Nanomed Res., Volume 2, Issue 5, 20 Pages, 2015
Heidari, “An experimental biospectroscopic study on seminal plasma in determination of semen quality for evaluation of male infertility”, Int J Adv Technol 7: e007, 2016
Heidari, “Extraction and preconcentration of N–tolyl–sulfonyl–phosphoramid– saeure–dichlorid as an anti–cancer drug from plants: A pharmacognosy study”, J Pharmacogn Nat Prod 2: e103, 2016
Heidari, “A thermodynamic study on hydration and dehydration of DNA and RNA−amphiphile complexes”, J Bioeng Biomed Sci S: 006, 2016
Heidari, “Computational studies on molecular structures and carbonyl and ketene groups’ effects of singlet and triplet energies of azidoketene O=C=CH–NNN and isocyanatoketene O=C=CH–N=C=O”, J Appl Computat Math 5: e142, 2016
Heidari, “Study of irradiations to enhance the induces the dissociation of hydrogen bonds between peptide chains and transition from helix structure to random coil structure using ATR–FTIR, Raman and 1HNMR spectroscopies”, J Biomol Res Ther 5: e146, 2016
Heidari, “Future prospects of point fluorescence spectroscopy, fluorescence imaging and fluorescence endoscopy in photodynamic therapy (PDT) for cancer cells”, J Bioanal Biomed 8: e135, 2016
Heidari, “A bio–spectroscopic study of DNA density and color role as determining factor for absorbed irradiation in cancer cells”, Adv Cancer Prev 1: e102, 2016
Heidari, “Manufacturing process of solar cells using cadmium oxide (CdO) and rhodium (III) oxide (Rh2O3) nanoparticles”, J Biotechnol Biomater 6: e125, 2016
Heidari, “A novel experimental and computational approach to photobiosimulation of telomeric DNA/RNA: A biospectroscopic and photobiological study”, J Res Development 4: 144, 2016
Heidari, “Biochemical and pharmacodynamical study of microporous molecularly imprinted polymer selective for vancomycin, teicoplanin, oritavancin, telavancin and dalbavancin binding”, Biochem Physiol 5: e146, 2016
Heidari, “Anti–cancer effect of UV irradiation at presence of cadmium oxide (CdO) nanoparticles on DNA of cancer cells: A photodynamic therapy study”, Arch Cancer Res. 4: 1, 2016
Heidari, “Biospectroscopic study on multi–component reactions (MCRs) in two A–type and B–type conformations of nucleic acids to determine ligand binding modes, binding constant and stability of nucleic acids in cadmium oxide (CdO) nanoparticles– nucleic acids complexes as anti–cancer drugs”, Arch Cancer Res. 4: 2, 2016
Heidari, “Simulation of temperature distribution of DNA/RNA of human cancer cells using time–dependent bio–heat equation and Nd: YAG lasers”, Arch Cancer Res. 4: 2, 2016
Heidari, “Quantitative structure–activity relationship (QSAR) approximation for cadmium oxide (CdO) and rhodium (III) oxide (Rh2O3) nanoparticles as anti–cancer drugs for the catalytic formation of proviral DNA from viral RNA using multiple linear and non–linear correlation approach”, Ann Clin Lab Res. 4: 1, 2016
Heidari, “Biomedical study of cancer cells DNA therapy using laser irradiations at presence of intelligent nanoparticles”, J Biomedical Sci. 5: 2, 2016
Heidari, “Measurement the amount of vitamin D2 (ergocalciferol), Vitamin D3 (cholecalciferol) and absorbable calcium (Ca2+), iron (II) (Fe2+), magnesium (Mg2+), phosphate (PO4–) and zinc (Zn2+) in apricot using high–performance liquid chromatography (HPLC) and spectroscopic techniques”, J Biom Biostat 7: 292, 2016
Heidari, “Spectroscopy and quantum mechanics of the helium dimer (He2+), neon dimer (Ne2+), argon dimer (Ar2+), krypton dimer (Kr2+), xenon dimer (Xe2+), radon dimer(Rn2+) and ununoctium dimer (Uuo2+) molecular cations”, Chem Sci J 7: e112, 2016
Heidari, “Human toxicity photodynamic therapy studies on DNA/RNA complexes as a promising new sensitizer for the treatment of malignant tumors using bio–spectroscopic techniques”, J Drug Metab Toxicol 7: e129, 2016
Heidari, “Novel and stable modifications of intelligent cadmium oxide (CdO) nanoparticles as anti–cancer drug in formation of nucleic acids complexes for human cancer cells’ treatment”, Biochem Pharmacol (Los Angel) 5: 207, 2016
Heidari, “A combined computational and QM/MM molecular dynamics study on boron nitride nanotubes (BNNTs), amorphous boron nitride nanotubes (a–BNNTs) and hexagonal boron nitride nanotubes (h–BNNTs) as hydrogen storage”, Struct Chem Crystallogr Commun 2: 1, 2016
Heidari, “Pharmaceutical and analytical chemistry study of cadmium oxide (CdO) nanoparticles synthesis methods and properties as anti–cancer drug and its effect on human cancer cells”, Pharm Anal Chem Open Access 2: 113, 2016
Heidari, “A chemotherapeutic and biospectroscopic investigation of the interaction of double–standard DNA/RNA–binding molecules with cadmium oxide (CdO) and rhodium (III) oxide (Rh2O3) nanoparticles as anti–cancer drugs for cancer cells’ treatment”, Chemo Open Access 5: e129, 2016
Heidari, “Pharmacokinetics and experimental therapeutic study of DNA and other biomolecules using lasers: Advantages and applications”, J Pharmacokinet Exp Ther 1: e005, 2016
Heidari, “Determination of ratio and stability constant of DNA/RNA in human cancer cells and cadmium oxide (CdO) nanoparticles complexes using analytical electrochemical and spectroscopic techniques”, Insights Anal Electrochem 2: 1, 2016
Heidari, “Combined theoretical and computational study of the Belousov– Zhabotinsky chaotic reaction and Curtius rearrangement for synthesis of mechlorethamine, cisplatin, streptozotocin, cyclophosphamide, melphalan, busulphan and BCNU as anti–cancer drugs”, Insights Med Phys. 1: 2, 2016
Heidari, “A translational biomedical approach to structural arrangement of amino acids’ complexes: A combined theoretical and computational study”, Transl Biomed. 7: 2, 2016
Heidari, “Ab initio and density functional theory (DFT) studies of dynamic NMR shielding tensors and vibrational frequencies of DNA/RNA and cadmium oxide (CdO) nanoparticles complexes in human cancer cells”, J Nanomedine Biotherapeutic Discov 6: e144, 2016
Heidari, “Molecular dynamics and Monte–Carlo simulations for replacement sugars in insulin resistance, obesity, LDL cholesterol, triglycerides, metabolic syndrome, type 2 diabetes and cardiovascular disease: A glycobiological study”, J Glycobiol 5: e111, 2016
Heidari, “Synthesis and study of 5–[(phenylsulfonyl)amino]–1,3,4–thiadiazole– 2–sulfonamide as potential anti–pertussis drug using chromatography and spectroscopy techniques”, Transl Med (Sunnyvale) 6: e138, 2016
Heidari, “Nitrogen, oxygen, phosphorus and sulphur heterocyclic anti–cancer nano drugs separation in the supercritical fluid of ozone (O3) using Soave–Redlich– Kwong (SRK) and Pang–Robinson (PR) equations”, Electronic J Biol 12: 4, 2016
Heidari, “An analytical and computational infrared spectroscopic review of vibrational modes in nucleic acids”, Austin J Anal Pharm Chem. 3 (1): 1058, 2016
Heidari, C. Brown, “Phase, composition and morphology study and analysis of Os–Pd/HfC nanocomposites”, Nano Res Appl. 2: 1, 2016
Heidari, C. Brown, “Vibrational spectroscopic study of intensities and shifts of symmetric vibration modes of ozone diluted by cumene”, International Journal of Advanced Chemistry, 4 (1) 5–9, 2016
Heidari, “Study of the role of anti–cancer molecules with different sizes for decreasing corresponding bulk tumor multiple organs or tissues”, Arch Can Res. 4: 2, 2016
Heidari, “Genomics and proteomics studies of zolpidem, necopidem, alpidem, saripidem, miroprofen, zolimidine, olprinone and abafungin as anti–tumor, peptide antibiotics, antiviral and central nervous system (CNS) drugs”, J Data Mining Genomics & Proteomics 7: e125, 2016
Heidari, “Pharmacogenomics and pharmacoproteomics studies of phosphodiesterase–5 (PDE5) inhibitors and paclitaxel albumin–stabilized nanoparticles as sandwiched anti–cancer nano drugs between two DNA/RNA molecules of human cancer cells”, J Pharmacogenomics Pharmacoproteomics 7: e153, 2016
Heidari, “Biotranslational medical and biospectroscopic studies of cadmium oxide (CdO) nanoparticles–DNA/RNA straight and cycle chain complexes as potent anti–viral, anti–tumor and anti–microbial drugs: A clinical approach”, Transl Biomed. 7: 2, 2016
Heidari, “A Comparative study on simultaneous determination and separation of adsorbed cadmium oxide (CdO) nanoparticles on DNA/RNA of human cancer cells using biospectroscopic techniques and dielectrophoresis (DEP) method”, Arch Can Res. 4: 2, 2016
Heidari, “Cheminformatics and system chemistry of cisplatin, carboplatin, nedaplatin, oxaliplatin, heptaplatin and lobaplatin as anti–cancer nano drugs: A combined computational and experimental study”, J Inform Data Min 1: 3, 2016
Heidari, “Linear and non–linear quantitative structure–anti–cancer–activity relationship (QSACAR) study of hydrous ruthenium (IV) oxide (RuO2) nanoparticles as non–nucleoside reverse transcriptase inhibitors (NNRTIs) and anti–cancer nano drugs”, J Integr Oncol 5: e110, 2016
Heidari, “Synthesis, characterization and biospectroscopic studies of cadmium oxide (CdO) nanoparticles–nucleic acids complexes absence of soluble polymer as a protective agent using nucleic acids condensation and solution reduction method”, J Nanosci Curr Res 1: e101, 2016
Heidari, “Coplanarity and collinearity of 4’–dinonyl–2,2’–bithiazole in one domain of bleomycin and pingyangmycin to be responsible for binding of cadmium oxide (CdO) nanoparticles to DNA/RNA bidentate ligands as anti–tumor nano drug”, Int J Drug Dev & Res 8: 007–008, 2016
Heidari, “A Pharmacovigilance study on linear and non–linear quantitative structure (chromatographic) retention relationships (QSRR) models for the prediction of retention time of anti–cancer nano drugs under synchrotron radiations”, J Pharmacovigil 4: e161, 2016
Heidari, “Nanotechnology in preparation of semipermeable polymers”, J Adv Chem Eng 6: 157, 2016
Heidari, “A gastrointestinal study on linear and non–linear quantitative structure (chromatographic) retention relationships (QSRR) models for analysis 5– aminosalicylates nano particles as digestive system nano drugs under synchrotron radiations”, J Gastrointest Dig Syst 6: e119, 2016
Heidari, “DNA/RNA fragmentation and cytolysis in human cancer cells treated with diphthamide nano particles derivatives”, Biomedical Data Mining 5: e102, 2016
Heidari, “Simulation of interaction of light and iridium nanoparticles using 3D finite element method (FEM) as an optothermal cancer cells treatment”, International Journal of Theoretical, Computational and Mathematical Chemistry, Volume 2, Number 1, Pages 11–16, 2016
Heidari, “Theoretical analysis of vibronic structure in vibrational spectra of ethanedioic acid (oxalic ccid) beyond the Franck–Condon approximation: A combined experimental and density functional theoretical study”, International Journal of Theoretical, Computational and Mathematical Chemistry, Volume 2, Number 1, Pages 17–19, 2016
Heidari, “The quantum entanglement dynamics induced by non–linear interaction between a moving 6–methoxy–8–[[6–methoxy–8–[[6–methoxy–2–methyl–1– (2–methylpropyl)–3,4–dihydro–1H–isoquinolin–7–yl]oxy]–2–methyl–1–(2– methylpropyl)–3,4–dihydro–1H–isoquinolin–7–yl]oxy]–2–methyl–1–(2–methylpropyl)– 3,4–dihydro–1H–isoquinolin–7–ol and a two–mode field with two–photon transitions using reduced Von Neumann entropy and Jaynes–Cummings model”, International Journal of Theoretical, Computational and Mathematical Chemistry, Volume 2, Number 1, Pages 20–22, 2016
Heidari, “Investigating the attenuated total reflectance Fourier transform infrared (ATR–FTIR) and Raman spectroscopies of single–walled carbon nanotubes (SWCNT) and multi–walled carbon nanotubes (MWCNT)”, International Journal of Theoretical, Computational and Mathematical Chemistry, Volume 2, Number 1, Pages 23–26, 2016
Heidari, “Quantum hydrodynamics (QHD) approach to single–walled carbon nanotubes (SWCNT) and multi–walled carbon nanotubes (MWCNT): A comparative and computational study”, International Journal of Theoretical, Computational and Mathematical Chemistry, Volume 2, Number 1, Pages 27–30, 2016
Heidari, “A successful strategy for the prediction of solubility in the construction of quantitative structure–activity relationship (QSAR) and quantitative structure–property relationship (QSPR) under synchrotron radiations using genetic function approximation (GFA) algorithm”, J Mol Biol Biotechnol 1: 1, 2016
Heidari, “Computational study on molecular structures of C20, C60, C240, C540, C960, C2160 and C3840 fullerene nano molecules under synchrotron radiations using fuzzy logic”, J Material Sci Eng 5: 282, 2016
Heidari, “Graph theoretical analysis of zigzag polyhexamethylene biguanide, polyhexamethylene adipamide, polyhexamethylene biguanide gauze and polyhexamethylene biguanide hydrochloride (PHMB) boron nitride nanotubes (BNNTs), amorphous boron nitride nanotubes (a–BNNTs) and hexagonal boron nitride nanotubes (h–BNNTs)”, J Appl Computat Math 5: e143, 2016
Heidari, “The impact of high resolution imaging on diagnosis”, Int J Clin Med Imaging 3: 1000e101, 2016
Heidari, “A comparative study of conformational behavior of isotretinoin (13– cis retinoic acid) and tretinoin (all–trans retinoic acid (ATRA)) nano particles as anti– cancer nano drugs under synchrotron radiations using Hartree–Fock (HF) and density functional theory (DFT) methods”, Insights in Biomed 1: 2, 2016
Heidari, “Advances in logic, operations and computational mathematics”, J Appl Computat Math 5: 5, 2016
Heidari, “Mathematical equations in predicting physical behavior”, J Appl Computat Math 5: 5, 2016
Heidari, “Chemotherapy a last resort for cancer treatment”, Chemo Open Access 5: 4, 2016
Heidari, “Separation and pre–concentration of metal cations–DNA/RNA chelates using molecular beam mass spectrometry with tunable vacuum ultraviolet (VUV) synchrotron radiation and various analytical methods”, Mass Spectrom Purif Tech 2: e101, 2016
Heidari, “Yoctosecond quantitative structure–activity relationship (QSAR) and quantitative structure–property relationship (QSPR) under synchrotron radiations studies for prediction of solubility of anti–cancer nano drugs in aqueous solutions using genetic function approximation (GFA) algorithm”, Insight Pharm Res. 1: 1, 2016
Heidari, “Cancer risk prediction and assessment in human cells under synchrotron radiations using quantitative structure activity relationship (QSAR) and quantitative structure properties relationship (QSPR) studies”, Int J Clin Med Imaging 3: 516, 2016
Heidari, “A novel approach to biology”, Electronic J Biol 12: 4, 2016
Heidari, “Innovative biomedical equipment’s for diagnosis and treatment”, J Bioengineer & Biomedical Sci 6: 2, 2016
Heidari, “Integrating precision cancer medicine into healthcare, medicare reimbursement changes and the practice of oncology: Trends in oncology medicine and practices”, J Oncol Med & Pract 1: 2, 2016
Heidari, “Promoting convergence in biomedical and biomaterials sciences and silk proteins for biomedical and biomaterials applications: An introduction to materials in medicine and bioengineering perspectives”, J Bioengineer & Biomedical Sci 6: 3, 2016
Heidari, “X–ray fluorescence and x–ray diffraction analysis on discrete element modeling of nano powder metallurgy processes in optimal container design”, J Powder Metall Min 6: 1, 2017
Heidari, “Biomolecular spectroscopy and dynamics of nano–sized molecules and clusters as cross–linking–induced anti–cancer and immune–oncology nano drugs delivery in DNA/RNA of uuman cancer cells’ membranes under synchrotron radiations: A payload–based perspective”, Arch Chem Res. 1: 2, 2017
Heidari, “Deficiencies in repair of double–standard DNA/RNA–binding molecules identified in many types of solid and liquid tumors oncology in human body for advancing cancer immunotherapy using computer simulations and data analysis: Number of mutations in a synchronous tumor varies by age and type of synchronous cancer”, J Appl Bioinforma Comput Biol, 6: 1, 2017
Heidari, “Electronic coupling among the five nanomolecules shuts down quantum tunneling in the presence and absence of an applied magnetic field for indication of the dimer or other provide different influences on the magnetic behavior of single molecular magnets (SMMs) as qubits for quantum computing”, Glob J Res Rev. 4: 2, 2017
Heidari, “Polymorphism in nano–sized graphene ligand–induced transformation of Au38–xAgx/xCux(SPh–tBu)24 to Au36–xAgx/xCux(SPh–tBu)24 (x = 1–12) nanomolecules for synthesis of Au144–xAgx/xCux[(SR)60, (SC4)60, (SC6)60, (SC12)60, (PET)60, (p–MBA)60, (F)60, (Cl)60, (Br)60, (I)60, (At)60, (Uus)60 and (SC6H13)60] nano clusters as anti–cancer nano drugs”, J Nanomater Mol Nanotechnol, 6: 3, 2017
Heidari, “Biomedical resource oncology and data mining to enable resource discovery in medical, medicinal, clinical, pharmaceutical, chemical and translational research and their applications in cancer research”, Int J Biomed Data Min 6: e103, 2017
Heidari, “Study of synthesis, pharmacokinetics, pharmacodynamics, dosing, stability, safety and efficacy of olympiadane nanomolecules as agent for cancer enzymotherapy, immunotherapy, chemotherapy, radiotherapy, hormone therapy and targeted therapy under synchrotorn radiation”, J Dev Drugs 6: e154, 2017
Heidari, “A Novel approach to future horizon of top seven biomedical research topics to watch in 2017: Alzheimer's, ebola, hypersomnia, human immunodeficiency virus (HIV), tuberculosis (TB), microbiome/antibiotic resistance and endovascular stroke”, J Bioengineer & Biomedical Sci 7: e127, 2017
Heidari, “Opinion on computational fluid dynamics (CFD) technique”, Fluid Mech Open Acc 4: 157, 2017
Heidari, “Concurrent diagnosis of oncology influence outcomes in emergency general surgery for colorectal cancer and multiple sclerosis (MS) treatment using magnetic resonance imaging (MRI) and Au329(SR)84, Au329–xAgx(SR)84, Au144(SR)60, Au68(SR)36, Au30(SR)18, Au102(SPh)44, Au38(SPh)24, Au38(SC2H4Ph)24, Au21S(SAdm)15, Au36(pMBA)24 and Au25(pMBA)18 nano clusters”, J Surgery Emerg Med 1: 21, 2017
Heidari, “Developmental cell biology in adult stem cells death and autophagy to trigger a preventive allergic reaction to common airborne allergens under synchrotron radiation using nanotechnology for therapeutic goals in particular allergy shots (immunotherapy)”, Cell Biol (Henderson, NV) 6: 1, 2017
Heidari, “Changing metal powder characteristics for elimination of the heavy metals toxicity and diseases in disruption of extracellular matrix (ECM) proteins adjustment in cancer metastases induced by osteosarcoma, chondrosarcoma, carcinoid, carcinoma, Ewing’s sarcoma, fibrosarcoma and secondary hematopoietic solid or soft tissue tumors”, J Powder Metall Min 6: 170, 2017
Heidari, “Nanomedicine–based combination anti–cancer therapy between nucleic acids and anti–cancer nano drugs in covalent nano drugs delivery systems for selective imaging and treatment of human brain tumors using hyaluronic acid, alguronic acid and sodium hyaluronate as anti–cancer nano drugs and nucleic acids delivery under synchrotron radiation”, Am J Drug Deliv 5: 2, 2017
Heidari, “Clinical trials of dendritic cell therapies for cancer exposing vulnerabilities in human cancer cells’ metabolism and metabolomics: New discoveries, unique features inform new therapeutic opportunities, biotech's bumpy road to the market and elucidating the biochemical programs that support cancer initiation and progression”, J Biol Med Science 1: e103, 2017
Heidari, “The design graphene–based nanosheets as a new nanomaterial in anti–cancer therapy and delivery of chemotherapeutics and biological nano drugs for liposomal anti–cancer nano drugs and gene delivery”, Br Biomed Bull 5: 305, 2017
Heidari, “Integrative approach to biological networks for emerging roles of proteomics, genomics and transcriptomics in the discovery and validation of human colorectal cancer biomarkers from DNA/RNA sequencing data under synchrotron radiation”, Transcriptomics 5: e117, 2017
Heidari, “Elimination of the heavy metals toxicity and diseases in disruption of extracellular matrix (ECM) proteins and cell adhesion intelligent nanomolecules adjustment in cancer metastases using metalloenzymes and under synchrotron radiation”, Lett Health Biol Sci 2 (2): 1–4, 2017
Heidari, “Treatment of breast cancer brain metastases through a targeted nanomolecule drug delivery system based on dopamine functionalized multi–wall carbon nanotubes (MWCNTs) coated with nano graphene oxide (GO) and protonated polyaniline (PANI) in situ during the polymerization of aniline autogenic nanoparticles for the delivery of anti–cancer nano drugs under synchrotron radiation”, Br J Res, 4 (3): 16, 2017
Heidari, “Sedative, analgesic and ultrasound–mediated gastrointestinal nano drugs delivery for gastrointestinal endoscopic procedure, nano drug–induced gastrointestinal disorders and nano drug treatment of gastric acidity”, Res Rep Gastroenterol, 1: 1, 2017
Heidari, “Synthesis, pharmacokinetics, pharmacodynamics, dosing, stability, safety and efficacy of orphan nano drugs to treat high cholesterol and related conditions and to prevent cardiovascular disease under synchrotron radiation”, J Pharm Sci Emerg Drugs 5: 1, 2017
Heidari, “Non–linear compact proton synchrotrons to improve human cancer cells and tissues treatments and diagnostics through particle therapy accelerators with monochromatic microbeams”, J Cell Biol Mol Sci 2 (1): 1–5, 2017
Heidari, “Design of targeted metal chelation therapeutics nanocapsules as colloidal carriers and blood–brain barrier (BBB) translocation to targeted deliver anti– cancer nano drugs into the human brain to treat alzheimer’s disease under synchrotron radiation”, J Nanotechnol Material Sci 4 (2): 1–5, 2017
R. Gobato, A. Heidari, “Calculations using quantum chemistry for inorganic molecule simulation BeLi2SeSi”, Science Journal of Analytical Chemistry, Vol. 5, No. 6, Pages 76–85, 2017
Heidari, “Different high–resolution simulations of medical, medicinal, clinical, pharmaceutical and therapeutics oncology of human lung cancer translational anti– cancer nano drugs delivery treatment process under synchrotron and x–ray radiations”, J Med Oncol. Vol. 1 No. 1: 1, 2017
Heidari, “A modern ethnomedicinal technique for transformation, prevention and treatment of human malignant gliomas tumors into human benign gliomas tumors under synchrotron radiation”, Am J Ethnomed, Vol. 4 No. 1: 10, 2017
Heidari, “Active targeted nanoparticles for anti–cancer nano drugs delivery across the blood–brain barrier for human brain cancer treatment, multiple sclerosis (MS) and alzheimer's diseases using chemical modifications of anti–cancer nano drugs or drug–nanoparticles through zika virus (ZIKV) nanocarriers under synchrotron radiation”, J Med Chem Toxicol, 2 (3): 1–5, 2017
Heidari, “Investigation of medical, medicinal, clinical and pharmaceutical applications of Estradiol, Mestranol (Norlutin), Norethindrone (NET), Norethisterone Acetate (NETA), Norethisterone Enanthate (NETE) and Testosterone nanoparticles as biological imaging, cell labeling, anti–microbial agents and anti–cancer nano drugs in nanomedicines based drug delivery systems for anti–cancer targeting and treatment”, Parana Journal of Science and Education (PJSE)–V.3, n.4, (10–19) October 12, 2017
Heidari, “A comparative computational and experimental study on different vibrational biospectroscopy methods, techniques and applications for human cancer cells in tumor tissues simulation, modeling, research, diagnosis and treatment”, Open J Anal Bioanal Chem 1 (1): 014–020, 2017
Heidari, “Combination of DNA/RNA ligands and linear/non–linear visible– synchrotron radiation–driven N–doped ordered mesoporous cadmium oxide (CdO) nanoparticles photocatalysts channels resulted in an interesting synergistic effect enhancing catalytic anti–cancer activity”, Enz Eng 6: 1, 2017
Heidari, “Modern approaches in designing ferritin, ferritin light chain, transferrin, beta–2 transferrin and bacterioferritin–based anti–cancer nano drugs encapsulating nanosphere as DNA–binding proteins from starved cells (DPS)”, Mod Appro Drug Des. 1 (1). MADD.000504. 2017
Heidari, “Potency of human interferon β–1a and human interferon β–1b in enzymotherapy, immunotherapy, chemotherapy, radiotherapy, hormone therapy and targeted therapy of encephalomyelitis disseminate/multiple sclerosis (MS) and hepatitis A, B, C, D, E, F and G virus enter and targets liver cells”, J Proteomics Enzymol 6: 1, 2017
Heidari, “Transport therapeutic active targeting of human brain tumors enable anti–cancer nanodrugs delivery across the blood–brain barrier (BBB) to treat brain diseases using nanoparticles and nanocarriers under synchrotron radiation”, J Pharm Pharmaceutics 4 (2): 1–5, 2017
Heidari, C. Brown, “Combinatorial therapeutic approaches to DNA/RNA and benzylpenicillin (penicillin G), fluoxetine hydrochloride (prozac and sarafem), propofol (diprivan), acetylsalicylic acid (ASA) (aspirin), naproxen sodium (aleve and naprosyn) and dextromethamphetamine nanocapsules with surface conjugated DNA/RNA to targeted nano drugs for enhanced anti–cancer efficacy and targeted cancer therapy using nano drugs delivery systems”, Ann Adv Chem. 1 (2): 061–069, 2017
Heidari, “High–resolution simulations of human brain cancer translational nano drugs delivery treatment process under synchrotron radiation”, J Transl Res. 1 (1): 1–3, 2017
Heidari, “Investigation of anti–cancer nano drugs’ effects’ trend on human pancreas cancer cells and tissues prevention, diagnosis and treatment process under synchrotron and x–ray radiations with the passage of time using Mathematica”, Current Trends Anal Bioanal Chem, 1 (1): 36–41, 2017
Heidari, “Pros and cons controversy on molecular imaging and dynamics of double–standard DNA/RNA of human preserving stem cells–binding nano molecules with androgens/anabolic steroids (AAS) or testosterone derivatives through tracking of helium–4 nucleus (alpha particle) using synchrotron radiation”, Arch Biotechnol Biomed. 1 (1): 067–0100, 2017
Heidari, “Visualizing metabolic changes in probing human cancer cells and tissues metabolism using vivo 1H or proton NMR, 13C NMR, 15N NMR and 31P NMR spectroscopy and self–organizing maps under synchrotron radiation”, SOJ Mater Sci Eng 5 (2): 1–6, 2017
Heidari, “Cavity ring–down spectroscopy (CRDS), circular dichroism spectroscopy, cold vapour atomic fluorescence spectroscopy and correlation spectroscopy comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, Enliven: Challenges Cancer Detect Ther 4 (2): e001, 2017
Heidari, “Laser spectroscopy, laser–induced breakdown spectroscopy and laser–induced plasma spectroscopy comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, Int J Hepatol Gastroenterol, 3 (4): 079–084, 2017
Heidari, “Time–resolved spectroscopy and time–stretch spectroscopy comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, Enliven: Pharmacovigilance and Drug Safety 4 (2): e001, 2017
Heidari, “Overview of the role of vitamins in reducing negative effect of decapeptyl (triptorelin acetate or pamoate salts) on prostate cancer cells and tissues in prostate cancer treatment process through transformation of malignant prostate tumors into benign prostate tumors under synchrotron radiation”, Open J Anal Bioanal Chem 1 (1): 021–026, 2017
Heidari, “Electron phenomenological spectroscopy, electron paramagnetic resonance (EPR) spectroscopy and electron spin resonance (ESR) spectroscopy comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, Austin J Anal Pharm Chem. 4 (3): 1091, 2017
Heidari, “Therapeutic nanomedicine different high–resolution experimental images and computational simulations for human brain cancer cells and tissues using nanocarriers deliver DNA/RNA to brain tumors under synchrotron radiation with the passage of time using Mathematica and MATLAB”, Madridge J Nano Tech. Sci. 2 (2): 77–83, 2017
Heidari, “A consensus and prospective study on restoring cadmium oxide (CdO) nanoparticles sensitivity in recurrent ovarian cancer by extending the cadmium oxide (CdO) nanoparticles–free interval using synchrotron radiation therapy as antibody–drug conjugate for the treatment of limited–stage small cell diverse epithelial cancers”, Cancer Clin Res Rep, 1: 2, e001, 2017
Heidari, “A novel and modern experimental imaging and spectroscopy comparative study on malignant and benign human cancer cells and tissues with the passage of time under white synchrotron radiation”, Cancer Sci Res Open Access 4 (2): 1–8, 2017
Heidari, “Different high–resolution simulations of medical, medicinal, clinical, pharmaceutical and therapeutics oncology of human breast cancer translational nano drugs delivery treatment process under synchrotron and x–ray radiations”, J Oral Cancer Res 1 (1): 12–17, 2017
Heidari, “Vibrational decihertz (dHz), centihertz (cHz), millihertz (mHz), microhertz (μHz), nanohertz (nHz), picohertz (pHz), femtohertz (fHz), attohertz (aHz), zeptohertz (zHz) and yoctohertz (yHz) imaging and spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, International Journal of Biomedicine, 7 (4), 335–340, 2017
Heidari, “Force spectroscopy and fluorescence spectroscopy comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, EC Cancer, 2 (5), 239–246, 2017
Heidari, “Photoacoustic spectroscopy, photoemission spectroscopy and photothermal spectroscopy comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, BAOJ Cancer Res Ther, 3: 3, 045–052, 2017
Heidari, “J–spectroscopy, exchange spectroscopy (EXSY), nuclear overhauser effect spectroscopy (NOESY) and total correlation spectroscopy (TOCSY) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, EMS Eng Sci J, 1 (2): 006–013, 2017
Heidari, “Neutron spin echo spectroscopy and spin noise spectroscopy comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, Int J Biopharm Sci, 1: 103–107, 2017
Heidari, “Vibrational decahertz (daHz), hectohertz (hHz), kilohertz (kHz), Megahertz (MHz), Gigahertz (GHz), Terahertz (THz), Petahertz (PHz), Exahertz (EHz), Zettahertz (ZHz) and Yottahertz (YHz) imaging and spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Madridge J Anal Sci Instrum, 2 (1): 41–46, 2017
Heidari, “Two–dimensional infrared correlation spectroscopy, linear two– dimensional infrared spectroscopy and non–linear two–dimensional infrared spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation with the passage of time”, J Mater Sci Nanotechnol 6 (1): 101, 2018
Heidari, “Fourier transform infrared (FTIR) spectroscopy, near–infrared spectroscopy (NIRS) and mid–infrared spectroscopy (MIRS) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation with the passage of time”, Int J Nanotechnol Nanomed, Volume 3, Issue 1, Pages 1–6, 2018
Heidari, “Infrared photo dissociation spectroscopy and infrared correlation table spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation with the passage of time”, Austin Pharmacol Pharm, 3 (1): 1011, 2018
Heidari, “Novel and transcendental prevention, diagnosis and treatment strategies for investigation of interaction among human blood cancer cells, tissues, tumors and metastases with synchrotron radiation under anti–cancer nano drugs delivery efficacy using MATLAB modeling and simulation”, Madridge J Nov Drug Res, 1 (1): 18– 24, 2017
Heidari, “Comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, Open Access J Trans Med Res, 2 (1): 00026–00032, 2018
M. R. R. Gobato, R. Gobato, A. Heidari, “Planting of Jaboticaba Trees for Landscape Repair of Degraded Area”, Landscape Architecture and Regional Planning, Vol. 3, No. 1, 2018, Pages 1–9, 2018
Heidari, “Fluorescence spectroscopy, phosphorescence spectroscopy and luminescence spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation with the passage of time”, SM J Clin. Med. Imaging, 4 (1): 1018, 2018
Heidari, “Nuclear inelastic scattering spectroscopy (NISS) and nuclear inelastic absorption spectroscopy (NIAS) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Int J Pharm Sci, 2 (1): 1– 14, 2018
Heidari, “X–ray diffraction (XRD), powder x–ray diffraction (PXRD) and energy–dispersive x–ray diffraction (EDXRD) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, J Oncol Res; 2 (1): 1–14, 2018
Heidari, “Correlation two–dimensional nuclear magnetic resonance (NMR) (2D–NMR) (COSY) imaging and spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, EMS Can Sci, 1– 1–001, 2018
Heidari, “Thermal spectroscopy, photothermal spectroscopy, thermal microspectroscopy, photothermal microspectroscopy, thermal macrospectroscopy and photothermal macrospectroscopy comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, SM J Biometrics Biostat, 3 (1): 1024, 2018
Heidari, “A modern and comprehensive experimental biospectroscopic comparative study on human common cancers’ cells, tissues and tumors before and after synchrotron radiation therapy”, Open Acc J Oncol Med. 1 (1), 2018
Heidari, “Heteronuclear correlation experiments such as heteronuclear single– quantum correlation spectroscopy (HSQC), heteronuclear multiple–quantum correlation spectroscopy (HMQC) and heteronuclear multiple–bond correlation spectroscopy (HMBC) comparative study on malignant and benign human endocrinology and thyroid cancer cells and tissues under synchrotron radiation”, J Endocrinol Thyroid Res, 3 (1): 555603, 2018
Heidari, “Nuclear resonance vibrational spectroscopy (NRVS), nuclear inelastic scattering spectroscopy (NISS), nuclear inelastic absorption spectroscopy (NIAS) and nuclear resonant inelastic x–ray scattering spectroscopy (NRIXSS) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Int J Bioorg Chem Mol Biol. 6 (1e): 1–5, 2018
Heidari, “A novel and modern experimental approach to vibrational circular dichroism spectroscopy and video spectroscopy comparative study on malignant and benign human cancer cells and tissues with the passage of time under white and monochromatic synchrotron radiation”, Glob J Endocrinol Metab. 1 (3). GJEM. 000514– 000519, 2018
Heidari, “Pros and cons controversy on heteronuclear correlation experiments such as heteronuclear single–quantum correlation spectroscopy (HSQC), heteronuclear multiple–quantum correlation spectroscopy (HMQC) and heteronuclear multiple–bond correlation spectroscopy (HMBC) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, EMS Pharma J. 1 (1): 002–008, 2018
Heidari, “A modern comparative and comprehensive experimental biospectroscopic study on different types of infrared spectroscopy of malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, J Analyt Molecul Tech. 3 (1): 8, 2018
Heidari, “Investigation of cancer types using synchrotron technology for proton beam therapy: An experimental biospectroscopic comparative study”, European Modern Studies Journal, Vol. 2, No. 1, 13–29, 2018
Heidari, “Saturated spectroscopy and unsaturated spectroscopy comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, Imaging J Clin Medical Sci. 5 (1): 001–007, 2018
Heidari, “Small–angle neutron scattering (SANS) and wide–angle x–ray diffraction (WAXD) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Int J Bioorg Chem Mol Biol. 6 (2e): 1–6, 2018
Heidari, “Investigation of bladder cancer, breast cancer, colorectal cancer, endometrial cancer, kidney cancer, leukemia, liver, lung cancer, melanoma, non–hodgkin lymphoma, pancreatic cancer, prostate cancer, thyroid cancer and non–melanoma skin cancer using synchrotron technology for proton beam therapy: An experimental biospectroscopic comparative study”, Ther Res Skin Dis 1 (1), 2018
Heidari, “Attenuated total reflectance fourier transform infrared (ATR–FTIR) spectroscopy, micro–attenuated total reflectance fourier transform infrared (micro–ATR– FTIR) spectroscopy and macro–attenuated total reflectance fourier transform infrared (macro–ATR–FTIR) spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation with the passage of time”, International Journal of Chemistry Papers, 2 (1): 1–12, 2018
Heidari, “Mössbauer spectroscopy, Mössbauer emission spectroscopy and 57Fe Mössbauer spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Acta Scientific Cancer Biology 2.3: 17–20, 2018
Heidari, “Comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation with the passage of time”, Organic & Medicinal Chem IJ. 6 (1): 555676, 2018
Heidari, “Correlation spectroscopy, exclusive correlation spectroscopy and total correlation spectroscopy comparative study on malignant and benign human aids–related cancers cells and tissues with the passage of time under synchrotron radiation”, Int J Bioanal Biomed. 2 (1): 001–007, 2018
Heidari, “Biomedical instrumentation and applications of biospectroscopic methods and techniques in malignant and benign human cancer cells and tissues studies under synchrotron radiation and anti–cancer nano drugs delivery”, Am J Nanotechnol Nanomed. 1 (1): 001–009, 2018
Heidari, “Vivo 1H or proton NMR, 13C NMR, 15N NMR and 31P NMR spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Ann Biomet Biostat. 1 (1): 1001, 2018
Heidari, “Grazing–incidence small–angle neutron scattering (GISANS) and grazing–incidence x–ray diffraction (GIXD) comparative study on malignant and benign human cancer cells, tissues and tumors under synchrotron radiation”, Ann Cardiovasc Surg. 1 (2): 1006, 2018
Heidari, “Adsorption isotherms and kinetics of multi–walled carbon nanotubes (MWCNTs), boron nitride nanotubes (BNNTs), amorphous boron nitride nanotubes (a– BNNTs) and hexagonal boron nitride nanotubes (h–BNNTs) for eliminating carcinoma, sarcoma, lymphoma, leukemia, germ cell tumor and blastoma cancer cells and tissues”, Clin Med Rev Case Rep 5: 201, 2018
Heidari, “Correlation spectroscopy (COSY), exclusive correlation spectroscopy (ECOSY), total correlation spectroscopy (TOCSY), incredible natural–abundance double–quantum transfer experiment (INADEQUATE), heteronuclear single–quantum correlation spectroscopy (HSQC), heteronuclear multiple–bond correlation spectroscopy (HMBC), nuclear overhauser effect spectroscopy (NOESY) and rotating frame nuclear overhauser effect spectroscopy (ROESY) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Acta Scientific Pharmaceutical Sciences 2.5: 30–35, 2018
Heidari, “Small–angle x–ray scattering (SAXS), ultra–small angle x–ray scattering (USAXS), fluctuation x–ray scattering (FXS), wide–angle x–ray scattering (WAXS), grazing–incidence small–angle x–ray scattering (GISAXS), grazing–incidence wide–angle x–Ray scattering (GIWAXS), small–angle neutron scattering (SANS), grazing–incidence small–angle neutron scattering (GISANS), x–ray diffraction (XRD), powder x–ray diffraction (PXRD), wide–angle x–ray diffraction (WAXD), grazing– incidence x–ray diffraction (GIXD) and energy–dispersive x–ray diffraction (EDXRD) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Oncol Res Rev, Volume 1 (1): 1–10, 2018
Heidari, “Pump–probe spectroscopy and transient grating spectroscopy comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, Adv Material Sci Engg, Volume 2, Issue 1, Pages 1–7, 2018
Heidari, “Grazing–incidence small–angle x–ray scattering (GISAXS) and grazing–incidence wide–angle x–ray scattering (GIWAXS) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Insights Pharmacol Pharm Sci 1 (1): 1–8, 2018
Heidari, “Acoustic spectroscopy, acoustic resonance spectroscopy and auger spectroscopy comparative study on anti–cancer nano drugs delivery in malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, Nanosci Technol 5 (1): 1–9, 2018
Heidari, “Niobium, technetium, ruthenium, rhodium, hafnium, rhenium, osmium and iridium ions incorporation into the nano polymeric matrix (NPM) by immersion of the nano polymeric modified electrode (NPME) as molecular enzymes and drug targets for human cancer cells, tissues and tumors treatment under synchrotron and synchrocyclotron radiations”, Nanomed Nanotechnol, 3 (2): 000138, 2018
Heidari, “Homonuclear correlation experiments such as homonuclear single– quantum correlation spectroscopy (HSQC), homonuclear multiple–quantum correlation spectroscopy (HMQC) and homonuclear multiple–bond correlation spectroscopy (HMBC) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Austin J Proteomics Bioinform & Genomics. 5 (1): 1024, 2018
Heidari, “Atomic force microscopy based infrared (AFM–IR) spectroscopy and nuclear resonance vibrational spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation with the passage of time”, J Appl Biotechnol Bioeng. 5 (3): 142‒148, 2018.
Heidari, “Time–dependent vibrational spectral analysis of malignant and benign human cancer cells and tissues under synchrotron radiation”, J Cancer Oncol, 2 (2): 000124, 2018
Heidari, “Palauamine and olympiadane nano molecules incorporation into the nano polymeric matrix (NPM) by immersion of the nano polymeric modified electrode (NPME) as molecular enzymes and drug targets for human cancer cells, tissues and tumors treatment under synchrotron and synchrocyclotron radiations”, Arc Org Inorg Chem Sci 3 (1), 2018
R. Gobato, A. Heidari, “Infrared spectrum and sites of action of sanguinarine by molecular mechanics and ab initio methods”, International Journal of Atmospheric and Oceanic Sciences. Vol. 2, No. 1, pp. 1–9, 2018
Heidari, “Angelic acid, diabolic acids, draculin and miraculin nano molecules incorporation into the nano polymeric matrix (NPM) by immersion of the nano polymeric modified electrode (NPME) as molecular enzymes and drug targets for human cancer cells, tissues and tumors treatment under synchrotron and synchrocyclotron radiations”, Med & Analy Chem Int J, 2 (1): 000111, 2018
Heidari, “Gamma linolenic methyl ester, 5–heptadeca–5,8,11–trienyl 1,3,4– oxadiazole–2–thiol, sulphoquinovosyl diacyl glycerol, ruscogenin, nocturnoside B, protodioscine B, parquisoside–B, leiocarposide, narangenin, 7–methoxy hespertin, lupeol, rosemariquinone, rosmanol and rosemadiol nano molecules incorporation into the nano polymeric matrix (NPM) by immersion of the nano polymeric modified electrode (NPME) as molecular enzymes and drug targets for human cancer cells, tissues and tumors treatment under synchrotron and synchrocyclotron radiations”, Int J Pharma Anal Acta, 2 (1): 007–014, 2018
Heidari, “Fourier transform infrared (FTIR) spectroscopy, attenuated total reflectance fourier transform infrared (ATR–FTIR) spectroscopy, micro–attenuated total reflectance fourier transform infrared (Micro–ATR–FTIR) spectroscopy, macro– attenuated total reflectance fourier transform infrared (Macro–ATR–FTIR) spectroscopy, two–dimensional infrared correlation spectroscopy, linear two–dimensional infrared spectroscopy, non–linear two–dimensional infrared spectroscopy, atomic force microscopy based infrared (AFM–IR) spectroscopy, infrared photodissociation spectroscopy, infrared correlation table spectroscopy, near–infrared spectroscopy (NIRS), mid–infrared spectroscopy (MIRS), nuclear resonance vibrational spectroscopy, thermal infrared spectroscopy and photothermal infrared spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation with the passage of time”, Glob Imaging Insights, Volume 3 (2): 1–14, 2018
Heidari, “Heteronuclear single–quantum correlation spectroscopy (HSQC) and heteronuclear multiple–bond correlation spectroscopy (HMBC) comparative study on malignant and benign human cancer cells, tissues and tumors under synchrotron and synchrocyclotron radiations”, Chronicle of Medicine and Surgery 2.3: 144–156, 2018
Heidari, “Tetrakis [3, 5–bis (trifluoromethyl) phenyl] borate (BARF)–enhanced precatalyst preparation stabilization and initiation (EPPSI) nano molecules”, Medical Research and Clinical Case Reports 2.1: 113–126, 2018
Heidari, “Sydnone, münchnone, montréalone, mogone, montelukast, quebecol and palau’amine–enhanced precatalyst preparation stabilization and initiation (EPPSI) nano molecules”, Sur Cas Stud Op Acc J. 1 (3), 2018
Heidari, “Fornacite, orotic acid, rhamnetin, sodium ethyl xanthate (SEX) and spermine (spermidine or polyamine) nanomolecules incorporation into the nanopolymeric matrix (NPM)”, International Journal of Biochemistry and Biomolecules, Vol. 4: Issue 1, Pages 1–19, 2018
Heidari, R. Gobato, “Putrescine, cadaverine, spermine and spermidine– enhanced precatalyst preparation stabilization and initiation (EPPSI) nano molecules”, Parana Journal of Science and Education (PJSE)–v.4, n.5, (1–14) July 1, 2018
Heidari, “Cadaverine (1,5–pentanediamine or pentamethylenediamine), diethyl azodicarboxylate (DEAD or DEADCAT) and putrescine (tetramethylenediamine) nano molecules incorporation into the nano polymeric matrix (NPM) by immersion of the nano polymeric modified electrode (NPME) as molecular enzymes and drug targets for human cancer cells, tissues and tumors treatment under synchrotron and synchrocyclotron radiations”, Hiv and Sexual Health Open Access Open Journal. 1 (1): 4–11, 2018
Heidari, “Improving the performance of nano–endofullerenes in polyaniline nanostructure–based biosensors by covering californium colloidal nanoparticles with multi–walled carbon nanotubes”, Journal of Advances in Nanomaterials, Vol. 3, No. 1, Pages 1–28, 2018
R. Gobato, A. Heidari, “Molecular mechanics and quantum chemical study on sites of action of sanguinarine using vibrational spectroscopy based on molecular mechanics and quantum chemical calculations”, Malaysian Journal of Chemistry, Vol. 20 (1), 1–23, 2018
Heidari, “Vibrational biospectroscopic studies on anti–cancer nanopharmaceuticals (Part I)”, Malaysian Journal of Chemistry, Vol. 20 (1), 33–73, 2018
Heidari, “Vibrational biospectroscopic studies on anti–cancer nanopharmaceuticals (Part II)”, Malaysian Journal of Chemistry, Vol. 20 (1), 74–117, 2018
Heidari, “Uranocene (U(C8H8)2) and bis(cyclooctatetraene)iron (Fe(C8H8)2 or Fe(COT)2)–enhanced precatalyst preparation stabilization and initiation (EPPSI) nano molecules”, Chemistry Reports, Vol. 1, Iss. 2, Pages 1–16, 2018
Heidari, “Biomedical systematic and emerging technological study on human malignant and benign cancer cells and tissues biospectroscopic analysis under synchrotron radiation”, Glob Imaging Insights, Volume 3 (3): 1–7, 2018
Heidari, “Deep–level transient spectroscopy and x–ray photoelectron spectroscopy (XPS) comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, Res Dev Material Sci. 7(2). RDMS.000659, 2018
Heidari, “C70–carboxyfullerenes nano molecules incorporation into the nano polymeric matrix (NPM) by immersion of the nano polymeric modified electrode (NPME) as molecular enzymes and drug targets for human cancer cells, tissues and tumors treatment under synchrotron and synchrocyclotron radiations”, Glob Imaging Insights, Volume 3 (3): 1–7, 2018
Heidari, “The effect of temperature on cadmium oxide (CdO) nanoparticles produced by synchrotron radiation in the human cancer cells, tissues and tumors”, International Journal of Advanced Chemistry, 6 (2) 140–156, 2018
Heidari, N. Heidari, M. Ghorbani, “A new approach to gold nanoparticles synthesis using l–alanine and stabilizing them by chitosan”, Quantum Matter. 1 (2), 149–152, 2012
Heidari, N. Heidari, M. Ghorbani, “A density functional theory approach to investigating lattice dynamics in La2−xBaxCuO4 superconductor: A density functional theory study”, Quantum Matter. 1 (1), 86–88, 2012
Heidari, “A clinical and molecular pathology investigation of correlation spectroscopy (COSY), exclusive correlation spectroscopy (ECOSY), total correlation spectroscopy (TOCSY), heteronuclear single–quantum correlation spectroscopy (HSQC) and heteronuclear multiple–bond correlation spectroscopy (HMBC) comparative study on malignant and benign human cancer cells, tissues and tumors under synchrotron and synchrocyclotron radiations using cyclotron versus synchrotron, synchrocyclotron and the large hadron collider (LHC) for delivery of proton and helium ion (charged particle) beams for oncology radiotherapy”, European Journal of Advances in Engineering and Technology, 5 (7): 414–426, 2018
Heidari, “Nano molecules incorporation into the nano polymeric matrix (NPM) by immersion of the nano polymeric modified electrode (NPME) as molecular enzymes and drug targets for human cancer cells, tissues and tumors treatment under synchrotron and synchrocyclotron radiations”, J Oncol Res; 1 (1): 1–20, 2018
Heidari, “Use of molecular enzymes in the treatment of chronic disorders”, Canc Oncol Open Access J. 1 (1): 12–15, 2018
Heidari, “Vibrational biospectroscopic study and chemical structure analysis of unsaturated polyamides nanoparticles as anti–cancer polymeric nanomedicines using synchrotron radiation”, International Journal of Advanced Chemistry, 6 (2), 167– 189, 2018
Heidari, “Adamantane, irene, naftazone and pyridine–enhanced precatalyst preparation stabilization and initiation (PEPPSI) nano molecules”, Madridge J Nov Drug Res. 2 (1): 61–67, 2018
Heidari, “Heteronuclear single–quantum correlation spectroscopy (HSQC) and heteronuclear multiple–bond correlation spectroscopy (HMBC) comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, Madridge J Nov Drug Res, 2 (1): 68–74, 2018
Heidari, R. Gobato, “A novel approach to reduce toxicities and to improve bioavailabilities of DNA/RNA of human cancer cells–containing cocaine (coke), lysergide (lysergic acid diethyl amide or LSD), Δ⁹–tetrahydrocannabinol (THC) [(–)– trans–Δ⁹– tetrahydrocannabinol], theobromine (xantheose), caffeine, aspartame (APM) (nutraSweet) and zidovudine (ZDV) [azidothymidine (AZT)] as anti–cancer nano drugs by coassembly of dual anti–cancer nano drugs to inhibit DNA/RNA of human cancer cells drug resistance”, Parana Journal of Science and Education (PJSE), v. 4, n. 6, pp. 1–17, 2018
Heidari, R. Gobato, “Ultraviolet photoelectron spectroscopy (UPS) and ultraviolet–visible (UV–Vis) spectroscopy comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, Parana Journal of Science and Education (PJSE), v. 4, n. 6, pp. 18–33, 2018
R. Gobato, A. Heidari, A. Mitra, “The creation of C13H20BeLi2SeSi. The proposal of a bio–inorganic molecule, using ab initio methods for the genesis of a nano membrane”, Arc Org Inorg Chem Sci 3 (4). AOICS.MS.ID.000167, 2018
R. Gobato, A. Heidari, “Using the quantum chemistry for genesis of a nano biomembrane with a combination of the elements Be, Li, Se, Si, C and H”, J Nanomed Res.7 (4): 241‒252, 2018
Heidari, “Bastadins and bastaranes–enhanced precatalyst preparation stabilization and initiation (EPPSI) nano molecules”, Glob Imaging Insights, Volume 3 (4): 1–7, 2018
Heidari, “Fucitol, pterodactyladiene, DEAD or DEADCAT (DiEthyl AzoDiCArboxylaTe), skatole, the nanoputians, thebacon, pikachurin, tie fighter, spermidine and mirasorvone nano molecules incorporation into the nano polymeric matrix (NPM) by immersion of the nano polymeric modified electrode (NPME) as molecular enzymes and drug targets for human cancer cells, tissues and tumors treatment under synchrotron and synchrocyclotron radiations”, Glob Imaging Insights, Volume 3 (4): 1–8, 2018
Dadvar, A. Heidari, “A review on separation techniques of graphene oxide (GO)/base on hybrid polymer membranes for eradication of dyes and oil compounds: Recent progress in graphene oxide (GO)/base on polymer membranes–related nanotechnologies”, Clin Med Rev Case Rep 5: 228, 2018
Heidari, R. Gobato, “First–time simulation of deoxyuridine monophosphate (dUMP) (deoxyuridylic acid or deoxyuridylate) and vomitoxin (deoxynivalenol (DON)) ((3α,7α)–3,7,15–trihydroxy–12,13–epoxytrichothec–9–en–8–one)–enhanced precatalyst preparation stabilization and initiation (EPPSI) nano molecules incorporation into the nano polymeric matrix (NPM) by immersion of the nano polymeric modified electrode (NPME) as molecular enzymes and drug targets for human cancer cells, tissues and tumors treatment under synchrotron and synchrocyclotron radiations”, Parana Journal of Science and Education (PJSE), Vol. 4, No. 6, pp. 46–67, 2018
Heidari, “Buckminsterfullerene (Fullerene), bullvalene, dickite and josiphos ligands nano molecules incorporation into the nano polymeric matrix (NPM) by immersion of the nano polymeric modified electrode (NPME) as molecular enzymes and drug targets for human hematology and thromboembolic diseases prevention, diagnosis and treatment under synchrotron and synchrocyclotron radiations”, Glob Imaging Insights, Volume 3 (4): 1–7, 2018
Heidari, “Fluctuation x–ray scattering (FXS) and wide–angle x–ray scattering (WAXS) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Glob Imaging Insights, Volume 3 (4): 1–7, 2018
Heidari, “A novel approach to correlation spectroscopy (COSY), exclusive correlation spectroscopy (ECOSY), total correlation spectroscopy (TOCSY), incredible natural–abundance double–quantum transfer experiment (INADEQUATE), heteronuclear single–quantum correlation spectroscopy (HSQC), heteronuclear multiple–bond correlation spectroscopy (HMBC), nuclear overhauser effect spectroscopy (NOESY) and rotating frame nuclear overhauser effect spectroscopy (ROESY) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Glob Imaging Insights, Volume 3 (5): 1–9, 2018
Heidari, “Terphenyl–based reversible receptor with rhodamine, rhodamine–based molecular probe, rhodamine–based using the spirolactam ring opening, rhodamine B with ferrocene substituent, calix[4]arene–based receptor, thioether + aniline–derived ligand framework linked to a fluorescein platform, mercuryfluor–1 (flourescent probe), N,N’–dibenzyl– 1,4,10,13–tetraraoxa–7,16–diazacyclooctadecane and terphenyl–based reversible receptor with pyrene and quinoline as the fluorophores–enhanced precatalyst preparation stabilization and initiation (EPPSI) nano molecules”, Glob Imaging Insights, Volume 3 (5): 1–9, 2018
Heidari, “Small–angle x–ray scattering (SAXS), ultra–small angle x–ray scattering (USAXS), fluctuation x–ray scattering (FXS), wide–angle x–ray scattering (WAXS), grazing– incidence small–angle x–ray scattering (GISAXS), grazing–incidence wide–angle x–ray scattering (GIWAXS), small–angle neutron scattering (SANS), grazing–incidence small–angle neutron scattering (GISANS), x–ray diffraction (XRD), powder x–ray diffraction (PXRD), wide– angle x–ray diffraction (WAXD), grazing–incidence x–ray diffraction (GIXD) and energy– dispersive x–ray diffraction (EDXRD) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Glob Imaging Insights, Volume 3 (5): 1–10, 2018
Heidari, “Nuclear resonant inelastic x–ray scattering spectroscopy (NRIXSS) and nuclear resonance vibrational spectroscopy (NRVS) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Glob Imaging Insights, Volume 3 (5): 1–7, 2018
Heidari, “Small–angle x–ray scattering (SAXS) and ultra–small angle x–ray scattering (USAXS) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Glob Imaging Insights, Volume 3 (5): 1–7, 2018
Heidari, “Curious chloride (CmCl3) and titanic chloride (TiCl4)–enhanced precatalyst preparation stabilization and initiation (EPPSI) nano molecules for cancer treatment and cellular therapeutics”, J. Cancer Research and Therapeutic Interventions, Volume 1, Issue 1, Pages 01–10, 2018
R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Spectroscopy and dipole moment of the molecule C13H20BeLi2SeSi via quantum chemistry using ab initio, hartree– fock method in the base set CC–pVTZ and 6–311G**(3df, 3pd)”, Arc Org Inorg Chem Sci 3 (5), Pages 402–409, 2018
Heidari, “C60 and C70–encapsulating carbon nanotubes incorporation into the nano polymeric matrix (npm) by immersion of the nano polymeric modified electrode (npme) as molecular enzymes and drug targets for human cancer cells, tissues and tumors treatment under synchrotron and synchrocyclotron radiations”, Integr Mol Med, Volume 5 (3): 1–8, 2018
Heidari, “Two–dimensional (2D) 1H or proton nmr, 13C nmr, 15N nmr and 31P nmr spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation with the passage of time”, Glob Imaging Insights, Volume 3 (6): 1–8, 2018
Heidari, “FT–raman spectroscopy, coherent anti–stokes raman spectroscopy (CARS) and raman optical activity spectroscopy (ROAS) comparative study on malignant and benign human cancer cells and tissues with the passage of time under synchrotron radiation”, Glob Imaging Insights, Volume 3 (6): 1–8. 2018
Heidari, “A modern and comprehensive investigation of inelastic electron tunneling spectroscopy (IETS) and scanning tunneling spectroscopy on malignant and benign human cancer cells, tissues and tumors through optimizing synchrotron microbeam radiotherapy for human cancer treatments and diagnostics: An experimental biospectroscopic comparative study”, Glob Imaging Insights, Volume 3 (6): 1–8. 2018
Heidari, “A hypertension approach to thermal infrared spectroscopy and photothermal infrared spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation with the passage of time”, Glob Imaging Insights, Volume 3 (6): 1–8. 2018
Heidari, “Incredible natural–abundance double–quantum transfer experiment (INADEQUATE), nuclear overhauser effect spectroscopy (NOESY) and rotating frame nuclear overhauser effect spectroscopy (ROESY) comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Glob Imaging Insights, Volume 3 (6): 1–8. 2018
Heidari, “2–amino–9–((1S, 3R, 4R)–4–hydroxy–3–(hydroxymethyl)–2– methylenecyclopentyl)–1H–purin–6(9H)–one, 2–amino–9–((1R, 3R, 4R)–4–hydroxy–3– (hydroxymethyl)–2–methylenecyclopentyl)–1H–purin–6(9H)–one, 2–amino–9–((1R, 3R, 4S)–4–hydroxy–3–(hydroxymethyl)–2–methylenecyclopentyl)–1H–purin–6(9H)–One and 2–amino–9–((1S, 3R, 4S)–4–hydroxy–3–(hydroxymethyl)–2– methylenecyclopentyl)–1H– purin–6(9H)–one–enhanced precatalyst preparation stabilization and initiation nano molecules”, Glob Imaging Insights, Volume 3 (6): 1–9. 2018
R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Spectroscopy and dipole moment of the molecule C13H20BeLi2SeSi via quantum chemistry using ab initio, hartree– fock method in the base set CC–pVTZ and 6–311G**(3df, 3pd)”, American Journal of Quantum Chemistry and Molecular Spectroscopy, Vol. 2, No. 1, pp. 9–17, 2018
Heidari, “Production of electrochemiluminescence (ECL) biosensor using Os– Pd/HfC nanocomposites for detecting and tracking of human gastroenterological cancer cells, tissues and tumors”, Int J Med Nano Res 5: 1, 022–034, 2018
Heidari, “Enhancing the Raman scattering for diagnosis and treatment of human cancer cells, tissues and tumors using cadmium oxide (CdO) nanoparticles”, J Toxicol Risk Assess 4: 1, 012–025, 2018
Heidari, “Human malignant and benign human cancer cells and tissues biospectroscopic analysis under synchrotron radiation using anti–cancer nano drugs delivery”, Integr Mol Med, Volume 5 (5): 1–13, 2018
Heidari, “Analogous nano compounds of the form M(C8H8)2 exist for M = (Nd, Tb, Pu, Pa, Np, Th, and Yb)–enhanced precatalyst preparation stabilization and initiation (EPPSI) nano molecules”, Integr Mol Med, Volume 5 (5): 1–8, 2018
Heidari, “Hadron spectroscopy, baryon spectroscopy and meson spectroscopy comparative study on malignant and benign human cancer cells and tissues under synchrotron radiation”, Integr Mol Med, Volume 5 (5): 1–8, 2018
R. Gobato, M. R. R. Gobato, A. Heidari, “Raman spectroscopy study of the nano molecule C13H20BeLi2SeSi using ab initio and hartree–fock methods in the basis set CC– pVTZ and 6–311G** (3df, 3pd)”, International Journal of Advanced Engineering and Science, Volume 7, Number 1, Pages 14–35, 2019
Heidari, R. Gobato, “Evaluating the effect of anti–cancer nano drugs dosage and reduced leukemia and polycythemia vera levels on trend of the human blood and bone marrow cancers under synchrotron radiation”, Trends in Res, Volume 2 (1): 1–8, 2019
Heidari, R. Gobato, “Assessing the variety of synchrotron, synchrocyclotron and laser radiations and their roles and applications in human cancer cells, tissues and tumors diagnosis and treatment”, Trends in Res, Volume 2 (1): 1–8, 2019
Heidari, R. Gobato, “Pros and cons controversy on malignant human cancer cells, tissues and tumors transformation process to benign human cancer cells, tissues and tumors”, Trends in Res, Volume 2 (1): 1–8, 2019
Heidari, R. Gobato, “Three–dimensional (3D) simulations of human cancer cells, tissues and tumors for using in human cancer cells, tissues and tumors diagnosis and treatment as a powerful tool in human cancer cells, tissues and tumors research and anti–cancer nano drugs sensitivity and delivery area discovery and evaluation”, Trends in Res, Volume 2 (1): 1–8, 2019
Heidari, R. Gobato, “Investigation of energy production by synchrotron, synchrocyclotron and laser radiations in human cancer cells, tissues and tumors and evaluation of their effective on human cancer cells, tissues and tumors treatment trend”, Trends in Res, Volume 2 (1): 1–8, 2019
Heidari, R. Gobato, “High–resolution mapping of DNA/RNA hypermethylation and hypomethylation process in human cancer cells, tissues and tumors under synchrotron radiation”, Trends in Res, Volume 2 (2): 1–9, 2019
Heidari, “A novel and comprehensive study on manufacturing and fabrication nanoparticles methods and techniques for processing cadmium oxide (CdO) nanoparticles colloidal solution”, Glob Imaging Insights, Volume 4 (1): 1–8, 2019
Heidari, “A combined experimental and computational study on the catalytic effect of aluminum nitride nanocrystal (AlN) on the polymerization of benzene, naphthalene, anthracene, phenanthrene, chrysene and tetracene”, Glob Imaging Insights, Volume 4 (1): 1–8, 2019
Heidari, “Novel experimental and three–dimensional (3D) multiphysics computational framework of michaelis–menten kinetics for catalyst processes innovation, characterization and carrier applications”, Glob Imaging Insights, Volume 4 (1): 1–8, 2019
Heidari, “The hydrolysis constants of copper (I) (Cu+) and copper (II) (Cu2+) in aqueous solution as a function of pH using a combination of pH measurement and biospectroscopic methods and techniques”, Glob Imaging Insights, Volume 4 (1): 1–8, 2019
Heidari, “Vibrational biospectroscopic study of ginormous virus–sized macromolecule and polypeptide macromolecule as mega macromolecules using attenuated total reflectance–fourier transform infrared (ATR–FTIR) spectroscopy and mathematica 11.3”, Glob Imaging Insights, Volume 4 (1): 1–8, 2019
Heidari, “Three–dimensional (3D) imaging spectroscopy of carcinoma, sarcoma, leukemia, lymphoma, multiple myeloma, melanoma, brain and spinal cord tumors, germ cell tumors, neuroendocrine tumors and carcinoid tumors under synchrotron radiation”, Glob Imaging Insights, Volume 4 (1): 1–9, 2019
R. Gobato, M. R. R. Gobato, A. Heidari, “Storm vortex in the center of Paraná state on June 6, 2017: A case study”, Sumerianz Journal of Scientific Research, Vol. 2, No. 2, Pages 24–31, 2019
R. Gobato, M. R. R. Gobato, A. Heidari, “Attenuated total reflection–fourier transform infrared (ATR–FTIR) spectroscopy study of the nano molecule C13H20BeLi2SeSi using ab initio and hartree–fock methods in the basis set RHF/CC–pVTZ and RHF/6–311G** (3df, 3pd): An experimental challenge to chemists”, Chemistry Reports, Vol. 2, No. 1, Pages 1–26, 2019
Heidari, “Three–Dimensional (3D) Imaging Spectroscopy of Carcinoma, Sarcoma, Leukemia, Lymphoma, Multiple Myeloma, Melanoma, Brain and Spinal Cord Tumors, Germ Cell Tumors, Neuroendocrine Tumors and Carcinoid Tumors under Synchrocyclotron Radiation”, Res Adv Biomed Sci Technol 1 (1): 01–17, 2019
R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “New Nano–Molecule Kurumi– C13H20BeLi2SeSi/C13H19BeLi2SeSi, and Raman Spectroscopy Using ab initio, Hartree– Fock Method in the Base Set CC–pVTZ and 6–311G** (3df, 3pd)”, J Anal Pharm Res. 8 (1): 1‒6, 2019
Heidari, J. Esposito, A. Caissutti, “The importance of attenuated total reflectance Fourier transform infrared (ATR–FTIR) and Raman biospectroscopy of single–walled carbon nanotubes (SWCNT) and multi–walled carbon nanotubes (MWCNT) in interpreting infrared and Raman spectra of human cancer cells, tissues and tumors”, Oncogen 2 (2): 1–21, 2019
Heidari, “Mechanism of action and their side effects at a glance prevention, treatment and management of immune system and human cancer nano chemotherapy”, Nanosci Technol 6 (1): 1–4, 2019
Heidari, J. Esposito, A. Caissutti, “The quantum entanglement dynamics induced by non–linear interaction between a moving nano molecule and a two–mode field with two–photon transitions using reduced Von Neumann entropy and Jaynes– Cummings model for human cancer cells, tissues and tumors diagnosis”, Int J Crit Care Emerg Med 5 (2): 071–084, 2019
Heidari, J. Esposito, A. Caissutti, “Palytoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, J Pharm Drug Res, 3 (1): 150–170, 2019
Heidari, J. Esposito, A. Caissutti, “Aplysiatoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, J Chem Sci Eng, 2 (2): 70–89, 2019
Heidari, J. Esposito, A. Caissutti, “Cyanotoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Br J Med Health Res. 6 (04): 21–60, 2019
Heidari, “Potential and theranostics applications of novel anti–cancer nano drugs delivery systems in preparing for clinical trials of synchrotron microbeam radiation therapy (SMRT) and synchrotron stereotactic radiotherapy (SSRT) for treatment of human cancer cells, tissues and tumors using image guided synchrotron radiotherapy (IGSR)”, Ann Nanosci Nanotechnol. 3 (1): 1006–1019, 2019
Heidari, J. Esposito, A. Caissutti, “Study of anti–cancer properties of thin layers of cadmium oxide (CdO) nanostructure”, Int J Analyt Bioanalyt Methods 1 (1): 003–022, 2019
Heidari, J. Esposito, A. Caissutti, “Alpha–conotoxin, omega–conotoxin and mu–conotoxin time–resolved aAbsorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, International Journal of Advanced Chemistry, 7 (1) 52–66, 2019
Heidari, “Clinical and medical pros and cons of human cancer cells’ enzymotherapy, immunotherapy, chemotherapy, radiotherapy, hormone therapy and targeted therapy process under synchrotron radiation: A case study on mechanism of action and their side effects”, Parana Journal of Science and Education (PJSE)–v. 5, n. 3, (1–23) May 2, 2019
Heidari, “The importance of the power in CMOS inverter circuit of synchrotron and synchrocyclotron radiations using 50 (nm) and 100 (nm) technologies and reducing the voltage of power supply”, Radiother Oncol Int. 1 (1): 1002–1015, 2019
Heidari, J. Esposito, A. Caissutti, “The importance of quantum hydrodynamics (QHD) approach to single–walled carbon nanotubes (SWCNT) and multi–walled carbon nanotubes (MWCNT) in genetic science”, SCIOL Genet Sci. 2 (1): 113–129, 2019
Heidari, J. Esposito, A. Caissutti, “Anatoxin–a and anatoxin–a(s) time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Saudi J Biomed Res, 4 (4): 174–194, 2019
R. Gobato, M. R. R. Gobato, A. Heidari, “Evidence of tornado storm hit the counties of Rio Branco do Ivaí and Rosario de Ivaí, Southern Brazil”, Sci Lett. 7 (1): 32– 40, 2019
M. Jeyaraj, V. Mahalingam, A. Indhuleka, P. Sennu, M. S. Ho, A. Heidari, “Chemical analysis of surface water quality of river noyyal connected tank in tirupur district, tamil nadu, India”, Water and Energy International, Volume 62r, Issue 1, pp. 63– 68, 2019
Heidari, J. Esposito, A. Caissutti, “6–methoxy–8–[[6–methoxy–8–[[6–methoxy– 2–methyl–1–(2–methylpropyl)–3,4–dihydro–1H–isoquinolin–7–yl]oxy]–2–methyl–1–(2– methylpropyl)–3,4–dihydro–1H–isoquinolin–7–yl]oxy]–2–methyl–1–(2–methylpropyl)– 3,4–dihydro–1H–isoquinolin–7–ol time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic– mode coupling structure in vibrational spectra analysis”, J. Adv. Phys. Chem., Volume 1, Issue 1, pp. 1–6, 2019
Heidari, J. Esposito, A. Caissutti, “Shiga toxin and shiga–like toxin (SLT) time– resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Annal Biostat & Biomed Appli. 2 (3): 1–4, 2019
Heidari, J. Esposito, A. Caissutti, “Alpha–bungarotoxin, beta–bungarotoxin and kappa–bungarotoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Archives of Pharmacology and Pharmaceutical Sciences, ReDelve, Volume 2019, Issue 01, pp. 1–24, 2019
Heidari, J. Esposito, A. Caissutti, “Okadaic acid time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Int J Analyt Bioanalyt Methods 1 (1): 1–19, 2019
Heidari, “Investigation of the processes of absorption, distribution, metabolism and elimination (ADME) as vital and important factors for modulating drug action and toxicity”, Open Access J Oncol, 2 (1): 180010–180012, 2019
Heidari, J. Esposito, A. Caissutti, “Pertussis toxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Chemistry Reports, Vol. 1 Iss. 2, Pages 1–5, 2019
R. Gobato, M. R. R. Gobato, A. Heidari, “Rhodochrosite as crystal oscillator”, Am J Biomed Sci & Res. 3 (2), 187, 2019
Heidari, J. Esposito, A. Caissutti, “Tetrodotoxin (TTX) time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Journal of New Developments in Chemistry, Volume No: 2, Issue No: 3, Page Numbers 26–48, 2019
Heidari, J. Esposito, A. Caissutti, “The importance of analysis of vibronic– mode coupling structure in vibrational spectra of supramolecular aggregates of (CA*M) cyanuric acid (CA) and melamine (M) beyond the Franck–Condon approximation”, Journal of Clinical and Medical Images, 2 (2): 1–20, 2019
Heidari, J. Esposito, A. Caissutti, “Microcystin–LR time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Malaysian Journal of Chemistry, Vol. 21 (1), 70–95, 2019
Heidari, J. Esposito, A. Caissutti, “Botulinum toxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Journal of Mechanical Design and Vibration, vol. 7, no. 1: 1–15, 2019
Heidari, J. Esposito, A. Caissutti, "Domoic acid (DA) time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis", Cientific Clinical Oncology Journal 1. 2: 03–07, 2019
Heidari, J. Esposito, A. Caissutti, "Surugatoxin (SGTX) time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis", Cientific Clinical Oncology Journal 1. 2: 14–18, 2019
Heidari, J. Esposito, A. Caissutti, "Decarbamoylsaxitoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis", Cientific Clinical Oncology Journal 1. 2: 19–23, 2019
Heidari, J. Esposito, A. Caissutti, "Gonyautoxin (GTX) time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis", Cientific Clinical Oncology Journal 1. 2: 24–28, 2019
Heidari, J. Esposito, A. Caissutti, "Hislrionicotoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis", Cientific Drug Delivery Research 1. 1: 01–06, 2019
Heidari, J. Esposito, A. Caissutti, "Dihydrokainic acid time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis", Cientific Drug Delivery Research 1. 1: 07–12, 2019
Heidari, J. Esposito, A. Caissutti, "Aflatoxin B1 (AFB1), B2 (AFB2), G1 (AFG1), G2 (AFG2), M1 (AFM1), M2 (AFM2), Q1 (AFQ1) and P1 (AFP1) time– resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis", Cientific Drug Delivery Research 1. 1: 25–32, 2019
Heidari, J. Esposito, A. Caissutti, "Mycotoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis", Cientific Drug Delivery Research 1. 1: 13–18, 2019
Heidari, J. Esposito, A. Caissutti, "Bufotoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis", Cientific Drug Delivery Research 1. 1: 19–24, 2019
Heidari, J. Esposito, A. Caissutti, "Kainic acid (kainite) time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis", Cientific Journal of Neurology 1. 2: 02–07, 2019
Heidari, J. Esposito, A. Caissutti, "Nereistoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis", Cientific Journal of Neurology 1. 2: 19–24, 2019
Heidari, J. Esposito, A. Caissutti, “Spider toxin and raventoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Parana Journal of Science and Education (PJSE). Vol. 5, No. 4, pp. 1–28, 2019
Heidari, J. Esposito, A. Caissutti, “Ochratoxin A, Ochratoxin B, Ochratoxin C, Ochratoxin α and Ochratoxin TA time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic– mode coupling structure in vibrational spectra analysis", Cientific Drug Delivery Research 1. 2: 03–10, 2019
Heidari, J. Esposito, A. Caissutti, “Brevetoxin A and B time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis", Cientific Drug Delivery Research 1. 2: 11–16, 2019
Heidari, J. Esposito, A. Caissutti, “Lyngbyatoxin–a time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis", Cientific Drug Delivery Research 1. 2: 23–28, 2019
Heidari, J. Esposito, A. Caissutti, “Balraechotoxin (BTX) time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Cientific Journal of Neurology 1. 3: 01–05, 2019
Heidari, J. Esposito, A. Caissutti, “Hanatoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Int. J. Pharm. Sci. Rev. Res., 57 (1), Pages: 21–32, 2019
Heidari, J. Esposito, A. Caissutti, “Neurotoxin and Alpha–Neurotoxin time– resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, J Biomed Sci & Res. 3 (6), 550–563, 2019
Heidari, J. Esposito, A. Caissutti, “Antillatoxin (ATX) time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure”, American Journal of Optics and Photonics. Vol. 7, No. 1, pp. 18–27, 2019
R. Gobato, M. R. R. Gobato, A. Heidari, “Calculation by UFF method of frequencies and vibrational temperatures of the unit cell of the rhodochrosite crystal”, International Journal of Advanced Chemistry, 7 (2) 77–81, 2019
Heidari, J. Esposito, A. Caissutti, “Analysis of vibronic–mode coupling structure in vibrational spectra of fuzeon as a 36 amino acid peptide for HIV therapy beyond the multi–dimensional Franck–Condon integrals approximation”, International Journal of Advanced Chemistry, 7 (2) 82–96, 2019
Heidari, J. Esposito, A. Caissutti, “Debromoaplysiatoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Applied Chemistry, 2 (1) 17–54, 2019
Heidari, J. Esposito, A. Caissutti, “Enterotoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, JRL J Sci Technol. vol1–iss2: jst1001, 1–16, 2019
R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Rhodochrosite optical indicatrix”, Peer Res Nest. 1 (3) 1–2, 2019
Heidari, J. Esposito, A. Caissutti, “Anthrax toxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Research & Reviews: Journal of Computational Biology. 8 (2): 23–51, 2019
Heidari, J. Esposito, A. Caissutti, “Kalkitoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Can J Biomed Res & Tech. 2 (1): 1–21, 2019
Heidari, J. Esposito, A. Caissutti, “Neosaxitoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Clin Case Studie Rep, Volume 2 (3): 1–14, 2019
Heidari, J. Esposito, A. Caissutti, “6–methoxy–8–[[6–methoxy–8–[[6–methoxy– 2–methyl–1–(2–methylpropyl)–3,4–dihydro–1H–isoquinolin–7–yl]oxy]–2–methyl–1–(2– methylpropyl)–3,4–dihydro–1H–isoquinolin–7–yl]oxy]–2–methyl–1–(2–methylpropyl)– 3,4–dihydro–1H–isoquinolin–7–ol time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic– mode coupling structure in vibrational spectra analysis”, Clin Case Studie Rep, Volume 2 (3): 1–14, 2019
Heidari, “Comparison of synchrotron radiation and synchrocyclotron radiation performance in monitoring of human cancer cells, tissues and tumors”, Clin Case Studie Rep, Volume 2 (3): 1–12, 2019
Heidari, J. Esposito, A. Caissutti, “Kalkitoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Clin Case Studie Rep, Volume 2 (3): 1–14, 2019
Heidari, J. Esposito, A. Caissutti, “Diphtheria Toxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Clin Case Studie Rep, Volume 2 (3): 1–14, 2019
Heidari, J. Esposito, A. Caissutti, “Symbiodinolide time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Clin Case Studie Rep, Volume 2 (3): 1–14, 2019
Heidari, J. Esposito, A. Caissutti, “Saxitoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Am J Exp Clin Res. 6 (4): 364–377, 2019
R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Hartree–Fock methods analysis protonated rhodochrosite crystal and potential in the elimination of cancer cells through synchrotron radiation”, Radiation Science and Technology, Vol. 5, No. 3, pp. 27–36, 2019
R. Gobato, I. K. K. Dosh, A. Heidari, A. Mitra, M. R. R. Gobato, “Perspectives on the elimination of cancer cells using rhodochrosite crystal through synchrotron radiation, and absorption the tumoral and non–tumoral tissues”, Arch Biomed Eng & Biotechnol. 3 (2): 1–2, 2019
R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Unrestricted hartree–fock computational simulation in a protonated rhodochrosite crystal”, Phys Astron Int J. 3 (6):220‒228, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Perspectives on sub– nanometer level of electronic structure of the synchrotron with mendelevium nanoparticles for elimination of human cancer cells, tissues and tumors treatment using mathematica 12.0”, Journal of Energy Conservation, Volume 1, Issue 2, Pages 46–73, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Simulation of interaction of synchrotron radiation emission as a function of the beam energy and bohrium nanoparticles using 3D finite element method (fem) as an optothermal human cancer cells, tissues and tumors treatment”, Current Research in Biochemistry and Molecular Biology, 1 (1), 17–44, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Investigation of interaction between synchrotron radiation and thulium nanoparticles for human cancer cells, tissues and tumors treatment”, European Journal of Scientific Exploration, Volume 2, Issue 3, Pages 1–8, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “The effectiveness of the treatment human cancer cells, tissues and tumors using darmstadtium nanoparticles and synchrotron radiation”, International Journal of Advanced Engineering and Science, Volume 9, Number 1, Pages 9–39, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Using 3D finite element method (FEM) as an optothermal human cancer cells, tissues and tumors treatment in simulation of interaction of synchrotron radiation emission as a function of the beam energy and uranium nanoparticles”, Nano Prog., 1 (2), 1–6, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “A new approach to interaction between beam energy and erbium nanoparticles”, Saudi J Biomed Res, 4 (11): 372–396, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Consideration of energy functions and wave functions of the synchrotron radiation and samarium nanoparticles interaction during human cancer cells, tissues and tumors treatment process”, Sci. Int. (Lahore), 31 (6), 885–908, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “An outlook on optothermal human cancer cells, tissues and tumors treatment using lanthanum nanoparticles under synchrotron radiation”, Journal of Materials Physics and Chemistry, Vol. 7, No. 1, 29– 45, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Effectiveness of einsteinium nanoparticles in optothermal human cancer cells, tissues and tumors treatment under synchrotron radiation”, Journal of Analytical Oncology, 8, 1, 43–62, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Study of relation between synchrotron radiation and dubnium nanoparticles in human cancer cells, tissues and tumors treatment process”, Int. Res. J. Applied Sci., Volume 1, Number 4, Pages 1–20, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “A novel prospect on interaction of synchrotron radiation emission and europium nanoparticles for human cancer cells, tissues and tumors treatment”, European Modern Studies Journal, 3 (5), 11– 24, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Advantages, effectiveness and efficiency of using neodymium nanoparticles by 3D finite element method (FEM) as an optothermal human cancer cells, tissues and tumors treatment under synchrotron radiation”, International Journal of Advanced Chemistry, 7 (2) 119–135, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Role and applications of promethium nanoparticles in human cancer cells, tissues and tumors treatment”, Scientific Modelling and Research, 4 (1): 8–14, 2019
Heidari, J. Esposito, A. Caissutti, “Maitotoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis: A spectroscopic study on an anti–cancer drug”, Glob Imaging Insights 4 (2), 1–13, 2019
Heidari, J. Esposito, A. Caissutti, “Biotoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Glob Imaging Insights 4 (2), 1–14, 2019
Heidari, J. Esposito, A. Caissutti, “Time–resolved resonance FT–IR and Raman spectroscopy and density functional theory investigation of vibronic–mode coupling structure in vibrational spectra of nanopolypeptide macromolecule beyond the multi– dimensional Franck–Condon integrals approximation and density matrix method”, Glob Imaging Insights 4 (2), 1–14, 2019
Heidari, J. Esposito, A. Caissutti, “Cholera toxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Glob Imaging Insights 4 (2), 1–14, 2019
Heidari, J. Esposito, A. Caissutti, “Nodularin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Glob Imaging Insights 4 (2), 1–14, 2019
Heidari, J. Esposito, A. Caissutti, “Cangitoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Glob Imaging Insights 4 (2), 1–13, 2019
Heidari, J. Esposito, A. Caissutti, “Ciguatoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Glob Imaging Insights 4 (2), 1–14, 2019
Heidari, J. Esposito, A. Caissutti, “Brevetoxin (a) and (b) time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis: A spectroscopic study on an anti–HIV drug”, Cientific Drug Delivery Research 1 (2), 11–16, 2019
Heidari, J. Esposito, A. Caissutti, “Cobrotoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Trends in Res 3 (1), 1–13, 2019
Heidari, J. Esposito, A. Caissutti, “Cylindrospermopsin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Trends in Res 3 (1), 1–14, 2019
Heidari, J. Esposito, A. Caissutti, “Anthrax toxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis”, Trends in Res 3 (1), 1–14, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Investigation of moscovium nanoparticles as anti–cancer nano drugs for human cancer cells, tissues and tumors treatment”, Elixir Appl. Chem. 137A, 53943–53963, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Study of function of the beam energy and holmium nanoparticles using 3D finite element method (FEM) as an optothermal human cancer cells, tissues and tumors treatment”, European Journal of Advances in Engineering and Technology, 6 (12): 34–62, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Human cancer cells, tissues and tumors treatment using dysprosium nanoparticles”, Asian J. Mat. Chem. 4 (3–4), pp. 47–51, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Simulation of interaction of synchrotron radiation emission as a function of the beam energy and plutonium nanoparticles using 3d finite element method (fem) as an optothermal human cancer cells, tissues and tumors treatment”, J. Cancer Research and Cellular Therapeutics, Volume 2 (4), Pages 1–19, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Study of gadolinium nanoparticles delivery effect on human cancer cells, tissues and tumors treatment under synchrotron radiation”, Applied Chemistry, 2 (2) 55–97, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, R. Gobato, “Pros and cons of livermorium nanoparticles for human cancer cells, tissues and tumors treatment under synchrotron radiation using mathematica 12.0”, Parana Journal of Science and Education (PJSE) – v. 6, n. 1, (1–31) January 11, 2020
R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Challenging giants. Hartree– fock methods analysis protonated rhodochrosite crystal and potential in the elimination of cancer cells through synchrotron radiation”, Biomed J Sci & Tech Res 25 (1), pp. 18843–18848, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Simulation of interaction between ytterbium nanoparticles and human gum cancer cells, Tissues and Tumors Treatment under Synchrotron Radiation”, Dent Oral Maxillofac Res, Volume 5, Issue 5, Pages 1–18, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Modelling of interaction between curium nanoparticles and human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 5, Issue 5, Pages 1–18, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Study of berkelium nanoparticles delivery effectiveness and efficiency on human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 5, Issue 5, Pages 1–18, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Fermium nanoparticles delivery mechanism in human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 5, Issue 5, Pages 1–17, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Advantages of lawrencium nanoparticles for human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 5, Issue 5, Pages 1–18, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Pros and cons of the roentgenium nanoparticles for human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 5, Issue 5, Pages 1–17, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Imagery of flerovium nanoparticles delivery process in human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 5, Issue 5, Pages 1–18, 2019
Heidari, J. Esposito, A. Caissutti, “Maitotoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis: A spectroscopic study on an anti–gum cancer drug”, Dent Oral Maxillofac Res, Volume 5, Issue 5, Pages 1–16, 2019
Heidari, J. Esposito, A. Caissutti, “Batrachotoxin time–resolved absorption and resonance FT–IR and Raman biospectroscopy and density functional theory (DFT) investigation of vibronic–mode coupling structure in vibrational spectra analysis: A spectroscopic study on an anti–gum cancer drug”, Dent Oral Maxillofac Res, Volume 5, Issue 6, Pages 1–16, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Hafnium nanoparticles and their roles and applications in human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 5, Issue 6, Pages 1–17, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Dramaturgy of technetium nanoparticles delivery process in human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 5, Issue 6, Pages 1–19, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Computational approach to interaction between synchrotron radiation emission as a function of the beam energy and ruthenium nanoparticles in human gum cancer cells, tissues and tumors treatment”, Dent Oral Maxillofac Res, Volume 5, Issue 6, Pages 1–18, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Appearance check of rhodium nanoparticles delivery trend in human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 5, Issue 6, Pages 1–19, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Orientation rhenium nanoparticles delivery target on human gum cancer cells, tissues and tumors under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 5, Issue 6, Pages 1–18, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Drug delivery systems (DDSs) of osmium nanoparticles on human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 5, Issue 6, Pages 1– 18, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Development of successful formulations for oral drug delivery concepts of iridium nanoparticles in human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 5, Issue 6, Pages 1–19, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Classification of drug delivery system of niobium nanoparticles in human gum cancer gum cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 6, Issue 1, Pages 1–17, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Types of drug delivery system slideshare of protactinium nanoparticles in human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 6, Issue 1, Pages 1–17, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “New drug delivery system in pharmaceutics of neptunium nanoparticles in human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 6, Issue 1, Pages 1–18, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Drug delivery describes the method and approach to delivering drugs or pharmaceuticals and other xenobiotics to their site of action within radon nanoparticles effects on human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 6, Issue 1, Pages 1–18, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Applications of oganesson nanoparticles in increasing rapidly with the promise of targeted and efficient drug delivery in human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 6, Issue 1, Pages 1–19, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Wheeler–Feynman time– symmetric study of effectiveness and efficiency of terbium nanoparticles delivery mechanism in human cancer cells, tissues and tumors under synchrotron radiation”, Frontiers Drug Chemistry Clinical Res, Volume 3, Issue 1, Pages 1–13, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Simulation of interaction of synchrotron radiation emission as a function of the beam energy and californium nanoparticles using 3d finite element method (FEM) as an optothermal human cancer cells, tissues and tumors treatment”, Oncol Res: Open Acce. 1 (1): 1–17, 2019
Heidari, “Market analysis of glycobiology and glycochemistry 2020”, J Genet Disor Genet Rep. 8: 1, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Synchrotron radiation emission as a function of the beam energy and thorium nanoparticles”, International Medicine; 2 (1): 67–73, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Stochastic study of relativistic lutetium nanoparticles moving in a quantum field of synchrotron radiation emission when charged lutetium nanoparticles are accelerated radially in human cancer cells, tissues and tumors treatment”, Frontiers Drug Chemistry Clinical Res, Volume 3, Issue 1, Pages 1–15, 2020
Heidari, A. Caissutti, M. Henderson, K. Schmitt, E. Besana, J. Esposito, V. Peterson, “Recent new results and achievements of california south university (CSU) biospectroscopy core research laboratory for COVID–19 or 2019–nCoV treatment: Diagnosis and treatment methodologies of “coronavirus”, Journal of Current Viruses and Treatment Methodologies, Vol–1, Issue 1, Pg. no. 3–41, 2020
Heidari, “Awards 2020 on glycobiology”, J Mol Biol Methods. 2: 2, 2019
Heidari, “Young research forum–young scientist awards at glycobiology 2020”, J Genet Disor Genet Rep. 8: 2, 2019
Heidari, “2020 awards on 2nd world congress on neurology”, J Neurol Neurophysiol. 10: 6, 2019
Heidari, “2020 conference announcement on 2nd world congress on neurology”, J Neurol Neurophysiol. 10: 6, 2019
Heidari, “Awards for best research: Gastroenterology and digestive disorders”, J. Med. Med. Sci. Vol. 10, No. 2, 2019
Heidari, “Market analysis: Gastroenterology and digestive disorders”, J. Med. Med. Sci. Vol. 10, No. 2, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “Study of human cancer cells, tissues and tumors treatment through interaction between synchrotron radiation and cerium nanoparticles”, Sci Lett. 8 (1): 7–17, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Study of characteristic polarization and the frequencies generated in interaction of synchrotron radiation emission and actinium nanoparticles in human cancer cells, tissues and tumors treatment process”, Parana Journal of Science and Education (PJSE)–v. 6, n.3, (13–47) April 15, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Californium nanoparticles and human cancer treatment: Commemorating the 100th (1920–2020) anniversary of the california south university (CSU)”, Parana Journal of Science and Education (PJSE)–v. 6, n. 3, (48–83) April 15, 2020
Heidari, “2020 conference announcement on materials chemistry”, J Polym Sci Appl. 3: 1, 2019
Heidari, “Announcement–materials chemistry–2020”, J Polym Sci Appl. 3: 1, 2019
Heidari, “Awards 2020 of 19th world congress on materials chemistry”, J Polym Sci Appl. 3: 1, 2019
Heidari, “Awards at materials chemistry & science conference 2020”, J Polym Sci Appl. 3: 1, 2019
Heidari, “Market analysis of 19th world congress on materials chemistry”, J Polym Sci Appl. 3: 1, 2019
Heidari, “Past conference report on materials chemistry”, J Polym Sci Appl. 3: 1, 2019
Heidari, “Market analysis”, J Polym Sci Appl. 3: 4, 2019
Heidari, “17th international conference materials science and engineering”, J Electr Eng Electron Technol. 8: 3, 2019
Heidari, “16th international conference on advance material & nanotechnology”, J Electr Eng Electron Technol. 8: 4, 2019
Heidari, “Young research forum on laser advanced materials processing”, J Electr Eng Electron Technol. 8: 4, 2019
Heidari, “Market analysis of materials science and engineering”, Biomater Med Appl. 3: 1, 2019
Heidari, “Nanotechnology 2020 conference announcement: nanotechnology and nano engineering”, Biomater Med Appl. 3: 1, 2019
Heidari, “17th international conference on material science and engineering”, Biomater Med Appl. 3: 2, 2019
Heidari, “Young scientist awards of pharmacovigilance 2020”, J Pharm Drug Deliv Res. 8: 1, 2019
Heidari, “Awards 2020 on pharmacovigilence & drug safety”, J Pharm Drug Deliv Res. 8: 2, 2019
Heidari, “2020 conference announcement of world congress on glycobiology & glycochemistry”, J Cell Biol Res Ther. 8: 3, 2019
Heidari, K. Schmitt, M. Henderson, E. Besana, “A chemical review on cancer immunology and immunodeficiency”, International Journal of Advanced Chemistry, 8 (1): 27–43, 2020
Heidari, V. Peterson, “A comprehensive review on functional roles of cancerous immunoglobulins and potential applications in cancer immunodiagnostics and immunotherapy”, International Journal of Advanced Chemistry, 8 (1): 44–58, 2020
Heidari, V. Peterson, “An encyclopedic review on stereotactic hypofrac tionated radiotherapy, re irradiation, and cancer genome research”, International Journal of Advanced Chemistry, 8 (1): 59–74, 2020
Heidari, V. Peterson, “A pervasive review on biomarker in cervical intraepithelial lesions and carcinoma”, International Journal of Advanced Chemistry, 8 (1): 75–88, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Hereditary immunity in cancer”, International Journal of Advanced Chemistry, 8 (1): 94–110, 2020
R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, I. K. K. Dosh, “Secret messages in enigmatic playful texts”, ABEB, 4 (2): 1–10, 2020
Heidari, R. Gobato, M. R. R. Gobato, A. Mitra, “Hartree–Fock methods analysis protonated rhodochrosite crystal and potential in the elimination of cancer cells through synchrotron radiation using small–angle x–ray scattering (SAXS), ultra–small angle x–ray scattering (USAXS), fluctuation x–ray scattering (FXS), wide–angle x–ray scattering (WAXS), grazing–incidence small–angle x–ray scattering (GISAXS), grazing– incidence wide–angle x–ray scattering (GIWAXS) and small–angle neutron scattering (SANS)”, AJAN, 1 (1): 1–8, 2020
Heidari, R. Gobato, I. K. K. Dosh, A. Mitra, M. R. R. Gobato, “Single layer bioinorganic membrane using the kurumi molecule”, AJAN, 1 (1): 16–20, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Study of pulsed time structure of nobelium nanoparticles in human cancer cells, tissues and tumors treatment process which covers from microwaves to hard x–rays”, Dent Oral Maxillofac Res, Volume 6, Issue 2, Pages 1–17, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Abraham–Lorentz–Dirac force approach to interaction of synchrotron radiation emission as a function of the beam energy and rutherfordium nanoparticles using 3D finite element method (FEM) as an optothermal human cancer cells, tissues and tumors treatment”, Dent Oral Maxillofac Res, Volume 6, Issue 2, Pages 1–17, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Liénard–Wiechert field study of interaction of synchrotron radiation emission as a function of the beam energy and seaborgium nanoparticles using 3d finite element method (FEM) as an optothermal human cancer cells, tissues and tumors treatment”, Dent Oral Maxillofac Res, Volume 6, Issue 2, Pages 1–17, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Lorenz gauge, electric and magnetic fields study of interaction of gravitationally accelerating ions through the super contorted 'tubular' polar areas of magnetic fields and hassium nanoparticles”, Dent Oral Maxillofac Res, Volume 6, Issue 2, Pages 1–18, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Scalar Abraham–Lorentz– Dirac–Langevin equation, radiation reaction and vacuum fluctuations simulation of interaction of synchrotron radiation emission as a function of the beam energy and tennessine nanoparticles using 3d finite element method (FEM) as an optothermal human cancer cells, tissues and tumors treatment”, Dent Oral Maxillofac Res, Volume 6, Issue 2, Pages 1–17, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “The dynamics and quantum mechanics of an interaction of synchrotron radiation emission as a function of the beam energy and meitnerium nanoparticles using 3d finite element method (FEM) as an optothermal human cancer cells, tissues and tumors treatment”, Dent Oral Maxillofac Res, Volume 6, Issue 2, Pages 1–17, 2020
Heidari, “Future advanced study of thin layers of DNA/RNA hybrid molecule nanostructure”, J Mol Nanot Nanom 2 (1): 110–116, 2020
Heidari, “Market analysis–artificial intelligence 2020”, J Comput Eng Inf Technol. 8: 4, 2019
Heidari, “Conference announcement on artificial intelligence”, J Appl Bioinformat Computat Biol. 8: 2, 2019
Heidari, “Awards on artificial intelligence and cognitive healthcare”, J Appl Bioinformat Computat Biol. 8: 2, 2019
Heidari, “Study of thin layers of cadmium oxide (CdO) nanostructure”, Nano Prog., 2 (3), 1–10, 2020
Heidari, “Young researchers awards: Young scientist awards & best poster awards at environmental chemistry and engineering conference”, J Civil Environ Eng. 9: 3, 2019
Heidari, “2020 market analysis of environmental chemistry and engineering conference August 19–20, 2020 | Paris, France”, J Civil Environ Eng. 9: 4, 2019
Heidari, “2020 awards for environmental chemistry and engineering conference August 19–20, 2020 | Paris, France”, J Civil Environ Eng. 9: 4, 2019
Heidari, “Past conference report of environmental chemistry and engineering conference”, J Civil Environ Eng. 9: 4, 2019
Heidari, “Awards announcement on world congress on glycobiology & glycochemistry”, J Appl Microbiol Biochem. Vol. 3 No. 3, 2019
Heidari, “Market analysis of glycobiology and glycochemistry 2020”, J Appl Microbiol Biochem. Vol. 3 No. 3, 2019
Heidari, “Young research forum–young scientist awards: Geriatric–health– 2020”, J Aging Geriatr Med. 3: 3, 2019
Heidari, “Young scientist awards at tissue engineering 2020 for the best researches in tissue engineering & regenerative medicine”, J Aging Geriatr Med. 3: 3, 2019
Heidari, “Effect of solvent on non–linear synchrotron absorption of multi– walled carbon nanotubes (MWCNTs) with DNA/RNA function”, Sci. Int. (Lahore), 32 (3), 291–315, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Study of copernicium nanoparticles delivery process in human cancer cells, tissues and tumors under gravitationally accelerating ions through the super contorted ‘tubular’ polar areas of magnetic fields”, Adv. Sci. Eng. Med. 12 (5), 571–575, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Specific and selective targeting human cancer cells, tissues and tumors with seaborgium nanoparticles as carriers and nano–enhanced drug delivery and therapeutic in cancer treatment and beyond under synchrotron radiation”, Parana Journal of Science and Education (PJSE). Vol. 6, No. 4, pp. 8–50, 2020
Heidari, “Enhancement of visible synchrotron absorption in cadmium oxide (CdO) nanoparticles thin layer using plasmonic nanostructures: A two–dimensional (2D) simulation”, Sci. Int. (Lahore), 32 (3), 329–354, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Nanomedicines based americium nanoparticles drug delivery systems for anti–cancer targeting and treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 6, Issue 3, Pages 1–18, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Study of exclusively focused on translational aspects of praseodymium nanoparticles drug delivery under super contorted tubular polar areas of magnetic fields as optothermal human gum cancer cells, tissues and tumors treatment technique under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 6, Issue 3, Pages 1–17, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Research activities on novel drug delivery systems of astatine nanoparticles in human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 6, Issue 3, Pages 1–17, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Unprecedented progresses of biomedical nanotechnology during conventional smart drug delivery systems (SDDSs) of francium nanoparticles in human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 6, Issue 3, Pages 1– 20, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Non–invasive image–guided targeted drug delivery of radium nanoparticles in human gum cancer cells, tissues and tumors treatment under synchrotron radiation”, Dent Oral Maxillofac Res, Volume 6, Issue 3, Pages 1–20, 2020
Heidari, “A novel approach to reduce toxicities and to improve bioavailabilities of DNA/RNA of human cancer cells–containing cocaine (coke), lysergide (lysergic acid diethyl amide or LSD), Δ9–tetrahydrocannabinol (THC) [(–)– trans–Δ⁹– tetrahydrocannabinol], theobromine (xantheose), caffeine, aspartame (APM) (nutrasweet) and zidovudine (ZDV) [azidothymidine (AZT)] as anti–cancer nano drugs by coassembly of dual anti–cancer nano drugs to inhibit DNA/RNA of human cancer cells drug resistance”, Ely J Mat Sci Tech 1 (1): 1–2, 2018
Heidari, “Investigation of prevention, protection and treatment of lopinavir effectiveness on coronavirus disease–2019 (COVID–19) infection using fourier transform raman (FT–Raman) biospectroscopy”, AJAN, 1 (3): 36–60, 2020
Heidari, “Stimulated FT–IR biospectroscopic study of lopinavir protective and therapeutic effect as a potent drug on coronavirus disease–2019 (COVID–19) infection”, AJAN, 1 (3): 61–85, 2020
Heidari, R. Gobato, “The comparison of active cooperative and traditional teaching methods in nanochemistry students' satisfaction and learning of clinical nanochemistry”, AJAN, 1 (3): 86–112, 2020
Heidari, R. Gobato, “Study of nanochemistry students' satisfaction and learning with blended education: An action research study”, AJAN, 1 (3): 113–138, 2020
Heidari, “Study of stimulated Raman biospectroscopy in lopinavir as a potent drug against coronavirus disease–2019 (COVID–19) infection”, AJAN, 1 (3): 139–163, 2020
Heidari, “In situ monitoring of ritonavir protective and therapeutic influence as a potent drug on coronavirus disease–2019 (COVID–19) infection by attenuated total reflectance–fourier transform infrared (ATR–FTIR fingerprint) biospectroscopy”, Saudi J Biomed Res, 5 (6): 128–151, 2020
Heidari, “A stimulated FT–IR biospectroscopic study of ritonavir protective and therapeutic effect as a potent drug on coronavirus disease–2019 (COVID–19) infection”, Saudi J Biomed Res, 5 (6): 152–174, 2020
Heidari, “Application of single–walled carbon nanotubes (SWCNT) in the production of glucose biosensors and improving their performance using gold colloidal nanoparticles and usage of polyaniline nanostructure–based biosensors for detecting glucose and cholesterol”, Malaysian Journal of Chemistry, Vol. 22 (2), 121– 162, 2020
Heidari, “In situ monitoring of lopinavir protective and therapeutic influence as a potent drug on coronavirus disease–2019 (COVID–19) infection by attenuated total reflectance–fourier transform infrared (ATR–FTIR fingerprint) biospectroscopy”, Parana Journal of Science and Education (PJSE), Vol. 6, No. 5, pp. 29–60, 2020
Heidari, K. Schmitt, M. Henderson, E. Besana, “Modelling and simulation of interaction of magnetobremsstrahlung radiation and nihonium nanoparticles using bending magnets, undulators and/or wigglers in storage rings for human cancer cells, tissues and tumors treatment”, Sci. Int. (Lahore), 32 (4), 361–385, 2020
Heidari, “Oncological study of thin layers of imatinib molecule nanostructure for chronic myelogenous leukemia (CML), acute lymphocytic leukemia (ALL), philadelphia chromosome–positive (Ph+), gastrointestinal stromal tumors (GIST), hypereosinophilic syndrome (HES), chronic eosinophilic leukemia (CEL), systemic mastocytosis and myelodysplastic syndrome treatment”, Adv. Sci. Eng. Med. 12 (6), 753–760, 2020
Heidari, “Infrastructure of synchrotronic biosensor based on semiconductor device fabrication for tracking, monitoring, imaging, measuring, diagnosing and detecting cancer cells”, Semiconductor Science and Information Devices, Volume 01, Issue 02, Pages 29–57, 2019
Heidari, “In situ characterization of lopinavir by ATR–FTIR biospectroscopy”, Computational Chemistry, 8 (3), 27–42, 2020
Heidari, “Study of stimulated Raman biospectroscopy in ritonavir as a potent drug against coronavirus disease–2019 (COVID–19) infection”, Saudi J Biomed Res, 5 (7): 188–211, 2020
Heidari, “Investigation of prevention, protection and treatment of ritonavir effectiveness on coronavirus disease–2019 (COVID–19) infection using Fourier transform Raman (FT–Raman) biospectroscopy”, Saudi J Biomed Res, 5 (7): 212–235, 2020
R. Gobato, A. Heidari, “Cyclone bomb hits southern brazil in mid–winter 2020”, Journal of Atmospheric Science Research, Volume 03, Issue 03, Pages 8–12, 2020
Heidari, “A biospectroscopic and bioimaging analysis of imatinib nanoparticles aggregation linked to DNA/RNA by bcr–abl tyrosine–kinase inhibitors (TKI) with various chain length”, Sci. Int. (Lahore), 32 (4), 459–482, 2020
Heidari, “Future perspectives and shaping trends in gastroenterology and digestive disorders”, J Health Med Res 1 (1): 47–48, 2019
Heidari, “Latest research works and innovations in the field of oncology”, J Carcinog Mutagen, Vol. 11, Iss. 4, No: e126, 2020
Heidari, “Investigating the effect of synchrotron removal from raman spectra for quantitative analysis of cancer tissues”, Current Research in Cytology and Histology, 1 (1): 29–35, 2020
R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Potential in the elimination of cancer cells through synchrotron radiation: A Hartree–Fock methods analysis protonated rhodochrosite crystal”, Dent Oral Maxillofac Res, Volume 6, Issue 4, Pages 1–8, 2020
R. Gobato, M. R. R. Gobato, A. Heidari, A. Mitra, “Infrared spectrum, apt charges and mulliken of Hartreefock methods protonated rhodochrosite crystal”, Dent Oral Maxillofac Res, Volume 6, Issue 4, Pages 1–8, 2020
R. Gobato, I. K. K. Dosh, A. Heidari, A. Mitra, M. R. R. Gobato, “A novel and exquisite approach to single layer bioinorganic membranes”, Dent Oral Maxillofac Res, Volume 6, Issue 4, Pages 1–4, 2020
Heidari, “Manufacture of synchrotronic biosensor using Os–Pd/HfC nanocomposite for tracking, monitoring, imaging, measuring, diagnosing and detecting cancer cells”, Journal of Clinical and Translational Oncology, 1 (1): 20–26, 2020
Heidari, “Role and applications of synchrotron removal from raman spectra for quantitative analysis of cancer tissues”, Aswan University Journal of Environmental Studies (AUJES), Vol. 1, No. 1, pp. 57–96, 2020
Heidari, “Investigation of role and applications of polymeric stimuli– responsive nanocomposite materials as biomolecules for cancer targeted in anti–cancer nano drugs delivery agents and systems”, Parana Journal of Science and Education (PJSE), Vol. 6, No. 9, pp. 39–74, 2020
R. Gobato, A. Heidari, A. Mitra, M. R. R. Gobato, “Vortex cotes’s spiral in an extratropical cyclone in the southern coast of Brazil”, Arch Biomed Eng & Biotechnol. 4 (5): 2020
R. Gobato, A. Heidari, “Vortex hits southern Brazil in 2020”, J Cur Tre Phy Res App, Volume 1, Issue 2, Pages 109–112, 2020
Heidari, “Synthesis of fructose biosensors and progressing their efficiency using californium colloidal nanoparticles for detecting fructose and triglycerides”, Adv. Sci. Eng. Med. 12 (8), 1002–1017, 2020
R. Gobato, A. Heidari, A. Mitra, M. R. R. Gobato, “Cotes's spiral vortex in extratropical cyclone bomb south atlantic oceans”, Aswan University Journal of Environmental Studies (AUJES), Vol. 1, No. 2, pp. 147–156, 2020
Heidari, “Young researcher forum for 2nd world congress on neurology”, J Neurol Neurophysiol, 10: 4, 2019
Heidari, “World congress on health and medical science”, Journal of Emerging Diseases and Preventive Medicine, Volume 3, Issue 4, Page 01, 2020
Heidari, “Scientific challenges and recent advancements of dermatology and cosmetology”, J Clin Exp Pathol, Volume 3, Issue 9, 2019
R. Gobato, A. Heidari, A. Mitra, “Bioinorganic membrane using kurumi, a new liquid crystal”, Sumerianz Journal of Biotechnology, Vol. 4, No. 1, pp. 4–7, 2021
Heidari, “A stimulated FT–IR biospectroscopic study of lopinavir protective and therapeutic effect as a potent drug on coronavirus disease–2019 (COVID–19) infection”, Parana Journal of Science and Education (PJSE)–v. 7, n. 2, (1–33) March 1, 2021
Heidari, “Simulation of the variations of surface synchrotron resonance spectrum of arranged cadmium oxide (CdO) nanoparticles over cancer tissues matrix with size and distance”, Parana Journal of Science and Education (PJSE)–v. 7, n. 2, (34– 67) March 1, 2021
Heidari, R. Gobato, “Spherical paramagnetic contribution to shielding tensor analysis of nuclear magnetic resonance signals in gum cancer cells, tissues and tumors”, Dent Oral Maxillofac Res, Volume 6, Issue 5, Pages 1–2, 2020
Heidari, R. Gobato, “Exact NMR simulation of anti–cancer nano drug– DNA/RNA complexes in gum cancer cells spin systems using tensor train formalism”, Dent Oral Maxillofac Res, Volume 6, Issue 5, Pages 1–2, 2020
Heidari, R. Gobato, “The anti–cancer nano drug delivery 13C–edited/13C– filtered transferred dynamic 15N{1H} NOE measurements for studying DNA/RNA interactions with short non–linear motifs: A modern tool for studying DNA/RNA dynamics in gum cancer cells”, Dent Oral Maxillofac Res, Volume 6, Issue 5, Pages 1– 2, 2020
Heidari, R. Gobato, “DNA/RNA of gum cancer cells—anti–cancer nano drugs ligands structure determination with the two–dimensional NMR molecular line shape analysis of single, multiple, zero and double quantum correlation experiments”, Dent Oral Maxillofac Res, Volume 6, Issue 5, Pages 1–3, 2020
Heidari, R. Gobato, “Investigation of the internal structure and dynamics of gum cancer cells, tissues and tumors by 13C–NMR spectra of DNA/RNA of gum cancer cells as an essential structural tool for integrative studies of gum cancer cells development”, Dent Oral Maxillofac Res, Volume 6, Issue 6, Pages 1–3, 2020
Heidari, R. Gobato, “NMR and molecular dynamics studies combined to anti– cancer nano drugs and DNA/RNA interactions in gum cancer cells and their modulations with resistance mutations”, Dent Oral Maxillofac Res, Volume 6, Issue 6, Pages 1–2, 2020
Heidari, R. Gobato, “Advanced isotopic labeling for the NMR investigation of challenging DNA/RNA of gum cancer cells and anti–cancer nano drugs for production of isotope–labeled DNA/RNA in gum cancer cells for NMR spectroscopy”, Dent Oral Maxillofac Res, Volume 6, Issue 6, Pages 1–3, 2020
Heidari, R. Gobato, “Simultaneous detection of intra– and inter–molecular paramagnetic relaxation enhancements in DNA/RNA of gum cancer cells–anti–cancer nano drugs complexes”, Dent Oral Maxillofac Res, Volume 6, Issue 6, Pages 1–2, 2020
Heidari, R. Gobato, “Impact of DNA/RNA self–alignment in a strong magnetic field on the interpretation of indirect spin–spin interactions using NMR line shape analysis of a multi–state DNA/RNA ligand binding mechanism in gum cancer cells”, Dent Oral Maxillofac Res, Volume 6, Issue 6, Pages 1–2, 2020
Heidari, R. Gobato, “Application of anti–cancer nano drugs particles (ACNDP) to NMR characterization of viral gum cancer cell membrane DNA/RNA interactions for extracting DNA/RNA dynamics information from overlapped NMR signals using relaxation dispersion difference NMR spectroscopy”, Dent Oral Maxillofac Res, Volume 6, Issue 6, Pages 1–2, 2020
Heidari, R. Gobato, “Diagnosis of gum cancer cells from DNA/RNA using database mining and support vector regression through high resolution 4D HPCH experiment for sequential assignment of 13C–labeled DNAs/RNAs in gum cancer cells”, Dent Oral Maxillofac Res, Volume 6, Issue 6, Pages 1–2, 2020
Heidari, R. Gobato, “New opportunities for tensor–free calculations of residual dipolar couplings for the study of dynamic nuclear polarization of nucleic acids with endogenously bound manganese in gum cancer cells”, Dent Oral Maxillofac Res, Volume 6, Issue 6, Pages 1–2, 2020
Heidari, “Pros and cons controversy on synchrotronic biosensor using Os– Pd/HfC nanocomposite for tracking, monitoring, imaging, measuring, diagnosing and detecting cancer cells, tissues and tumors”, Indones. J. Cancer Chemoprevent., Volume 12, Number 1, Pages 1–10, 2021
R. Gobato, A. Heidari, L. F. Valverde, “ACTG based on silicon getting news structures Asi, Csi, Tsi and Gsi”, Arch Biomed Eng & Biotechnol. 5 (3): 1–2, 2021
Heidari, R. Gobato, “A biospectroscopic assignment technique for gum cancer cell membrane DNA/RNA reconstituted in magnetically aligned gum cancer cells for solid–state NMR analysis of gum cancer cell membrane DNA/RNA and nucleic acids aggregates by proton detected spectroscopy”, Glob Imaging Insights, Volume 6 (1): 1– 2, 2021
A. Heidari, R. Gobato, “Integrated analysis of the conformation of a DNA/RNA– linked spin label by combining NMR ensembles and molecular dynamics simulations provides more realistic models of DNA/RNA structures in gum cancer cells using optimization of NMR spectroscopy of encapsulated DNA/RNA dissolved in gum cancer cells”, Glob Imaging Insights, Volume 6 (1): 1–3, 2021

b) Conference Publications:

Alireza Heidari, “Study of band gap and determination of size of Ga Al As/Ga As quantum dots and the evaluation of resonant tunneling transmission coefficient from multilayer structures Ga Al Ad/Ga As from using Mathematica”, 3rd Iranian National Congress on Chemistry, 30–31 May 2007, Varamin, Iran
Alireza Heidari and Niloofar Heidari, “The nano–science of C60 molecule”, National Conference of Modern Technology in the Environment, 04 March 2008, Tehran, Iran
Alireza Heidari and Sahel Tofani, “Kinetics and mechanism of NH3 synthesis of a Fe (100) and K Fe (100) model catalysts”, International Catalysis Conference (ICC2008), 28–30 April 2008, Tehran, Iran
Alireza Heidari, Narges Shojafard, Niloofar Heidari, “Calculation of rotational structure of CF4 molecule by using the J. Moret–Bailly theory”, 15th Iranian Seminar of Organic Chemistry, 27–29 August 2008, Kermanshah, Iran
Alireza Heidari, Sahel Toufani, Narges Shojafard, Niloofar Heidari, “Methane conversion into hydrocarbons by double electrical discharge”, The 12th Iranian Chemical Engineering Congress, 20–23 October 2008, Tabriz, Iran
Alireza Heidari and Narges Shojafard, “The calculated neutron energy spectrum of –n source using the Monte–Carlo method”, National Conference of Computing in Chemistry, 12–13 November 2008, Arak, Iran
Alireza Heidari and Narges Shojafard, “Fabrication and study of carbon nanotube by plasma enhanced chemical vapor deposition: PECVD”, The 2nd International Student Conference of Biotechnology, 15–17 November 2008, Tehran, Iran
Alireza Heidari, “Numerical solution of the homonuclear diatomic nuclear Schrödinger equation using various empirical potential functions via the Numerov method”, National Physics Conference, 10–11 December 2008, Shahreza, Iran
Sahel Toufani, Sayyed Abolfazl SeyedSadjadi, Manzarbanoo Esnaashari, Narges Shojafard, Shakila Motamedi, Mona Farahani, Maryam Moghaddam and Alireza Heidari, “Biological elimination of azo dies from textile industry waterwaste by using the Aspergillus niger fungus”, 1st Scientific Student Conference of Sciences & Color Technology, 03–05 March 2009, Tehran, Iran
Alireza Heidari, Sayyed Abolfazl SayyedSadjadi, Sahel Toufani, Manzarbanoo Esnaashari, Narges Shojafard, Niloofar Heidari, “Sea surface temperature and Ekman transport in the Persian Gulf”, 3rd Conference & Exhibition on Environmental Engineering, 17–21 October 2009, Tehran, Iran
Sahel Toufani, Sayyed Abolfazl SayyedSadjadi, Shakila Motamedi, Mona Farahani and Alireza Heidari, “Use of scrap tire as asphalt modifier”, 3rd Conference & Exhibition on Environmental Engineering, 17–21 October 2009, Tehran, Iran
Manouchehr Nikazar, Mohammad Ali Safarpour, Sahel Toufani, Alireza Heidari, “The effects of surfactants on asphaltene precipitation onset in present nano–tetra phenyl porphyrin”, 13th Iranian Physical Chemistry Conference, 12–15 April 2010, Shiraz, Iran
Sayyed Abolfazl Seyed Sadjadi, Mohammad Hadi Riazi, Abbas Banaei, Alireza Heidari, “Electrochemical synthesis of copper nanoparticles in surfactant solutions”, 13th Iranian Physical Chemistry Conference, 12–15 April 2010, Shiraz, Iran
P. Oseloka Ezepue, O. Anwar Bég, Alireza Heidari, “Chaos, complexity, theory, global financial crisis and the prospects for financial engineering research in (pre– emerging) financial markets: A work–in–progress”, 3rd Chaotic Modeling and Simulation International Conference, 01–04 June 2010, Chania Crete, Greece
Alireza Heidari, O. Anwar Bég, P. Oseloka Ezepue, “An analytical and numerical investigation into dissipative chaos in semiconductor superlattices”, 3rd International Conference on Chaotic Simulation and Modeling, 01–04 June 2010, Chania Crete, Greece
Alireza Heidari, “HRR TEA–CO2 laser with 220W average output power”, National Congress on Laser in Medicine, 16–18 February 2011, Tehran, Iran
Alireza Heidari, “Investigation and study of electron trajectories in free electron lasers with realizable helical wiggler and ion channel guiding by using the Mathematica”, National Congress on Laser in Medicine, 16–18 February 2011, Tehran, Iran
Alireza Heidari, “MIR–difference laser spectrometer for CO detection in combustions”, National Congress on Laser in Medicine, 16–18 February 2011, Tehran, Iran
Alireza Heidari, “Design and construction of a tunable semiconductor laser”, National Congress on Laser in Medicine, 16–18 February 2011, Tehran, Iran
Alireza Heidari, “FT–Raman spectroscopic studies of Nd: YAG laser–irradiated human dental enamel”, National Congress on Laser in Medicine, 16–18 February 2011, Tehran, Iran
Roozbeh Amiri, Foad Khademi Jahromi, Alireza Heidari, “Study and investigation into the effects of AgNO3 concentration on the formation of Ag nanoparticles in Sol–Gel derived Ag–SiO2 thin films”, 1st Conference on Nanothechnology Applications in the Petroleum and Petrochemical Industries, 18–19 May 2011, Mahshahr, Iran
Roozbeh Amiri, Foad Khademi Jahromi, Alireza Heidari, “Investigation and study into the effects of Al2O3 nanopowder addition on phase formation and superconducting properties of Bi1.6Pb0.4Sr1.9Ca2.1Cu3O10–y”, 1st Conference on Nanothechnology Application in the Petroleum and Petrochemical Industries, 18–19 May 2011, Mahshahr, Iran
Foad Khademi Jahromi, Roozbeh Amiri, Alireza Heidari, “The study of carbon nanotubes doped with trivalent elements using back scattering Raman vibrational spectroscopy”, 1st conference on the application of Nanothechnology applications in the Petroleum and Petrochemical Industries, 18–19 May 2011, Mahshahr, Iran
Ahmet Yıldırım, Behrouz Raftari, Alireza Heidari, “Non–perturbative solution of a nonlinear ODE arising in magnetohydrodynamic”, International Conference on Applied Analysis and Algebra, 29th June–03rd July 2011, Istanbul, Turkey
Serap Tutkun, Ahmet Yıldırım, Hüseyin Koçak, Alireza Heidari, “The solution of Smoluchowski’s coagulation equation”, International Conference on Applied Analysis and Algebra, 29th June–03rd July 2011, Istanbul, Turkey
Zehra Pınar, Ahmet Yıldırım, Syed Tauseef Mohyud–Din, Alireza Heidari, “Solitary and periodic solutions of Fitzhugh–Nagumo equation”, International Conference on Applied Analysis and Algebra, 29th June–03rd July 2011, Istanbul, Turkey
Dilek Sunay, Ahmet Yıldırım, Subir Das, K. Vishal, Praveen Kumar Gupta, Alireza Heidari, “An efficient technique for solving time–fractional telegraph equations”, International Conference on Applied Analysis and Algebra, 29th June–03rd July 2011, Istanbul, Turkey
Moltem Turan, Ahmet Yıldırım, Davood Younesian, Hassan Askari, Zia Saadatnia, Alireza Heidari, “Approximate periodic solutions for conservative nonlinear oscillator containing a fraction order elastic force”, International Conference on Applied Analysis and Algebra, 29th June–03rd July 2011, Istanbul, Turkey
Semiha Özgül, Ahmet Yıldırım, Zia Saadatnia, Hassan Askari, Alireza Heidari, “A study of nonlinear oscillators with rational and irrational elastic terms”, International Conference on Applied Analysis and Algebra, 29th June–03rd July 2011, Istanbul, Turkey
Roozbeh Amiri, Foad Khademi Jahromi, Alireza Heidari, “A study and investigation into the effects of temperature and atmosphere on the spinel phase formation of nano–manganese ferrite”, 1st National Student Conference on Nanotechnology, 10–11 July 2011, Shahreza, Iran
Roozbeh Amiri, Foad Khademi Jahromi, Alireza Heidari, “A study and investigation into the effects of Ag nanoparticles as flux pinning centers in YBa2Cu3O7– δ”, The 1st National Student Conference on Nanotechnology, 10–11 July 2011, Shahreza, Iran
Foad Khademi Jahromi, Roozbeh Amiri, Alireza Heidari, “A new approach into superconductivity within single wall carbon nanotubes”, 1st National Student Conference on Nanotechnology, 10–11 July 2011, Shahreza, Iran
Foad Khademi Jahromi, Roozbeh Amiri, Alireza Heidari, “A study and investigation into the electrical conductance within a single wall carbon nanotube (SWCNT): Tight binding model”, 1st National Student Conference on Nanotechnology, 10–11 July 2011, Shahreza, Iran
Alireza Heidari, “Investigation into 1, 4–ditiooctans analytical conformation through quantum mechanic calculations: A HF and DFT study”, The 13th European Symposium on Organic Reactivity, 11–16 September 2011, Tartu, Estonia
Alireza Heidari, “Ab initio study of conformational properties and thermodynamic properties of 1,3–ditiooctan isomers”, 13th European Symposium on Organic Reactivity, 11–16 September 2011, Tartu, Estonia
Alireza Heidari, Participant, NanoThailand 2012, 09–11 April 2012, Khon Kaen, Thailand
Mohammadali Ghorbani, Alireza Heidari, Niloofar Heidari, Ahmet Yıldırım, “Studying forms of aza–cyclo alkadienes with middle size via the ab initio method”, 14th International Conference on the Union of Pure and Applied Chemistry within Polymers and Organic Chemistry, 06–09 January 2012, Doha, Qatar
Mohammadali Ghorbani, Alireza Heidari, Niloofar Heidari, Ahmet Yıldırım, “Conformational, structural and aromatic features of (8,8) close–ended carbon nanotube 7/5/7 ring arrangement: A theoretical ab initio study”, 14th International Conference on the Union of Pure and Applied Chemistry within Polymers and Organic Chemistry, 06–09 January 2012, Doha, Qatar
Mohammadali Ghorbani, Alireza Heidari, Niloofar Heidari, Ahmet Yıldırım, “Ab initio study into 5,6 dihydroxy naphtalen 1,4 dion and derivatives, NICS and the ring current effect”, 14th International Conference on the Union of Pure and Applied Chemistry within Polymers and Organic Chemistry, 06–09 January 2012, Doha, Qatar
Alireza Heidari, Niloofar Heidari, Mohammadali Ghorbani, Ahmet Yıldırım, “An analytical and numerical approach into LZ complexity within chaotic dynamical systems and the quasiperiodic Fibonacci sequence”, 4th International Interdisciplinary Chaos Symposium on Chaos and Complex Systems, 29 April–02 May 2012, Antalya, Turkey
Alireza Heidari, Niloofar Heidari, Mohammadali Ghorbani, Ahmet Yıldırım, “A new approach to recognizing chaotic states in stadium billiards by calculating gyration radius”, 4th International Interdisciplinary Chaos Symposium on Chaos and Complex Systems, 29 April–02 May 2012, Antalya, Turkey
Alireza Heidari, Pravindya Haputhanthri, Ekaterina Izgorodina, Bayden Wood, “Analysis of conformations and vibrational frequencies of AMP, ADP, and ATP: A combined computational and experimental study”, PhysChem 2013, 04–06 December 2013, Hobart, Tasmania, Australia
Alireza Heidari, Organizing Committee Member (OCM), 10th Global Annual Oncologists Meeting, 11–13 July 2016, Cologne, Germany
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Mucosal Immunology and Vaccine Development, 28–29 July 2016, Melbourne, Victoria, Australia
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference and Expo on Pharmaceutics and Biologic Drugs, 14–16 September 2016, San Antonio, Texas, USA
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Gastrointestinal Cancer and Therapeutics, 31 October 2016–01 November 2016, Toronto, Ontario, Canada
Alireza Heidari, Invited, Key and Renowned Speaker, “Prediction and detection of DNA/RNA of human cancer cells using synchrotron radiations and various biospectroscopic techniques”, BIT's 4th Annual Global Health Conference–2016 (AGHC–2016), 18–20 November 2016, Kaohsiung, Taiwan
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Radiation Oncology & Anti–Cancer Therapy, 21–22 November 2016, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 14th World Cancer & Anti–Cancer Therapy Convention, 21–22 November 2016, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Cancer Care and Cure (Cancer Care–2016), 01–02 December 2016, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Health and Hospital Management, 08–09 December 2016, Dubai, UAE
Alireza Heidari, Editor Board Member of Conference, 1st International Conference on Futuristic Trends in Engineering, Science, Pharmacy and Management, 23–24 December 2016, Gandhinagar, Gujarat, India
Alireza Heidari, Invited, Key and Renowned Speaker, “Commercialization of High Technologies”, The Third Festival on the Commercialization of High Technologies, 26– 27 January 2017, Kish Island, Hormozgan, Iran
Alireza Heidari, Organizing Committee Member (OCM), 15th Annual Summit on Vaccines and Immunization, 20–21 February 2017, Berlin, Germany
Alireza Heidari, Advisory Board & Faculty, 2nd Global Cancer Summit, 22–24 March 2017, Kuala Lumpur, Malaysia
Alireza Heidari, Conference Committee and Reviewers Member, International Conference on Teacher Preparation in the Muslim World (ICTEM), 24–25 March 2017, Dubai, UAE
Alireza Heidari, Conference Committee and Reviewers Member, International Conference on Educational Studies (ICES), 24–25 March 2017, Dubai, UAE
Alireza Heidari, Conference Committee and Reviewers Member, International Conference on Language Teaching and Learning in the 21st Century (ICLTL), 24–25 March 2017, Dubai, UAE
Alireza Heidari, Conference Committee and Reviewers Member, International Conference on Interdisciplinary Social Sciences (ICISS), 24–25 March 2017, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), World Congress & Expo on Biotechnology and Bioengineering, 27–29 March 2017, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Congress & Expo on Pharmaceutics & Drug Delivery Systems, 27–29 March 2017, Kuala Lumpur, Malaysia
Alireza Heidari, Organizing Committee Member (OCM), Global Conference and Expo on Applied Science, Management and Technology, 06–08 April 2017, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 16th Global Annual Oncologists Meeting, 24–25 April 2017, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 4th Annual Congress and Expo on Biofuels and Bioenergy, 27–28 April 2017, Dubai, UAE
Alireza Heidari, Invited, Key and Renowned Speaker, “Transdermal drug delivery system: Quality by design (QBD) approach”, World Congress on Pharmaceutical & Chemical Sciences, 03–05 May 2017, Madrid, Spain
Alireza Heidari, Invited, Key and Renowned Speaker, “Role of synchrotron radiations in prediction and detection of DNA/RNA of human cancer cells”, BIT’s 10 th Annual World Cancer Congress–2017 (WCC–2017), 19–21 May 2017, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Biotherapeutics, 22–23 May 2017, Mexico City, Mexico
Alireza Heidari, Organizing Committee Member (OCM), 8th International Conference on Proteomics and Bioinformatics (Proteomics 2017), 22–24 May 2017, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), 6th World Congress on Medicinal Chemistry, 07–08 June 2017, Milan, Italy
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Metabolic and Bariatric Surgery, 12–13 June 2017, Rome, Italy
Alireza Heidari, Honorable Advisory Board Member (HABM), International Summit on Pharma & Clinical Trials (Innovative Pharma 2017), 12–13 June 2017, Sydney, New South Wales, Australia
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Pancreatic Cancer & Liver Diseases (Pancreatic Cancer 2017), 12–13 June 2017, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 8th International Conference on Blood Cancer & Treatment, 26–27 June 2017, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 8th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit (BABE 2017), 26–27 June 2017, San Diego, California, USA
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Oncology Nursing, 03–04 July 2017, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Congress on Molecular Genetics and Gene Therapy, 03–05 July 2017, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), 9th Asia Pacific Global Summit on Healthcare, 03–05 July 2017, Kuala Lumpur, Malaysia
Alireza Heidari, Scientific Advisory Board Member (SABM), 2017 PCS 3rd Annual World Pathology Conference (WPC–2017), 08–09 July 2017, Rome, Italy
Alireza Heidari, Invited, Key and Renowned Speaker, “Study of Excimer and Exciplex Lasers Treatment for Human Cancer Cells and Tissues”, 2017 PCS 3rd Annual World Pathology Conference (WPC–2017), 08–09 July 2017, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 5th International Conference on Sustainable Bioplastics, 20–21 July 2017, Munich, Germany
Alireza Heidari, Organizing Committee Member (OCM), 6th International Conference on Environmental Chemistry and Engineering, 24–25 July, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Nuclear Medicine & Radiation Therapy, 27–28 July 2017, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 10th International Conference on Clinical and Surgical Ophthalmology, 07–09 August 2017, Beijing, China
Alireza Heidari, Organizing Committee Member (OCM), 8th Asian Biologics and Biosimilars Congress (Asian Biosimilars 2017), 10–12 August 2017, Beijing, China
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference and Expo on Holistic Medicine and Nursing (Holistic Medicine–2017), 14– 15 August 2017, Toronto, Ontario, Canada
Alireza Heidari, Organizing Committee Member (OCM), Annual Biotechnology Congress 2017, 17–18 August 2017, Toronto, Ontario, Canada
Alireza Heidari, Organizing Committee Member (OCM), 3rd Global Nanotechnology Congress and Expo, 21–23 August 2017, Dallas, Texas, USA
Alireza Heidari, Organizing Committee Member (OCM), 9th International Conference and Expo on Molecular & Cancer Biomarkers (World Biomarkers 2017), 24–25 August 2017, Birmingham, UK
Alireza Heidari, Organizing Committee Member (OCM), 14th International Conference and Exhibition on Pharmaceutical Formulations (Formulation 2017), 28–29 August 2017, Brussels, Belgium
Alireza Heidari, Organizing Committee Member (OCM), 20th International Conference on Radiation Oncology & Anti–Cancer Therapy (Anti–Cancer Therapy 2017), 28–29 August 2017, Brussels, Belgium
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Conference on Biopharmaceutics and Biologic Drugs (Biopharma 2017), 31 August 2017–01 September 2017, Philadelphia, Pennsylvania, USA
Alireza Heidari, Organizing Committee Member (OCM), 11th International Conference on Advanced Materials & Processing (Advanced Materials 2017), 7–8 September 2017, Edinburgh, Scotland
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Biotherapeutics and Bioanalytical Techniques (Biotherapeutics 2017), 11–13 September 2017, Dallas, Texas, USA
Alireza Heidari, Organizing Committee Member (OCM), International Congress on Gastroenterology & Hepatology (ICGH–2017), 11–13 September 2017, Miami, Florida, USA
Alireza Heidari, Scientific Committee Member (SCM), International Conference on Women’s Health, Gynecology & Obstetrics, 18–19 September 2017, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), Global Bioanalysis Summit 2017, 18–19 September 2017, San Diego, California, USA
Alireza Heidari, Organizing Committee Member (OCM), Global Bioanalysis Summit (Bioanalysis Summit 2017), 18–20 September 2017, San Francisco, California, USA
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Conference on Advanced Clinical Research and Clinical Trials, 20–21 September 2017, Dublin, Ireland
Alireza Heidari, Organizing Committee Member (OCM),10th Pharmacovigilance Congress, 20–21 September 2017, Charlotte, North Carolina, USA
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Congress on Medical Sociology and Community Health (Medical Sociology 2017), 25–26 September 2017, Atlanta, Georgia, USA
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Mycology, Mushrooms & Mycotechnology (Mycology 2017), 25–26 September 2017, Chicago, Illinois, USA
Alireza Heidari, Organizing Committee Member (OCM), 5th International summit on Medical Biology & Bioengineering (Bioengineering 2017), 27–28 September 2017, Chicago, Illinois, USA
Alireza Heidari, Organizing Committee Member (OCM), 8th International Conference and Exhibition on Biosensors and Bioelectronics, 27–29 September 2017, Chicago, Illinois, USA
Alireza Heidari, Organizing Committee Member (OCM), 9th Annual Pharmaceutical Chemical Analysis Congress (Pharma Analysis 2017), 02–03 October 2017, Vienna, Austria
Alireza Heidari, Organizing Committee Member (OCM), 7th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics, 05–06 October 2017, Chicago, Illinois, USA
Alireza Heidari, Review Board Member (RBM), International Biotechnology and Pharmaceutical Industry Forum (Biopharma–2017), 09–10 October 2017, New Delhi, India
Alireza Heidari, Organizing Committee Member (OCM), International Congress on Gastroenterology & Hepatology (Gastroenterology–2017), 09–11 October 2017, Chicago, Illinois, USA
Alireza Heidari, Organizing Committee Member (OCM), 5th World Conference on Applied Science, Engineering and Technology (WCASET–17), 11–12 October 2017, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), Global Experts Meeting On Pharmaceutics & Drug Delivery Systems (Pharmaceutics Meeting 2017), 12–13 October 2017, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), International Meeting on Biopolymers and Polymer Chemistry (Biopolymers Meeting 2017), 12–13 October 2017, Osaka, Japan
Alireza Heidari, Program Technical Committee Member (PTCM), 2nd International Conference on Conscientious & Unimpeachable Technologies 2017 (ICCUT–2017), 14 October 2017, Haryana, India
Alireza Heidari, Organizing Committee Member (OCM), 3rd World Congress on Natural Products Chemistry and Research (Natural Products Congress 2017), 16–17 October 2017, Budapest, Hungary
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Pharmaceutical and Biomedical Engineering (Pharma Engineering 2017), 16–17 October 2017, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Nanoscience and Nano Technology (Asia Pacific Nano Congress 2017), 16–17 October 2017, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 4th International Biomedical Engineering Conference (Biomedical 2017), 16–17 October 2017, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Past and Present Research Systems of Green Chemistry (Green Chemistry 2017), 16–18 October 2017, Atlanta, Georgia, USA
Alireza Heidari, Organizing Committee Member (OCM), 5th International Conference on Nanotechnology and Materials Science (Nanotek–2017), 16–18 October 2017, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Gastrointestinal Cancer and Therapeutics (GI Cancer 2017), 16–18 October 2017, Baltimore, Maryland, USA
Alireza Heidari, Organizing Committee Member (OCM), 11th World Drug Delivery Summit (Drug Delivery 2017), 16–18 October 2017, Baltimore, Maryland, USA
Alireza Heidari, Organizing Committee Member (OCM), 15th World Medical Nanotechnology Congress & Expo, 18–19 October 2017, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), 10th International Conference on Biomarkers & Clinical Research, 18–20 October 2017 (Biomarkers 2017), Baltimore, Maryland, USA
Alireza Heidari, Organizing Committee Member (OCM), 9th Annual Congress on Drug Design & Drug Formulation (Drug Formulation 2017), 19–20 October 2017, Seoul, South Korea
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Conference and Exhibition on Theoretical and Condensed Matter Physics, 19–21 October 2017, New York, USA
Alireza Heidari, Scientific Committee Member (SCM), Global Conference on Catalysis and Reaction Engineering (GCR 2017), 19–21 October 2017, Las Vegas, Nevada, USA
Alireza Heidari, Advisory Board Member (ABM), Frontiers of Applied Microbiology, 23–24 October 2017, International Online Conference, UK
Alireza Heidari, Organizing Committee Member (OCM), 10th World Congress on Stem Cell and Biobanking (Stem Cell Convention 2017), 23–24 October 2017, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), Global Proteomics Conference (Proteomics Meeting 2017), 25–26 October 2017, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Gastroenterology and Endoscopy, 30–31 October 2017, Toronto, Ontario, Canada
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Conference on Transcriptomics (Transcriptomics 2017), 30 October 2017–01 November 2017, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), 6th World Congress on Breast Cancer, 01–02 November 2017, Toronto, Ontario, Canada
Alireza Heidari, Advisory Board Member (ABM), New Trends in Nano Science & Nanotechnology, 01–02 November 2017, International Online Conference, UK
Alireza Heidari, Organizing Committee Member (OCM), 4th International Congress on Drug Discovery, Designing and Development (Drug Discovery 2017), 02– 03 November 2017, Chicago, Illinois, USA
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Healthcare & Hospital Management, 06–07 November 2017, Vienna, Austria
Alireza Heidari, Organizing Committee Member (OCM), International Healthcare and Patient Safety Conference, 06–07 November 2017, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Obesity and Weight Loss (Obesity–2017), 06–08 November 2017, Barcelona, Spain
Alireza Heidari, Recent Trends in Novel Drug Delivery System, Advisory Board Member (ABM), 08–09 November 2017, International Online Conference, UK
Alireza Heidari, Organizing Committee Member (OCM), Global Summit and Expo on Proteomics (Proteomics–2017), 09–11 November 2017, Valencia, Spain
Alireza Heidari, Scientific Advisory Board Member (SABM), BIT’s 1st World Congress of Biomedical Engineering 2017 (WCBME–2017), 09–11 November 2017, Xi'an, China
Alireza Heidari, Invited, Key and Renowned Speaker, “Biomedical Applications of Synchrotron Radiation in Human Cancer Cells Treatment”, BIT’s 1st World Congress of Biomedical Engineering 2017 (WCBME–2017), 09–11 November 2017, Xi'an, China
Alireza Heidari, Organizing Committee Member (OCM), 19th International Conference on Nanotechnology and Expo (Nanotech 2017), 13–14 November 2017, Atlanta, Georgia, USA
Alireza Heidari, Organizing Committee Member (OCM), Annual Meeting on Pharmacology, 16–17 November 2017, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference and Exhibition on Nanotechnology & Materials Science, 20–22 November 2017, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Biotechnology Congress, 04–05 December 2017, Sao Paulo, Brazil
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Bioequivalence & Bioavailability (BEBA–2017), 04–06 December 2017, San Francisco, California, USA
Alireza Heidari, Organizing Committee Member (OCM), Global Meeting on Materials Science & Nanotechnology (Materials Meeting 2017), 11–12 December 2017, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Pharmaceutics and Novel Drug Delivery Systems (Pharma 2017), 11–13 December 2017, Dubai, UAE
Alireza Heidari, Scientific Advisory Committee Member (SACM), 3rd World Congress on Pharmaceutics and Drug Discovery (WCPDD 2017), 15–16 December 2017, Dubai, UAE
Alireza Heidari, International Advisory Board Member (IABM), International Online Medical Conference (IOMC 2017), 2017, India
Alireza Heidari, Organizing Committee Member (OCM), International Conference and Exhibition on Nanotechnology (Nano USA 2018), 07–09 February 2018, San Diego, California, USA
Alireza Heidari, Technical Committee Member (TCM), 4th International Conference on Information Management and Industrial Engineering (ICII 2018), 10–13 February 2018, Cape Town, South Africa
Alireza Heidari, Organizing Committee Member (OCM), 12th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry (Pharmaceutical Sciences 2018), 26–27 February 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 3rd Global Summit and Expo on Dental & Oral Diseases (GSEDOD–2018), 26–27 February 2018, Abu Dhabi, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Metabolomics (ICOM 2018), 26–28 February 2018, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), 13th International Conference on Laboratory Medicine & Pathology (Laboratory Medicine 2018), 05–07 March 2018, Berlin, Germany
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Condensed Matter and Materials Physics (Materials Physics 2018), 12–13 March 2018, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), 8th Edition of International Conference on Mass Spectrometry (Mass Spectrometry 2018), 12–13 March 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 23rd International Conference on Nanomaterials and Nanotechnology (Nanomaterials 2018), 15–16 March 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 3rd World Congress & Expo on Pharmaceutics & Drug Delivery Systems (Pharmaceutics–2018), 19–20 March 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 29th International Conference on Vaccines and Immunization (Vaccines Summit 2018), 19–20 March 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 11th Edition of International Conference on Proteomics, 22–23 March 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 16th International Conference on Emerging Materials and Nanotechnology (Emerging Materials Congress 2018), 22–23 March 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 7th Edition of International Conference on Internal Medicine & Patient Care (Internal Medicine 2018), 26–27 March 2018, Vienna, Austria
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Conference on Nuclear Medicine & Radiation Therapy (Nuclear Medicine 2018), 26–27 March 2018, Edinburgh, Scotland
Alireza Heidari, Organizing Committee Member (OCM), International Conference & Exhibition on Biologics and Biosimilars (Biosimilars 2018), 26–27 March 2018, Orlando, Florida, USA
Alireza Heidari, Organizing Committee Member (OCM), 9th Edition of International Conference on Analytical Chemistry, 26–28 March 2018, Vienna, Austria
Alireza Heidari, Organizing Committee Member (OCM), 6th Edition of International Conference on Pain Management, 26–28 March 2018, Vienna, Austria
Alireza Heidari, Scientific Advisory Board Member (SABM), BIT’s 6th Annual Conference of AnalytiX 2018 (AnalytiX–2018), 26–28 March 2018, Miami, Florida, USA
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Congress on Embryology and In Vitro Fertilization (Embryology 2018), 30–31 March 2018, Orlando, Florida, USA
Alireza Heidari, Scientific Committee Member (SCM), Global Pharma Meet & Expo 2018 (Pharma Meet 2018), 02–04 April 2018, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Pharmacy and Pharmaceutical Sciences (Pharmacy Conference 2018), 09–11 April 2018, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Materials Science and Graphene Technology 2018 (Materials Science 2018), 09–11 April 2018, Dubai, UAE
Alireza Heidari, Technical Committee Member (TCM), 2018 International Conference on Nanomaterials, Materials and Manufacturing Engineering (ICNMM 2018), 13–15 April 2018, Chengdu, China
Alireza Heidari, Organizing Committee Member (OCM), 6th Edition of International Conference on Pharmacognosy and Medicinal Plants (Pharmacognosy 2018), 16–17 April 2018, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), EuroSciCon Conference on Stem Cell, 16–17 April 2018, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference and Expo on Graphene & Semiconductors (Graphene 2018), 16–17 April 2018, Las Vegas, Nevada, USA
Alireza Heidari, Keynote Speaker, Global Summit on Nursing and Medical Devices Expo (Nursing–2018), 16–18 April 2018, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Nanoscience & Nanoengineering (NSNE 2018), 18–19 April 2018, Las Vegas, Nevada, USA
Alireza Heidari, Organizing Committee Member (OCM), 22nd International Conference on Neurology & Neurophysiology (Neuro’18), 23–25 April 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), International Translational and Regenerative Medicine Conference (ITMC–2018), 25–27 April 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Congress and Expo on Biotechnology and Bioengineering, 07–09 May 2018, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 12th Edition of International Conference on Tissue Engineering and Regenerative Medicine (Tissue Science 2018), 10–11 May 2018, Frankfürt, Germany
Alireza Heidari, Organizing Committee Member (OCM), 22nd Edition of International Conference on Immunology and Evolution of Infectious Diseases (Immunology Research 2018), 10–11 May 2018, Frankfürt, Germany
Alireza Heidari, Organizing Committee Member (OCM), 5th World Congress on Advanced Clinical Trials and Clinical Research (Clinical Trials Congress 2018), 14–15 May 2018, Singapore City, Singapore
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Neurology and Mental Disorders–2018 (Neurology Conference–2018), 14–16 May 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 11th Global Experts Meeting on Chemistry, 17–19 May 2018, Singapore City, Singapore
Alireza Heidari, Organizing Committee Member (OCM), 10th International Conference on Genomics and Molecular Biology, 21–23 May 2018, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), Global Summit on Biopharma and Biotherapeutics, 23–24 May 2018, Montreal, Quebec, Canada
Alireza Heidari, Organizing Committee Member (OCM), 2nd Global Summit on Nutritional Science & Food Chemistry (Nutritionalscience–2018), 24–25 May 2018, Valencia, Spain
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Women Health and Breast Cancer (Women Health–2018), 24–25 May 2018, Valencia, Spain
Alireza Heidari, Organizing Committee Member (OCM), 22nd Global Annual Oncologists Meeting (Oncologists–2018), 24–25 May 2018, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), 8th Edition of International Conference on Case Reports, 28–29 May 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 14th Edition of International Conference on Health & Primary Care (Healthcare 2018), 28–29 May 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Cell and Structural Biology (Cell Biologists Congress 2018), 28–29 May 2018, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), 4th Edition of international conference on Polymer Science and Technology (Polymer Congress 2018), 04–05 June 2018, London, UK
Alireza Heidari, Scientific Committee Member (SCM), 2nd Global Conference on Pharmaceutics and Drug Delivery Systems (PDDS–2018), 04–06 June 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), Nano World: Current and Future Perspectives in Nanotechnology (Nano World 2018), 06–07 June 2018, Baltimore, Maryland, USA
Alireza Heidari, Organizing Committee Member (OCM), World Summit on Toxicology (Toxicology–2018), 11–12 June 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Congress on Surgery & Anesthesia, 11–12 June 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Systems and Synthetic Biology (Synthetic Biology 2018), 11–12 June 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 2 nd Edition of International Conference on Chemistry and Chemical Engineering (Chemical Engineering 2018), 14–15 June 2018, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), 2nd Global Summit & Expo on Laser Optics & Photonics (Optics–2018), 14–16 June 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Congress and Expo on Traditional and Alternative Medicine (Traditional Medicine–2018), 14–16 June 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 2 nd International Conference on Social Sciences & Interdisciplinary Studies (Social Sciences 2018), 18– 19 June 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 14th International Conference on Leukemia and Hematologic Oncology (Hematologic Oncology 2018), 20–21 June 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 11th International Conference and Exhibition on Pharmacovigilance & Drug Safety (Pharmacovigilance 2018), 21–22 June 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems (Pharmaceutics 2018), 21–23 June 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 21st International Conference on Advanced Nanoscience and Nanotechnology (Nanoscience 2018), 21–23 June 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Chronic Diseases (Chronic Diseases 2018), 25–26 June 2018, Berlin, Germany
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Gastroenterology (Gastro Congress 2018), 25–26 June 2018, Dublin, Ireland
Alireza Heidari, Organizing Committee Member (OCM), 12th International Conference on Abdominal Imaging and Endoscopy (Endoscopy–2018), 28–29 June 2018, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Structural Biology (Structural Biology 2018), 28–29 June 2018, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Influenza and Zoonotic Diseases (Influenza 2018), 2–3 July 2018, Vienna, Austria
Alireza Heidari, Organizing Committee Member (OCM), 22nd World Congress on Biotechnology, 10–11 July 2018, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), 18th International Conference on HPLC & Related Chromatographic Techniques (HPLC 2018), 11–12 July 2018, Toronto, Ontario, Canada
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Environmental Toxicology and Health, 11–12 July 2018, Sydney, New South Wales, Australia
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference and Exhibition on Marine Drugs & Natural Products (Natural Products 2018), 11–13 July 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), Global Cardiology Summit, 12–13 July 2018, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), 9th International Conference on Tissue Science and Regenerative Medicine (Tissue Science Congress 2018), 13–14 July 2018, Sydney, New South Wales, Australia
Alireza Heidari, Scientific Advisory Board Member (SABM), 2018 PCS 4th Annual World Pathology Conference (WPC–2018), 14–15 July 2018, Budapest, Hungary
Alireza Heidari, Organizing Committee Member (OCM), International Research Summit on Biomaterials and Nanotechnology (Biomat 2018), 16–17 July 2018, Atlanta, Georgia, USA
Alireza Heidari, Organizing Committee Member (OCM), 9th Edition of International Conference on Preventive Medicine & Public Health (Preventive Medicine 2018), 16–17 July 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Sleep Disorders and Medicine, 16–17 July 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Synthetic Biology (Synthetic Biology 2018), 16–17 July 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 4 th Annual Conference on Preventive Oncology (Preventive Oncology 2018), 18–19 July 2018, Atlanta, Georgia, USA
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Mass Spectrometry and Chromatography (Mass Spectra 2018), 19–20 July 2018, Prague, Czech Republic
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference & Expo on Green Chemistry and Engineering (ICEGCE–2018), 23–24 July 2018, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Conference on Agricultural & Food Chemistry (Food Chemistry 2018), 23–24 July 2018, Rome Italy
Alireza Heidari, Organizing Committee Member (OCM), World Conference on Analytical & Bioanalytical Chemistry (WCABC–2018), 23–24 July 2018, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), 20th Asia Pacific Nanotechnology Congress (Nanotek Congress 2018), 23–24 July 2018, Sydney, New South Wales, Australia
Alireza Heidari, Keynote Speaker, 2nd World Congress on Pharmaceutical and Chemical Sciences, 23–25 July 2018, Milan, Italy
Alireza Heidari, Organizing Committee Member (OCM), Global Conference on Magnetism and Magnetic Materials (GCMMM–2018), 23–25 July 2018, Osaka, Japan
Alireza Heidari, Scientific Committee Member (SCM), 2nd International Conference on Advances in Biotechnology (Biotechnology Research 2018), 23–25 July 2018, Kuala Lumpur, Malaysia
Alireza Heidari, Organizing Committee Member (OCM), 12th World Cancer Congress, 23–25 July 2018, Moscow, Russia
Alireza Heidari, Organizing Committee Member (OCM), 20th International Conference on Medicinal Chemistry and Pharmacology, 25–26 July 2018, Vancouver, British Columbia, Canada
Alireza Heidari, Organizing Committee Member (OCM), 5th International Conference on Medicinal Practices: Herbal, Holistic and Traditional (Medicinal Practices 2018), 25–26 July 2018, Kuala Lumpur, Malaysia
Alireza Heidari, Organizing Committee Member (OCM), 35th European Dental Congress (Dental 2018), 26–28 July 2018, Moscow, Russia
Alireza Heidari, Organizing Committee Member (OCM), Global Conference on Tissue Engineering and Regenerative Medicine (Regenerative Medicine 2018), 30–31 July 2018, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Cancer Diagnosis & Treatment (Cancer Treatment 2018), 02–03 August 2018, Oslo, Norway
Alireza Heidari, Organizing Committee Member (OCM), 14th Global Biomarkers Summit, 02–03 August 2018, Oslo, Norway
Alireza Heidari, Organizing Committee Member (OCM), International Conference and Exhibition onMaterial Science and Nanotechnology (Materials Congress 2018), 02–03 August 2018, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), 14th Annual Congress on Gastroenterology & Hepatology (Gastroenterology Summit 2018), 06–07 August 2018, Hyatt Regency Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), 28th Euro Congress on Cancer Science & Therapy (Cancer Science 2018), 09–10 August 2018, Madrid, Spain
Alireza Heidari, Organizing Committee Member (OCM), Annual Summit Oncology and Cancer (Oncology 2018), 09–10 August 2018, Vienna, Austria
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Congress on Nano Science and Nano Technology (Asia Pacific Nano Congress 2018), 10–11 August 2018, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), 20th International Conference on Advanced Energy Materials and Research (Advanced Energy Materials 2018), 13–14 August 2018, Dublin, Ireland
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Molecular Biology and Stem Cells (Molecular Biology Congress), 13–15 August 2018, Copenhagen, Denmark
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Cell and Gene Therapy (Gene Therapy 2018), 13–15 August 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 12th Edition of International Conference on Nanopharmaceutics and Advanced Drug Delivery (Nano Drug Delivery 2018), 16–17 August 2018, Dublin, Ireland
Alireza Heidari, Organizing Committee Member (OCM), Global Meeting on Oncology and Radiology, 16–17 August 2018, Tokyo, Japan
Alireza Heidari, Organizing Committee Member (OCM), 25th Nano Congress for Future Advancements (Nano Congress 2018), 16–18 August 2018, Dublin, Ireland
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Industrial Biotechnology and Bioprocessing (Industrial Biotechnology 2018), 16–18 August 2018, Copenhagen, Denmark
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Cell & Stem Cell Research (Cell 2018), 17–18 August 2018, Singapore City, Singapore
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Nano Medicine and Nanoparticles (Nano Medicine 2018), 18–19 August 2018, Las Vegas, Nevada, USA
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Congress and Exhibition on Pharmacy (Pharmacy–2018), 20–21 August 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), International Congress and Expo on Flu Science & Infectious Diseases (ICEFSID–2018), 20–21 August 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Medicinal Chemistry & Drug Design (Medicinal Chemistry–2018), 20– 21 August 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Advanced Pharmacy and Industrial Research (Advanced Pharmacy 2018), 20–22 August 2018, Beijing, China
Alireza Heidari, Organizing Committee Member (OCM), 16th World Medical Nanotechnology Congress (Medical Nanotechnology 2018), 20–22 August 2018, Tokyo, Japan
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Materials Science and Materials Chemistry (Materials Chemistry 2018), 20–22 August 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 26th International Conference on Diabetes and Endocrinology (Diabetes Congress 2018), 20–22 August 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), World Congress & Expo on Healthcare IT, 21–22 August 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Advanced Structural and Molecular Biology 2018 (Advanced Structural Biology 2018), 22–23 August 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Addiction Therapy & Clinical Reports (Addiction Therapy–2018), 23–24 August 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Gerontology & Palliative Care (Gerontology–2018), 23–24 August 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), Global Congress on Cancer Science and Therapy (Cancer Congress 2018), 23–24 August 2018, Madrid, Spain
Alireza Heidari, Organizing Committee Member (OCM), 17th Asia Pacific Ophthalmologists Annual Meeting, 24–25 August 2018, Tokyo, Japan
Alireza Heidari, Organizing Committee Member (OCM), 9th World Congress on Biosensors and Bioelectronics (Biosensors Congress 2018), 24–25 August 2018, Tokyo, Japan
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Renewable Energy and Resources, 27–28 August 2018, Boston, Massachusetts, USA
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Energy Materials and Fuel Cell Research (Energy Materials 2018), 27–28 August 2018, Boston, Massachusetts, USA
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Planetary Science and Particle Physics (Planetary Science 2018), 27–28 August 2018, Boston, Massachusetts, USA
Alireza Heidari, Organizing Committee Member (OCM)/International Committee, Global Congress on Advancements in Catalysis and Chemical Engineering Process (Catalysis 2018), 27–28 August 2018, Madrid, Spain
Alireza Heidari, Organizing Committee Member (OCM), 9th International Congress on Surgery, 27–28 August 2018, Tokyo, Japan
Alireza Heidari, Organizing Committee Member (OCM), Annual Congress and Expo on Vaccines & Immunology (Vaccines Research 2018), 27–29 August 2018, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Materials Physics and Materials Science (Materials Physics Congress 2018), 27–29 August 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 18th International Conference on Analytical Chemistry, 29–30 August 2018, Toronto, Ontario, Canada
Alireza Heidari, Organizing Committee Member (OCM), International Conference on In Vitro Diagnostics & In Vitro Fertilization (In Vitro Diagnostics 2018), 03–04 September 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 12th Global Summit and Expo on Biomass and Bioenergy (Biomass 2018), 04–05 September 2018, Zürich, Switzerland
Alireza Heidari, Organizing Committee Member (OCM), 7th International Conference and Exhibition on Pain Research and Management (Pain Management 2018), 04–05 September 2018, Zürich, Switzerland
Alireza Heidari, Scientific Committee Member (SCM), International Conference on Science and Technology (ICONST 2018), 05–09 September 2018, Prizren, Kosovo
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference and Expo on Drug Discovery, Designing & Development (Drug Discovery 2018), 06–07 September 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Polymerization Catalysis and Flexible Polymer (Polymer Catalysis 2018), 06–07 September 2018, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 14th International Conference on Gastro Education (Gastro Education 2018), 06–07 September 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 28th World Conference on Nursing Diagnosis & Care Plans (Nursing Diagnosis 2018), 10–11 September 2018, Prague, Czech Republic
Alireza Heidari, Organizing Committee Member (OCM), 30 th Annual Congress on Nanotechnology and Nanomaterials (Nanotech 2018), 10–11 September 2018, Stockholm, Sweden
Alireza Heidari, Organizing Committee Member (OCM), 22 nd Global Biotechnology Congress (Global Biotechnology 2018), 10–11 September 2018, Stockholm, Sweden
Alireza Heidari, Organizing Committee Member (OCM), International Conference on STD, AIDS and Communicable Disease (stdaids2018), 10–12 September 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), World Congress and Expo on Cell & Stem Cell Research (Stem Cell 2018), 13–15 September 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 19th World Congress on Analytical & Bioanalytical Techniques (Analytika 2018), 17–18 September 2018, Singapore City, Singapore
Alireza Heidari, Organizing Committee Member (OCM), 18th Global Summit on Environmental Toxicology and Pharmacology (EnviTox Summit 2018), 17–18 September 2018, Singapore City, Singapore
Alireza Heidari, Organizing Committee Member (OCM), 6th World Congress on Public Health, Epidemiology & Nutrition (Global Public Health 2018), 17–18 September 2018, Hong Kong
Alireza Heidari, Organizing Committee Member (OCM), 20th World Congress on Radiology and Oncology, 17–18 September 2018, Chicago, Illinois, USA
Alireza Heidari, Organizing Committee Member (OCM), International Epigenetics and Epitranscriptomics Conference (Epitranscriptomics 2018), 17–18 September 2018, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Mass Spectrometry and Chromatography (Mass Spectrometry–2018), 17– 19 September 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Alzheimer’s Disease & Dementia (Dementia 2018), 17–19 September 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 4th Global Summit on Heart Diseases (Heart Diseases Summit 2018), 19–20 September 2018, Singapore City, Singapore
Alireza Heidari, Organizing Committee Member (OCM), 7th Edition of International Conference on Green Energy, Green Engineering and Technology (Green Technologies 2018), 20–21 September 2018, Berlin, Germany
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Gynecology & Obstetrics (WCGO–2018), 20–21 September 2018, Toronto, Ontario, Canada
Alireza Heidari, Organizing Committee Member (OCM), Annual Biomarkers Congress (Biomarkers Congress 2018), 20–21 September 2018, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Biomedicine & Pharmacotherapy (Biomedicine 2018), 20–22 September 2018, Frankfürt, Germany
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Nanotechnology (Nanotek Summit 2018), 21–22 September 2018, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 3th International Conference and Expo on Natural Medicine & Products (Natural Medicine 2018), 24–25 September 2018, Montreal, Quebec, Canada
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Nano Science & Technology (Nano Science 2018), 24–25 September 2018, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 11th World Congress on Food Chemistry & Food Microbiology (Food Chemistry Microbiology Congress 2018), 26–27 September 2018, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Nutrition, Health and Aging (Nutrition–2018), 26–28 September 2018, Frankfürt, Germany
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Nuclear Medicine & Radiation Therapy, 01–02 October 2018, Stockholm, Sweden
Alireza Heidari, Organizing Committee Member (OCM), 26th International Conference on Advanced Nanotechnology, 04–05 October 2018, Moscow, Russia
Alireza Heidari, Organizing Committee Member (OCM), 17th Edition of International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems (Pharmaceutics 2018), 04–06 October 2018, Moscow, Russia
Alireza Heidari, Organizing Committee Member (OCM), 4th Edition of World Congress on Cancer Survivorship, Prevention and Management (Cancer Survivorship 2018), 08–10 October 2018, Moscow, Russia
Alireza Heidari, Organizing Committee Member (OCM), EuroSciCon Congress on Biochemistry & Molecular Biology (Biochemistry 2018), 11–12 October 2018, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Conference on Environmental Health & Preventive Medicine (Environmental Health 2018), 15–16 October 2018, Warsaw, Poland
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Cell and Gene Therapy (Gene Therapy 2018), 15–16 October 2018, Vienna, Austria
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Diabetes and Cholesterol Metabolism (Metabolic Diseases 2018), 15–17 October 2018, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Human Placenta, Fetal Nutrition and Metabolism (Placenta 2018), 17–18 October 2018, Las Vegas, Nevada, USA
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Advanced Biomaterials and Tissue Engineering (Advanced Biomaterials 2018), 17–18 October 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Advanced Structural and Molecular Biology 2018 (Advanced Structural Biology 2018), 17–18 October 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 19th International Conference on Cellular and Molecular Medicine, 17–18 October 2018, Tokyo, Japan
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Drug Discovery and Advanced Drug Delivery Systems & Technologies (Drug Discovery 2018), 18–19 October 2018, Warsaw, Poland
Alireza Heidari, Organizing Committee Member (OCM), 14th Global Biomarkers Summit (Global Biomarker Summit 2018), 18–19 October 2018, Amsterdam, Netherlands
Alireza Heidari, Keynote Speaker, 3rd International Conference & Expo on Obesity and Diet Management (Obesity and Diet Management–2018), 18–20 October 2018, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), 13th World Conference on Applied Science, Engineering and Technology (13th WCASET–18), 19–20 October 2018, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), International Healthcare Simulation Conference (Healthcare Simulation 2018), 22–23 October 2018, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Nursing & Healthcare (Nursing & Healthcare 2018), 22–24 October 2018, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), 27th European Cardiology Conference (Eurocardiology 2018), 22–24 October 2018, Rome, Italy
Alireza Heidari, Co–Chair, BIT’s 8th Annual World Congress of Nano Science & Technology (Nano S&T–2018), 24–26 October 2018, Potsdam, Germany
Alireza Heidari, “Multi–walled nanotubes roles in eliminating human cancer cells and tissues”, BIT’s 8th Annual World Congress of Nano Science & Technology (Nano S&T–2018), 24–26 October 2018, Potsdam, Germany
Alireza Heidari, Organizing Committee Member (OCM), 31st European Congress on Nanotechnology & Materials Engineering (Nano Mat 2018), 25–26 October 2018, Budapest, Hungary
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Congress on Biotechnology (Biotechnology Congress 2018), 25–27 October 2018, Frankfürt, Germany
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Biomedicine & Pharmacotherapy (Biomedicine 2018), 26–27 October 2018, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Gastrointestinal Cancer and Therapeutics (GI Cancer 2018), 29–30 October 2018, San Francisco, California, USA
Alireza Heidari, Invited, Key and Renowned Speaker, “Elimination of human cancer cells and tissues using nanotechnology”, International Conference on Gastrointestinal Cancer and Therapeutics (GI Cancer 2018), 29–30 October 2018, San Francisco, California, USA
Alireza Heidari, Organizing Committee Member (OCM), 26th Annual Congress on Cancer Science and Targeted Therapies, 29–30 October 2018, San Francisco, California, USA
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Materials Research and Development, 29–30 October 2018, Prague, Czech Republic
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Magnetism & Magnetic Materials (Magnetism 2018), 01–02 November 2018, Paris, France
Alireza Heidari, Scientific Committee Member (SCM), International Conference on Pharmaceutical Sciences and Drug Development (IPSDD 2018), 05–06 November 2018, Prague, Czech Republic
Alireza Heidari, Organizing Committee Member (OCM), International Conference and Expo on Proteomics and Molecular Medicine (Proteomics 2018), 05–07 November 2018, Chicago, Illinois, USA
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference and Exhibition on Pharmaceutics and Advanced Drug Delivery Systems (Pharmaceutical Sciences 2018), 08–10 November 2018, Chicago, Illinois, USA
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Petroleum Processing and Industrial Chemistry (Petroleum Processing 2018), 09–10 November 2018, Birmingham, Alabama, USA
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Bio–organic and Medicinal Chemistry (Bio–organic and Medicinal 2018), 12–13 November 2018, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 8th World Congress and Expo on RECYCLING, 12–14 November 2018, Berlin, Germany
Alireza Heidari, Organizing Committee Member (OCM), World Congress and Expo on Clinical and Medical Sciences, 12–14 November 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), World Congress and Expo on Virology and Bacteriology (Virology 2018), 12–14 November 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Gastroenterology and Digestive Disorders (Gastroenterologists 2018), 15–17 November 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 2nd Global Summit on Gastroenterology & Hepatology (Gastroenterology–2018), 19–20 November 2018, Dallas, Texas, USA
Alireza Heidari, Organizing Committee Member (OCM), 2nd Global Summit and Expo on Proteomics (Proteomics–2018), 19–20 November 2018, Dallas, Texas, USA
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Molecular Biology and Stem Cells (Molecular Biology 2018), 19–20 November 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 26th International Conference on Diabetes and Endocrinology (Diabetes Congress 2018), 22–24 November 2018, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), Nanotechnology and Nanomaterials Conference 2018 (Nanotechnology 2018), 23–24 November 2018, Las Vegas, Nevada, USA
Alireza Heidari, Organizing Committee Member (OCM), 5th International Conference on Theoretical, Materials and Condensed Matter Physics (Condensed Matter Physics 2018), 27–29 November 2018, Los Angeles, California, USA
Alireza Heidari, Organizing Committee Member (OCM), 18th International Conference on Chemistry & Drug Designing (ICCDD 2018), 03–04 December 2018, Mexico City, Mexico
Alireza Heidari, Organizing Committee Member (OCM), 9thAnnual Congress on Nursing & Healthcare, 03–04 December 2018, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), European Congress on Protein & Proteomics, 03–04 December 2018, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Toxicology (Toxicology 2018), 03–04 December 2018, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Nanotechnology (Nanotech 2018), 03–04 December 2018, Edinburgh, Scotland
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Proteomics and Genomics (Proteomics–2018), 03–05 December 2018, Valencia, Spain
Alireza Heidari, Organizing Committee Member (OCM), 28th International Conference on Chemistry & Drug Discovery 2018 (ICCDD 2018), 05–06 December 2018, Vancouver, British Columbia, Canada
Alireza Heidari, Organizing Committee Member (OCM), 11th International Conference on Alzheimer's Disease and Dementia (Alzheimer’s 2018), 06–07 December 2018, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Congress on Vaccines & Immunology, 06–07 December 2018, Amsterdam, Netherlands
Alireza Heidari, Program Committee and Technical Committee Chair (TCC), 2018 International Joint Conference on Metallurgical and Materials Engineering (JCMME 2018), 10–12 December 2018, Wellington, New Zealand
Alireza Heidari, Technical Committee Chair (TCC) and Program Committee Member (PCM), 2018 International Joint Conference on Metallurgical and Martials Engineering (JCMME 2018), 21–23 December 2018, Cairo, Egypt
Alireza Heidari, Technical Committee Member (TCM), 2019 IEEE 10th International Conference on Mechanical and Intelligent Manufacturing Technologies (ICMIMT 2019), 15–17 February 2019, Cape Town, South Africa
Alireza Heidari, Technical Committee Member (TCM), 2019 5th International Conference on Information Management and Industrial Engineering (ICII 2019), 15–17 February 2019, Cape Town, South Africa
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Microbiology & Applied Microbiology, 21–22 February 2019, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), Conference on Oncology and Stem Cells, 25–26 February 2018, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), Conference on Oncology and Cancer Therapy, 25–26 February 2019, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 3th International Conference on Advanced Dentistry and Dental Science (Advanced Dentistry 2019), 25– 26 February 2019, Toronto, Ontario, Canada
Alireza Heidari, Organizing Committee Member (OCM), CPD Accredited International Conference on Clinical Trials & Pharmacovigilance (Clinical Trials 2019), 28 February–01 March, 2019, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 28th World Congress on Neurology and Therapeutics (Neurology 2019), 28 February–01 March 2019, Berlin, Germany
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Pharmaceutical Chemistry (Pharmaceutical Chemistry 2019), 04–06 March 2019, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 22nd International Conference on New Horizons in Cardiology & Cardiologists Education (Cardiology Insights 2019), 07–08 March 2019, Berlin, Germany
Alireza Heidari, Organizing Committee Member (OCM), 8th World Congress on Immunology (Immunology World 2019), 11–12 March 2019, London, UK
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Tissue Engineering and Regenerative Medicine (Tissue Engineering), 14–15 March 2019, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 12th International Conference on Vascular Dementia and Dementia (Vascular Dementia 2019), 14–16 March 2019, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 4th Global Summit on Heart Diseases (Heart Diseases Summit 2019), 15–16 March 2019, Singapore City, Singapore
Alireza Heidari, Organizing Committee Member (OCM), 14th Global Summit on Oncology and Cancer (Oncology 2019), 18–19 March 2019, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 5th International Conference on Nanotechnology for Renewable Materials (Nano Materials 2019), 18–19 March 2019, Singapore City, Singapore
Alireza Heidari, Organizing Committee Member (OCM), 15th Global Biomarkers Summit (Biomarkers Summit–2019), 20–21 March 2019, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Toxicology and Risk Assessment (Toxicology–2019), 20–22 March 2019, Frankfürt, Germany
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Pharma Conference and Expo (Pharma–2019), 20–22 March 2019, Frankfürt, Germany
Alireza Heidari, Organizing Committee Member (OCM), 4th World Congress and Expo on Pharmaceutics and Drug Delivery Systems (Pharmaceutics–2019), 25–26 March 2019, Milan, Italy
Alireza Heidari, Organizing Committee Member (OCM), 3rd World Congress & Expo on Biotechnology and Bioengineering (Biotechnology–2019), 25–26 March 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 3rd World Congress & Expo on Nanotechnology & Materials Science (Nanotechnology Congress), 25–26 March 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Biochemistry and Enzymology (World Biochem 2019), 25–26 March 2019, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Congress on Drug Safety and Pharmacovigilance (Drug Safety Congress), 27–28 March 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 9th Edition of International Conference on Clinical & Medical Case Reports (Clinical Case Reports 2019), 27–28 March 2019, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), 2nd Global Meeting on Clinical Oncology and Radiology (Clinical Oncology Conference 2019), 27–28 March 2019, Hong Kong
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Mechanical, Metallurgy and Materials Science (Metallurgy–2019), 28–29 March 2019, Milan, Italy
Alireza Heidari, Organizing Committee Member (OCM), Global Conference on Carbon Nanotubes and Graphene Technologies (Graphene Technology–2019), 28–29 March 2019, Milan, Italy
Alireza Heidari, Organizing Committee Member (OCM), 7th International Conference on Smart Materials and Sustainable Technologies (Smart Materials 2019), 08–09 April 2019, Toronto, Ontario, Canada
Alireza Heidari, Catalysts Committee Member (CCM), International Conference on Applied Catalysis & Chemical Engineering (ACC–2019), 08–10 April 2019, Dubai, UAE
Alireza Heidari, Scientific Advisory Board Member (SABM) and Chairman of the Session “Breaking Research on Bioanalysis”, BIT’s 7th Annual Conference of AnalytiX–2019 (AnalytiX–2019), 12–14 April 2019, Singapore City, Singapore
Alireza Heidari, Invited, Key and Renowned Speaker, “Analytical chemistry and human cancer prevention, diagnosis and treatment: Perspective and prospect”, 7th Annual Conference of AnalytiX–019 (AnalytiX–2019), 12–14 April 2019, Singapore City, Singapore
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Translational and Regenerative Medicine Conference (ITMC–2019), 15–17 April 2019, Valencia, Spain
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Advanced Metabolomics and Systems Biology (Metabolomics 2019), 16–17 April 2019, Las Vegas, Nevada, USA
Alireza Heidari, Organizing Committee Member (OCM), Global Conference on Infectious Diseases (Infectious Diseases 2019), 22–24 April 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 7th International Conference on Earth Science & Space Technology, 13–14 May 2019, Athens, Greece
Alireza Heidari, Organizing Committee Member (OCM), 9th World Congress on Chemistry & Medicinal Chemistry (Chemistry 2019), 13–14 May 2019, Prague, Czech Republic
Alireza Heidari, Organizing Committee Member (OCM), Global Conference on Catalysis Chemical Engineering & Technology, 13–14 May 2019, Rome, Italy
Alireza Heidari, Chairman of the Track “Caner Drug Mechanisms and Resistance”, BIT's 12th Annual World Cancer Congress–2019 (WCC–2019), 15–17 May 2019, Osaka, Japan
Alireza Heidari, Invited, Key and Renowned Speaker, “Anti–caner nano drugs delivery mechanisms and resistance in human cancer cells, tissues and tumors under synchrotron and synchrocyclptron radiations with passage of time”, BIT's 12th Annual World Cancer Congress–2019 (WCC–2019), 15–17 May 2019, Osaka, Japan
Alireza Heidari, Technical Committee Member (TCM), 2nd International Conference on Nanomaterials, Materials and Manufacturing Engineering (ICNMM 2019), 17–19 May 2019, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Gastroenterology and Endoscopy (Gastro 2019), 20–21 May 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on CPD accredited Medical Microbiology 2019 (Medical Microbiology 2019), 20–21 May 2019, Vienna, Austria
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Reproductive Medicine & Biology (Reproductive Biology–2019 (ICRMB19)), 22–23 May 2019, Las Vegas, Nevada, USA
Alireza Heidari, Organizing Committee Member (OCM), 15th Edition of International Conference on Healthcare (Healthcare 2019), 27–29 May 2019, Barcelona, Spain
Alireza Heidari, Program Committee Member (PCM), 2nd World Summit on Toxicology & Applied Pharmacology (Toxicology–2019), 03–04 June 2019, Berlin, Germany
Alireza Heidari, Scientific Committee Board (SCB), World Pharma Summit R&D, Market and B2B (World Pharma Summit 2019), 03–04 June 2019, London, UK
Alireza Heidari, Organizing Committee Member (OCM), World Conference on Chemistry (WCC–2019), 03–05 June 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Clinical Research & Biomarkers (Biomarkers–2019), 03–05 June 2019, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Molecular Biology and Stem Cells (Molecular Biology 2019), 06–07 June 2019, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Central Nervous System and Therapeutics (CNS 2019), 10–11 June 2019, Edinburgh, Scotland
Alireza Heidari, Organizing Committee Member (OCM), 8th European Clinical Microbiology and Immunology Congress (Clinical Microbiology 2019), 12–13 June 2019, Edinburgh, Scotland
Alireza Heidari, Conference Committee Member (CCM), International Conference on Oncology and Hematology (SciTech Oncology 2019), 17–18 June 2019, Dubai, UAE
Alireza Heidari, Conference Committee Member (CCM), Global Meet on Pharmaceutical Sciences, Drug Formulation & Delivery (Pharma Meet 2019), 19–20 June 2019, Venice, Italy
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Conference on Biomaterials, Cellular and Tissue Engineering (Biomaterials Congress 2019), 19–20 June 2019, Dublin, Ireland
Alireza Heidari, Conference Committee Member (CCM), 3rd World Congress and Expo on Nanotechnology and Materials Science (Nanotechnology & Materials Science 2019), 01–02 July 2019, Dubai, UAE
Alireza Heidari, Conference Committee Member (CCM), International Conference on Tissue Science & Regenerative Medicine, 01–03 July 2019, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 3rd Global Pharmaceutical Conference and Expo (i–Pharma UK 2019), 03–05 July 2019, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference and Exhibition on Pharmaceutical Sciences & Research (Pharma Congress), 04–05 July 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Global Heart Congress (Heart Congress 2019), 08–10 July 2019, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Bacteriology and Emerging Diseases, 08–10 July 2019, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Green & Sustainable Chemistry (Green Chemistry 2019), 15–16 July 2019, Zürich, Switzerland
Alireza Heidari, Experts Advisory Board Member (EABM), World–Wide Congregation on Physics (Physics Summit 2019), 17–18 July 2019, Zürich, Switzerland
Alireza Heidari, Scientific Committee Member (SCM), World Congress on Obesity, 22–23 July 2019, Kuala Lumpur, Malaysia
Alireza Heidari, Organizing Committee Member (OCM) and also Invited, Key and Renowned Speaker, International Conference on Alzheimer’s & Dementia (Dementia–2019), 22–24 July 2019, London, UK
Alireza Heidari, International Scientific Advisory Board Member (ISABM), International Congress on Advanced Materials Sciences and Engineering 2019 (ASME– 2019), 22–24 July 2019, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), 3rd European Pharma and Pharmaceutical Sciences Congress (European Pharma 2019), 25–26 July 2019, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 8th International Conference on Smart Materials and Structures (Smart Materials Congress 2019), 01–02 August 2019, Dublin, Ireland
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Pharma Conference and Expo (Pharma–2019), 01–02 August 2019, Valencia, Spain
Alireza Heidari, Organizing Committee Member (OCM), 24th World Congress on Pharmacology, 19–20 August 2019, Vienna, Austria
Alireza Heidari, Organizing Committee Member (OCM), Global Conference on Cancer & Therapeutic Approaches (Cancer Congress–2019/GCTA–2019), 19–21 August 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Nutrition, Health and Aging (Nutrition–2019), 28–29 August 2019, Valencia, Spain
Alireza Heidari, Organizing Committee Member (OCM), 13th Edition of International Conference on Nanomedicine and Advanced Drug Delivery (Nano Drug Delivery 2019), 29–30 August 2019, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 5th International Conference on Condensed Matter and Materials Physics (Euro Condensed Matter Physics 2019), 02–03 September 2019, Berlin, Germany
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference and Exhibition on Pharmaceutical Sciences & Research (Pharma Congress), 04–05 September 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 31st International Conference on Cancer Research and Therapy (Cancer Research–2019), 09–10 September 2019, Zürich, Switzerland
Alireza Heidari, Organizing Committee Member (OCM), International Congress on Surgery and Anaesthesia (ICSA 2019), 09–11 September 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Nanomedicine and Nanotechnology (Nanotechnology 2019), 12–13 September 2019, Edinburgh, Scotland
Alireza Heidari, International Advisory Committee Member (IACM), 2nd Indo Oncology Summit–19, 13–14 September 2019, Bhubaneswar, India
Alireza Heidari, Organizing Committee Member (OCM), 3rd World Congress on Clinical Research & Biomarkers (WCCRB–2019), 16–17 September 2019, Miami, Florida, USA
Alireza Heidari, Scientific Committee Member (SCM), World Congress on Physics (Physics Congress 2019), 16–17 September 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 10th International Conference on Organic Chemistry 2019 (Organic Chemistry 2019), 20–21 September 2019, Singapore City, Singapore
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Pharmaceutics and Drug Delivery Research (Pharmaceutics–2019), 23– 24 September 2019, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), 31st European Congress on Nanotechnology and Materials Engineering, 03–04 October 2019, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 23rd International Conference on Food Technology & Processing (Food Technology 2019), 07–08 October 2019, Dublin, Ireland
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Public Health Care and Management (Public Health 2019), 07–09 October 2019, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Cancer and Oncotherapy (Cancer–2019), 14–16 October 2019, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 6th International Conference on Diabetes Treatment & Research (Diabetes Research 2019), 16–17 October 2019, Vancouver, British Columbia, Canada
Alireza Heidari, Organizing Committee Member (OCM), 4th World Congress and Expo Traditional Medicine & Herbals (WCETMH–2019), 21–22 October 2019, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), Global Meeting on Biomarkers, Clinical Research and Therapeutics, 21–22 October 2019, Milan, Italy
Alireza Heidari, Organizing Committee Member (OCM), 21st World Congress on Advances in Gastroenterology and Hepatology (Asian Gastro 2019), 21–22 October 2019, Melbourne, Victoria, Australia
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Vaccines and Immunization (Vaccines 2019), 21–23 October 2019, Milan, Italy
Alireza Heidari, Organizing Committee Member (OCM), PedIatrIcs & Neonatology Summit (Ped Summit 2019), 21–23 October 2019, Tokyo, Japan
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Conference on Obesity and Weight Loss (Obesity–2019), 23–24 October 2019, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), Annual Summit on Metabolomics (Metabolomics Summit 2019), 23–24 October 2019, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Organic and Inorganic Chemistry (Organic Chemistry Congress 2019), 24–25 October 2019, Zürich, Switzerland
Alireza Heidari, Organizing Committee Member (OCM), 20th Global Ophthalmologists Annual Meeting (Ophthalmologists 2019), 28–29 October 2019, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), 10th International Conference on Immunology & Immunogenetics (Molecular Immunology 2019), 30–31 October 2019, London, UK
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Cell Science and Molecular Biology, 04–06 November 2019, Vienna, Austria
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Molecular Biology and Genetic Engineering (Genetic Engineering Summit 2019), 07–08 November 2019, Melbourne, Victoria, Australia
Alireza Heidari, Organizing Committee Member (OCM), Global Experts Meet on Advanced Technologies in Diabetes Research and Therapy (Diabetes Meet 2019), 11–12 November 2019, San Francisco, California, USA
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Bioavailability and Bioequivalence (BABE 2019), 11–12 November 2019, London, UK
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Bacteriology and Environmental Microbiology, 11–13 November 2019, Berlin, Germany
Alireza Heidari, Organizing Committee Member (OCM), 23rd World Congress on Biotechnology (Biotechnology–2019), 14–15 November 2019, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), International Summit on Physics & Astronomy (Physics–2k19), 14–15 November 2019, Osaka, Japan
Alireza Heidari, Advisory Board Member (ABM), BIT’17th Annual Congress of International Drug Discovery Science and Technology–2019 (IDDST–2019), 15–17 November 2019, Nanjing, China
Alireza Heidari, International Advisory Committee Member (IACM), 2nd Indo Oncology Summit–19, 15–17 November 2019, Bhubaneswar, Odisha, India
Alireza Heidari, Scientific Committee Member (SCM), 2nd International Conference on Food, Agriculture, Horticulture and Aquaculture 2019, 18–19 November 2019, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), 8th Global Conference on Mass Spectrometry (Mass Spectra 2019), 18–19 November 2019, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Community Nursing and Public Health, 18–19 November 2019, Johannesburg, South Africa
Alireza Heidari, Organizing Committee Member (OCM), 3rd Global Summit on Gastroenterology & Hepatology (Gastroenterology–2019), 18–19 November 2019, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), European Conference on Pharmacovigilance & Drug Safety (Euro Pharmacovigilance 2019), 18–19 November 2019, Prague, Czech Republic
Alireza Heidari, Scientific Committee Member (SCM), 2nd International Conference on Food, Agriculture, Horticulture and Aquaculture 2019, 18–20 November 2019, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), Advances & Scientific Merits in Food and Agriculture, 18–20 November 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), Advances and Scientific Merits in Vaccines, Pharmacology & Clinical Trials, 18–20 November 2019, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), Global Summit on Nanotechnology, Electronics & Computer Science (GNCE–2k19), 21–22 November 2019, Kuala Lumpur, Malaysia
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Pharmaceutics, Pharmacognosy and Medicinal Plants, 25–26 November 2019, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Alzheimer’s Disease & Associated Disorders (Alzheimers–2019), 28–29 November 2019, Kuala Lumpur, Malaysia
Alireza Heidari, Scientific Committee Member (SCM), Scholars International Conference on Pharmaceutics and Drug Delivery Research (Pharmaceutics 2019), 02–03 December 2019, Madrid, Spain
Alireza Heidari, Organizing Committee Member (OCM), International Conference Green Energy and Recycling (Energy 2019), 02–03 December 2019, Berlin, Germany
Alireza Heidari, Organizing Committee Member (OCM), 7th Global Nanotechnology Congress and Expo (Nanotechnology–2019), 02–04 December 2019, Bali, Indonesia
Alireza Heidari, Experts Advisory Board Member (EABM), Renewable Materials 2019, 04–05 December 2019, New York, USA
Alireza Heidari, Organizing Committee Member (OCM), 5th International Conference on Cosmetology and Dermatology (Cosmetology 2019), 04–05 December 2019, Abu Dhabi, UAE
Alireza Heidari, Organizing Committee Member (OCM), 8th International Conference on Central Nervous System (CNS 2019), 04–05 December 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 4th Global Virology Congress & Expo (Virology–2019), 06–07 December 2019, Kuala Lumpur, Malaysia
Alireza Heidari, Organizing Committee Member (OCM), 14th International Conference on Cancer and Cancer Therapy (Cancer 2019), 09–10 December 2019, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 7th International Conference on Vaccines and Immunology (Vaccines Congress 2019), 09–10 December 2019, Abu Dhabi, UAE
Alireza Heidari, Technical Committee Chair (TCC) and Program Committee Member (PCM), 2nd International Joint Conference on Metallurgical and Materials Engineering (JCMME 2019), 10–12 December 2019, Auckland, New Zealand
Alireza Heidari, Technical Committee Member (TCM), 2020 International Conference on Frontiers of Nanomaterials and Nanotechnology (NanoMT 2020), 10–12 January 2020, Athens, Greece
Alireza Heidari, International Scientific Committee Member (ISCM), 3rd International Joint Conference on Materials Science and Mechanical Engineering (CMSME 2020), 10–12 January 2020, Athens, Greece
Alireza Heidari, Organizing Committee Member (OCM), 3rd Edition of International Conference on Materials Technology and Manufacturing Innovations (Materials Manufacturing 2020), 20–21 January 2020, Barcelona, Spain
Alireza Heidari, Technical Committee Member (TCM), 6th International Conference on Information Management and Industrial Engineering (ICII 2020), 20–22 January 2020, Cape Town, South Africa
Alireza Heidari, Technical Committee Member (TCM), 2020 IEEE 11th International Conference on Mechanical and Intelligent Manufacturing Technologies (ICMIMT 2020), 20–22 January 2020, Cape Town, South Africa
Alireza Heidari, Organizing Committee Member (OCM), 31st European Congress on Nanotechnology and Materials Engineering (Nanomat 2020), 12–13 February 2020, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Catalysis, Chemical Engineering and Technology (Catalysis 2020), 19–20 Fubruary 2020, Phuket, Thailand
Alireza Heidari, Organizing Committee Member (OCM), 20th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry (Pharma Industry 2020), 24–25 February 2020, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Medical and Health Sciences, 24–25 February 2020, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 22nd International Conference on Nanotechnology and Nano–Medicine (Nanotechnology 2020), 24–25 February 2020, London, UK
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Primary Healthcare and Pain Management (Primary Healthcare 2020), 27–28 February 2020, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Applied Science and Engineering (ICASE–2020), 20–21 April 2020, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Neurology and Brain Disorders (Neuro Congress 2020), 20–21 April 2020, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), 12th International Conference & Expo on Chromatography Techniques (Chromatography 2020), 20–21 April 2020, Berlin, Germany
Alireza Heidari, Organizing Committee Member (OCM), 20th European Dermatology Congress (Euro Dermatology 2020), 29–30 April 2020, Prague, Czech Republic
Alireza Heidari, Invited, Key and Renowned Speaker, “Roles and Applications of Modern Nanotechnology in Human Skin Cancer Cells’ DNA/RNA Hypermethylation and Hypomethylation for Human Skin Cancer Cells, Tissues and Tumors Diagnosis and Treatment under Synchrotron Radiation”, 20th European Dermatology Congress (Euro Dermatology 2020), 29–30 April 2020, Prague, Czech Republic
Alireza Heidari, Organizing Committee Member (OCM), 4th Europen Congress on Pharma and Pharmaceutical Sciences (Europaen Pharma 2020), 02–03 March 2020, Edinburgh, Scotland
Alireza Heidari, Scientific Advisory Board Member (SABM), BIT’s 8th Annual Conference on Analytix–2020 (AnalytiX–2020), 04–06 March 2020, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), Advances and Scientific Merits in Chemistry, 05–07 March 2020, San Francisco, California, USA
Alireza Heidari, International Scientific Advisory Board Member (ISABM), International Conference on Nano Research and Development (ICNRD–2020), 12–14 March 2020, Singapore City, Singapore
Alireza Heidari, Organizing Committee Member (OCM), 7th World Congress and Exhibition on Antibiotics and Antibiotic Resistance (Antibiotics 2020), 16–17 March 2020, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 10th International Conference and Exhibition on Advanced Cell and Gene Therapy (Cell Therapy 2020), 16–17 March 2020, Berlin, Germany
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Orphan Drugs & Rare Diseases (Orphan Drugs 2020), 16–17 March 2020, Berlin, Germany
Alireza Heidari, Scientific Advisory Board Member (SABM), Smart Devices Symposium 2020 (SDS2020), 17–19 March 2020, Osaka, Japan
Alireza Heidari, Conference Committee Member (CCM), International Cinference on Chemical Engineering & Catalysis (Chemical Research 2020/ICCEC– 2020), 19–20 March 2020, Berlin, Germany
Alireza Heidari, Conference Committee Member (CCM), 3rd International Conference on Obesity and Weight Loss (Obesity–2020), 19–20 March 2020, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Eye & Vision Congress (Eye & Vision 2020), 25–26 March 2020, Miami, Florida, USA
Alireza Heidari, Organizing Committee Member (OCM), 14th International Conference on Materials Science and Technology (Materials Technology 2020), 25–26 March 2020, Miami, Florida, USA
Alireza Heidari, Organizing Committee Member (OCM), Global Congress and Expo on Pure and Applied Chemistry (Applied Chemistry–2020), 04–05 May 2020, Porto, Portugal
Alireza Heidari, Organizing Committee Member (OCM), Global Congress and Expo on Advances in 3D Printing & Modelling (3DPrinting–2020), 07–08 May 2020, Porto, Portugal
Alireza Heidari, Organizing Committee Member (OCM), 4th World Congress on Cell Science and Molecular Biology (Cell Science–2020), 11–12 May 2020, Manchester, UK
Alireza Heidari, Organizing Committee Member (OCM), 36th World Congress on Materials Science and Nanotechnology (Materials Summit 2020), 13–14 May 2020, Tokyo, Japan
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference On Virology (Virology–2020), 25–26 May 2020, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 15th International Conference on Material Chemistry & Science (Material Chemistry 2020), 25–26 May 2020, Tokyo, Japan
Alireza Heidari, Organizing Committee Member (OCM), 13th Edition of International Conference on Infectious Diseases (Infectious Diseases 2020), 27–28 May, 2020, Dublin, Ireland
Alireza Heidari, Program Committee Member (PCM), World Conference on Diabetes, Metabolism and Endocrinology (WCDME–2020), 28–29 May 2020, Los Angeles, California, USA
Alireza Heidari, Organizing Committee Member (OCM), International Conference and Expo on Materials Science and Nano Science (Materials–Science– 2020), 08–09 June 2020, Kuala Lumpur, Malaysia
Alireza Heidari, Organizing Committee Member (OCM), Global Summit on Material Science and Engineering (Material Science 2020), 08–09 June 2020, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference and Expo on Condensed Matter Physics (Condensed–Matter–2020), 08–09 June 2020, Kuala Lumpur, Malaysia
Alireza Heidari, Organizing Committee Member (OCM), 33rd International Conference on Nanomaterials and Nanotechnology (Nanomaterials 2020), 15–16 June 2020, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Conference on Toxicology and Clinical Toxicology (Toxicology 2020), 17–18 June 2020, Rome, Italy
Alireza Heidari, Scientific Committee Member (SCM), World Congress on Pharmaceuticals Sciences and Chemistry (Pharma–2020 Conference), 17–19 June 2020, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 3rd Global Summit on Stem Cell Biology & Regenerative Medicine (SCRM–2020), 18–19 June 2020, Saint Petersburg, Russia
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Hematologists Summit (Hematology–2020), 18–19 June 2020, Saint Petersburg, Russia
Alireza Heidari, Technical Committee Member (TCM), 2020 International Workshop on Industrial Informatics (IWoII 2020), 19–21 June 2020, Prague, Czech Republic
Alireza Heidari, Organizing Committee Member (OCM), 18th International Conference on Nanotechnology and Nanoengineering (Nanotechnology 2020), 22–23 June 2020, Venice, Italy
Alireza Heidari, Invited, Key and Renowned Speaker, “Market Analysis of Glycobiology and Glycochemistry 2020”, 18th International Conference on Nanotechnology and Nanoengineering (Nanotechnology 2020), 22–23 June 2020, Venice, Italy
Alireza Heidari, Organizing Committee Member (OCM), 3rd World congress on Antibiotics (Antibiotics–2020), 22–23 June 2020, Zürich, Switzerland
Alireza Heidari, Organizing Committee Member (OCM), 11th International Conference on Glycobiology & Glycochemistry (Glycobiology 2020), 22–23 June 2020, Venice, Italy
Alireza Heidari, Organizing Committee Member (OCM), Materials Chemistry & Science (Materials Chemistry 2020), 22–23 June 2020, Osaka, Japan
Alireza Heidari, Organizing Committee Member (OCM), 26th International Conference on Advanced Materials, Nanotechnology and Engineering (Nanomedicine Research on Effective Treatment for COVID–19), 22–23 June 2020, Webinar
Alireza Heidari, Organizing Committee Member (OCM), World Summit on Management Sciences (SciTech Management Sciences Conference 2020), 29–30 June 2020, ibis Styles Bangkok Khaosan Viengtai, Thailand
Alireza Heidari, Conference Committee Member (CCM), International Congress on Food Sciences (SciTech Food Sciences 2020), 01–02 July 2020, Thailand
Alireza Heidari, Organizing Committee Member (OCM), 25th World Biotechnology Congress (World Biotechnology 2020), 15–16 July 2020, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 2nd Annual Congress on Cellular Therapies, Cancer, Stem Cells and Bio Medical Engineering (Cellular Therapies 2020), 17–18 July 2020, Vienna, Austria
Alireza Heidari, Technical Committee Chair (TCC) and Program Committee Member (PCM), 3rd International Joint Conference on Metallurgical and Materials Engineering (JCMME 2020), 20–22 July 2020, Seoul, South Korea
Alireza Heidari, Organizing Committee Member (OCM), 4th International Congress and Exhibition on Pharmacy (ICEP–2020), 13–14 August 2020, Atlanta, Georgia, USA
Alireza Heidari, Organizing Committee Member (OCM), 9th International Conference on Brain Disorders and Therapeutics (Brain Disorders 2020), 21–22 August 2020, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 5th World Congress on Frontiers in Cancer Research and Therapy (Frontiers in Cancer 2020), 24–25 August 2020, Kyoto, Japan
Alireza Heidari, Organizing Committee Member (OCM), 33rd World Congress on Pharmacology, 26–27 August 2020, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Artificial Intelligence, Automation and Robotics (Artificial Intelligence- 2020), 26–27 August 2020, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), World Congress on Clinical Research & Biomarkers (WCCRB–2020), 14–15 September 2020, Vancouver, British Columbia, Canada
Alireza Heidari, Organizing Committee Member (OCM), 4th World Congress on Breast Cancer and Women’s Health (Breast Cancer 2020), 14–16 September 2020, Sydney, New South Wales, Australia
Alireza Heidari, Organizing Committee Member (OCM), 4th International Cancer Conference and Expo (iCancer 2020), 16–18 September 2020, Baltimore, Maryland, USA
Alireza Heidari, Organizing Committee Member (OCM), World Summit on Management Sciences, 20–21 September 2020, Webinar
Alireza Heidari, Organizing Committee Member (OCM), 14th Annual Conference on Stem Cell & Regenerative Medicine (Stem Cell 2020), 24–25 September 2020, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference and Exhibition on Nutritional Science & Food Chemistry (OLCNSFC– 2020), 08–09 October 2020, Lisbon, Portugal
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Heart and Brain Congress, 12–13 October 2020, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 9th International Conference on Smart Materials and Structures (Smart Materials 2020), 19–20 October 2020, Amsterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), 9th International Conference on Environmental Chemistry (Environmental Chemistry 2020), 19–20 October 2020, Athens, Greece
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Congress on Peptide (Peptide 2020), 19–20 October 2020, London, UK
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Microbiology & Infectious Diseases (Microbiology 2020), 19–21 October 2020, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), Global Congress & Expo on Nanotechnology (ISTNANO–2020), 21–22 October 2020, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 33rd World Neuroscience and Neurology Conference (Neuroscience 2020), 02–03 November 2020, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 5th World Congress and Expo on Immunology (Immunology–2020), 16–17 November 2020, Budapest, Hungary
Alireza Heidari, Scientific Board Member (SBM), Global Conferecne on Nephrology (Nephro–2020), 19–20 November 2020, Luxembourg City, Luxembourg
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Cardiology & Cardiovascular Diseases (Cardiology Summit 2020), 19– 20 November 2020, Kuala Lumpur, Malaysia
Alireza Heidari, Organizing Committee Member (OCM), 12th International Conference on Preventive Medicine & Public Health (Preventive Medicine 2020) 23–24 November 2020, London, UK
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Advanced Materials and Sustainable Development (Advanced Materials 2020), 24–25 November 2020, Vancouver, British Columbia, Canada
Alireza Heidari, International Advisory Committee Member (IACM), 3rd International Conference on Recent Trends in Multidisciplinary Research (ICRTMDR– 20), 26–27 December 2020, Malé, Maldives
Alireza Heidari, International Scientific Committee Member (ISCM), 4th International Joint Conference on Materials Science and Mechanical Engineering (CMSME 2021), 15–17 January 2021, Singapore City, Singapore
Alireza Heidari, Experts Advisory Board Member (EABM), 6th Annual Congress on Cell Sciences, Stem Cells and Regenerative Medicine (Stem Cells 2021), 26–27 February 2021, Webinar
Alireza Heidari, Expert Advisory Committee Member (EACM), World Health Conference 2021 (WHC–2021), 11–15 March 2021, Nanjing, China
Alireza Heidari, Organizing Committee Member (OCM), 1st International Conference on Stem Cell and Regenerative Medicine (Stem Cell 2021), 21–22 April 2021, Berlin, Germany
Alireza Heidari, Technical Committee Member (TCM), 2021 IEEE 12th International Conference on Mechanical and Intelligent Manufacturing Technologies (ICMIMT 2021), 13–15 May 2021, Cape Town, South Africa
Alireza Heidari, Technical Committee Member (TCM), 7th International Conference on Information Management and Industrial Engineering (ICII 2021), 13–15 May 2021, Cape Town, South Africa
Alireza Heidari, Scientific Advisory Board Member (SABM), BIT’s 8th Annual Conference of AnalytiX–2021 (AnalytiX–2021), 19–21 May 2021, Osaka, Japan
Alireza Heidari, International Advisory Committee Member (IACM), 1st International Conference on Engineering, Social–Sciences, and Humanities (IC–ESSU), 26–27 May 2021, Eastern Samar State University (ESSU)–Borongan Campus in Association with the Institute for Engineering Research and Publication (IFERP), Borongan City, Eastern Samar, Philippines
Alireza Heidari, Technical Committee Member (TCM), 2021 IEEE the 4th International Conference on Nanoscience and Technology (ICNST 2021), 26–28 June 2021, Chengdu, China
Alireza Heidari, Scientific Committee Member (SCM) and Keynote Speaker, International Conference on Science, Engineering & Technological Innovations (ICSETI–2021), 10–11 July 2021, Bangkok, Thailand
Alireza Heidari, Program Committee Member (PCM), World Conference on Diabetes, Metabolism and Endocrinology (WCDME–2021), 15–16 July 2021, Chicago, Illinois, USA
Alireza Heidari, Expert Advisory Board Member (EABM), International Conference on Heart and Cardiovascular Diseases (Heart and Cardiovascular 2021), 21– 22 July 2021, Webinar
Alireza Heidari, Plenary Speaker, Global Conference on Nursing and Health Care (Nursing–2021), 22–24 July 2021, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), 2021 International Conference on Nanotechnology and Applications (ICNA2021), 23–25 July 2021, Guilin, China
Alireza Heidari, Organizing Committee Member (OCM), World Congress of Diabetes and Pediatric Endocrinology (Pediatric Endocrinology 2021), 20–21 August 2021, Toronto, Ontario, Canada
Alireza Heidari, Iternational Advisory Committee Member (IACM), 1st International Conference on Science Technology and Management (ICSTM–21), 23–24 September 2021, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), 8th International Conference on Molecular Biology & Biochemistry (Molecular Biology–Biochemistry 2021), 18–19 October 2021, Tokyo, Japan
Alireza Heidari, Organizing Committee Member (OCM), Webinar of Chemical Science and Chemical Emgineering, 20–21 October 2021, Webinar
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Geriatrics and Gerontology (ICGG–2021), 25–27 October 2021, Vancouver, British Columbia, Canada
Alireza Heidari, Organizing Committee Member (OCM), 38th Global Nanotechnology Congress (Nanotechnology 2021), 01–02 November 2021, Rome, Italy
Alireza Heidari, Program Committee Member (PCM) and Technical Committee Member (TCM), 2021 International Conference on Intelligent Vehicles (ICoIV 2021), 7– 9 November 2021, Chengdu, China
Alireza Heidari, Scientific Board Member (SBM), International Conference on Immunology and Microbiology (ICIM–2021), 15–17 November 2021, Luxembourg City, Luxembourg
Alireza Heidari, Organizing Committee Member (OCM), 20th International Conference on Pharmacology and Toxicology (Pharma 2021), 18–19 November 2021, Vienna, Austria
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Healthcare and Health Management (Health 2022), 7–8 March 2022, Edinburgh, Scotland
Alireza Heidari, Plenary Speaker, Global Conference on Traditional and Alternative Medicine (GCTAM–2022), 14–16 March 2022, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), 7th International Conference on Neuroscience and Neurological Disorders (Advanced Neurology 2022), 18–19 March 2022, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 35th International Conference on Nanomaterials and Nanotechnology (Nano Expo 2021), 21–22 March 2022, Rome, Italy
Alireza Heidari, Eminent and Keynote Speaker, International Conference (Online) on Environment, Development and Sustainability (An Interdisciplinary Conference) (ICEDS 2022), 29–30 March 2022, Mumbai, India
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Nanoscience and Nanotechnology (Nanotechnology 2022), 18–19 April 2022, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), Vaccines World Forum (VaccinesForum–2022), 18–20 April 2022, Porto, Portugal
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Stem Cells Research, Cell and Gene Therapy (Stemcells–2022), 20–21 April 2022, Miami, Florida, USA
Alireza Heidari, Organizing Committee Member (OCM), 11th International Conference on Brain Disorders and Therapeutics (Brain Disorders 2022), 04–05 May 2022, Zürich, Switzerland
Alireza Heidari, Organizing Committee Member (OCM), 25th International Conference on Advanced Nanoscience and Nanotechnology (Nanoscience 2022), 06–07 May 2022, Barcelona, Spain
Alireza Heidari, Expert Advisory Board Member (EABM) and Distinguished Speaker, 4th World Congress on Smart Material & Material Science (Smart Material– 2022), 20–21 May 2022, London, UK
Alireza Heidari, Technical Committee Member (TCM), 8th International Conference on Information Management and Industrial Engineering (ICII 2022), 25–27 May 2022, Cape Town, South Africa
Alireza Heidari, Technical Program Committee Member (TPCM), 2022 IEEE 13th International Conference on Mechanical and Intelligent Manufacturing Technologies (ICMIMT 2022), 25–27 May 2022, Cape Town, South Africa
Alireza Heidari, Scientific Board Member (SBM), Global Conference on Nursing and Health Care (Nursing–2022), 06–08 June 2022, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Congress on Surgery and Anaesthesia (ICSA 2022), 20–22 June 2022, Zürich, Switzerland
Alireza Heidari, Organizing Committee Member (OCM), Global Webinar on Graphene and 2D Materials (GW2DMAT–2022), 25–26 June 2022, Webinar
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Healthcare and Patient Safety (Healthcare 2022), 11–12 July 2022, Virtual Event
Alireza Heidari, Organizing Committee Member (OCM), Nanotechnology Research and Applications World Forum (NanoReAp2022), 15–17 August 2022, Berlin, Germany
Alireza Heidari, Technical Committee Member (TCM), 2022 5th International Conference on Mechanical Manufacturing and Industrial Engineering (MMIE 2022), 24– 26 August 2022, Tokyo, Japan
Alireza Heidari, Technical Committee Member (TCM), 2022 the 5th International Conference on Nanoscience and Technology (ICNST 2022), 24–26 August 2022, Tokyo, Japan
Alireza Heidari, Scientific Committee Member (SCM), Global Meet on Vaccines (GMVACCINES2022), 5–7 September 2022, Amsterdam, Netherlands
Alireza Heidari, Scientific Committee Member (SCM), 5th Edition of International Cancer Conference (ICC 2022), 16–17 September 2022, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 2nd Global Summit on Polymer Science and Composite Materials (PolyScience2022), 19–21 September 2022, Barcelona, Spain
Alireza Heidari, International Advisory Committee Member (IACM), Institute for Engineering Research and Publication (IFERP) 1st International Conference on Future of Engineering (ICFE–2022), 22–23 Sepetember, Manila, Philippines
Alireza Heidari, Technical Committee Member (TCM), 2022 International Conference on Frontiers of Nanomaterials and Nanotechnology (NanoMT 2022), 23–25 September 2022, Nanjing, China
Alireza Heidari, Technical Committee Member (TCM), 2022 6th International Conference on Material Engineering and Advanced Manufacturing Technology (MEAMT 2022), 23–25 September 2022, Nanjing, China
Alireza Heidari, Organizing Committee Member (OCM), 6th International Conference on Nanomaterials and Nanotechnology (Nanomaterials 2022), 13–14 October 2022, Dubai, UAE
Alireza Heidari, Technical Committee Member (TCM), 2022 International Conference on Intelligent Vehicles (ICoIV 2022), 14–16 October 2022, Chengdu, China
Alireza Heidari, Technical Committee Member (TCM), 2022 International Conference on Industrial Automation, Robotics and Control Engineering (IARCE 2022), 14–16 October 2022, Chengdu, China
Alireza Heidari, Technical Chair, International Conference on Intelligent Manufacturing, Advanced Sensing and Big Data (IMASBD 2022), 15–17 October 2022, Guilin, China
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Stem Cell, Tissue Engineering and Regenerative Medicine (Stem Cells 2022), 17–18 October 2022, Miami, Florida, USA
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Orphan Drugs and Rare Diseases (Orphan Drugs–2022), 21–22 October 2022, Miami, Florida, USA
Alireza Heidari, International Advisory Committee Member (IACM), World Conference on Multidisciplinary Research & Innovation (WCMRI–2022), 28–29 October 2022, Singapore City, Singapore
Alireza Heidari, Organizing Committee Member (OCM), 4th Global Conference on Surgery and Anesthesia (Surgeons 2022), 07–08 November 2022, Valencia, Spain
Alireza Heidari, Scientific Board Member (SBM), Global Conference on Materials Science and Engineering (GCMSE–2022), 07–09 November 2022, Valencia, Spain
Alireza Heidari, Scientific Board Member (SBM), Global Conference on 3D Printing and Additive Manufacturing (3DPAM2022), 10–12 November 2022, Valencia, Spain
Alireza Heidari, Organizing Scientific Committee Member (OSCM), World Congress on Materials Science & Engineering 2022 (MSE2022), 10–12 November 2022, San Francisco, California, USA
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Nanoscience and Nanotechnology (Nanotechnology 2022), 17–18 November 2022, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Biomaterials and Biomedical Engineering (Biomaterials 2022), 17–18 November 2022, Dubai, UAE
Alireza Heidari, International Advisory Committee Member (IACM), International Conference on Multidisciplinary Research and Practices (ICMRP–2022), 22–23 November 2022, Phuket, Thailand
Alireza Heidari, Technical Committee Member (TCM), 2022 the 7th International Conference on Design and Manufacturing Engineering (ICDME 2022), 25–27 November 2022, Johannesburg, South Africa
Alireza Heidari, Technical Committee Member (TCM), 2022 International Conference on Mechanical, Aerospace and Electronic Systems (MAES 2022), 25–27 November 2022, Johannesburg, South Africa
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Congress on Neurology and Brain Disorders (ICNBD 2022), 05–07 December 2022, San Francisco, California, USA
Alireza Heidari, International Advisory Committee Member (IACM), 3rd International Conference on Advancing Knowledge from Multidisciplinary Perspectives in Engineering & Technology (ICAKMPET–2022), 23–24 December 2022, Manila, Philippines
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Nanophysics, Nano Optics, and Nanotechnology (NANO 2023 Congress), 02–03 March 2023, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), Global Conference on Rheumatology, Orthopedics & Physiotherapy (GCROP 2023), 09–10 March 2023, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Drug Discovery Chemistry (Drug Discovery 2023), 13–15 March 2023, Osaka, Japan
Alireza Heidari, Scientific Committee Member (SCM), Global Meet on Food Science and Technology (GMFST2023), 23–25 March 2023, Las Vegas, Nevada, USA
Alireza Heidari, Scientific Committee Member (SCM), 4th International Conference on Multidisciplinary and Current Educational Research (ICMCER), 11–12 April 2023, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), 6th European Congress on Immunology, Allergy and Vaccination (Euro Immunology Conference 2023), 17–19 April 2023, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), International Summit on Graphene and 2D Materials (ISG2D2023), 24–26 April 2023, Valencia, Spain
Alireza Heidari, Organizing Committee Member (OCM), 15th International Conference on Clinical Chemistry (Clinical Chemistry 2023), 08–09 May 2023, Tokyo, Japan
Alireza Heidari, Scientific Committee Member (SCM) and Speaker, 3rd International Conference on Cancer (Cancer 2023), 17–19 May 2023, Lisbon, Portugal
Alireza Heidari, Organizing Committee Member (OCM), 5th International conference on Stem Cell, Tissue Engineering and Regenerative Medicine (Stem Cells 2023), 18–19 May 2023, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), World Conference on Gastroenterology, Hepatology and Endoscopy (WCGHE–Barcelona–2023), 18–19 May 2023, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), World Conference on Orthopedics, Sports Medicine and Rehabilitation (WCOSMR–Barcelona–2023), 18–19 May 2023, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), World Conference on Gynecology and Reproductive Medicine (WCGRM–Barcelona–2023), 18–19 May 2023, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), World Conference on Nursing, Healthcare and Hospital Management (WCNHHM–Barcelona–2023), 18–19 May 2023, Barcelona, Spain
Alireza Heidari, Organizing Committee Member (OCM), 2nd World Conference on Chemistry and Chemical Engineering (WCCCE–Berlin–2023), 22–23 May 2023, Berlin, Germany
Alireza Heidari, Organizing Committee Member (OCM), 9th International Conference on Organic and Inorganic Chemistry (Organic and Inorganic Chemistry 2023), 24–25 May 2023, Vienna, Austria
Alireza Heidari, “A New Revolution of Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Diagnosis and Treatment”, International Conference on Nano Research and Development (ICNRD–2023), 24–26 May 2023, Rotterdam, Netherlands
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Advances in Computer Engineering, Communication Systems and Business Development (ICACECSBD–2023), 26–27 May 2023, Virtual Conference
Alireza Heidari, Technical Program Committee Member (TPCM), 2023 IEEE 14th International Conference on Mechanical and Intelligent Manufacturing Technologies (ICMIMT 2023), 26–28 May 2023, Cape Town, South Africa
Alireza Heidari, Technical Committee Member (TCM), 2023 International Conference on Intelligent Vehicles (ICoIV 2023), 26–28 May 2023, Changsha, China
Alireza Heidari, Organizing Committee Member (OCM), International Summit on Power and Energy Engineering (ISPEE2023), 12–14 June 2023, Paris, France
Alireza Heidari, Scientific Committee Member (SCM), 11th International Conference on Recent Challenges in Engineering and Technology (ICRCET), 16–17 June 2023, Jakarta, Indonesia
Alireza Heidari, Organizing Committee Member (OCM), 17th International Conference on Alzheimer's Disease and Dementia (Alzheimer's Disease 2023), 19–20 June 2023, Edinburgh, Scotland
Alireza Heidari, Organizing Committee Member (OCM), 7th International Conference on Nanoscience (Nanoscience Conference 2023), 28–30 June 2023, London, UK
Alireza Heidari, Organizing Committee Member (OCM), Global Meet on Oncology and Cancer Research (GMOCR23), 29–30 June 2023, Rome, Italy
Alireza Heidari, Scientific Committee Member (SCM) and Keynote Speaker, 6th Edition of International Cancer Conference (ICC 2023), 17–19 August 2023, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 3rd Global Summit on 3D Printing and Additive Manufacturing (3D Printing 2023), 24–26 August 2023, London, UK
Alireza Heidari, Technical Committee Member (TCM), 2023 7th International Conference on Material Engineering and Advanced Manufacturing Technology (MEAMT 2023), 25–27 August 2023, Wuhan, China
Alireza Heidari, Advisory Board Member (ABM), International Conference on Finance Management, Business and Entrepreneurship (ICFMBE–2023), 26–27 August, Webinar
Alireza Heidari, Organizing Committee Member (OCM), 3rd Global Summit on 3D Printing & Additive Manufacturing (3DPrinting2023), 28–30 August 2023, London, UK
Alireza Heidari, Organizing Committee Member (OCM), 16th International Conference on Pharmaceutics and Drug Safety (Drug Safety 2023), 30–31 August 2023, Dublin, Ireland
Alireza Heidari, Steering Committee Member (SCM), CANWEST Internacional Research Congress 2023 (CANWEST IRC'23), 11–13 September 2023, Madrid, Spain
Alireza Heidari, Organizing Committee Member (OCM), Global Congress on Materials Science and Engineering (GCMSE–2023), 11–13 September 2023, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), Global Congress on Biomaterials, Biomedical Science and Biotechnology (BMSA–2023), 11– 13 September 2023, Dubai, UAE
Alireza Heidari, Invited Speaker, 2nd International Meet & Expo on Materials Science and Nanomaterials Conference (MATERIALSMEET2023), 18–20 September 2023, Lisbon, Portugal
Alireza Heidari, Scientific Committee Member (SCM), 2nd International Conference on Multidisciplinary Research and Practices (ICMRP–2023), 20–21 September 2023, Jakarta, Indonesia
Alireza Heidari, Technical Committee Member (TCM), 2023 International Conference on Frontiers of Nanomaterials and Nanotechnology (NanoMT 2023), 22–24 Septmber 2023, Wuhan, China
Alireza Heidari, Organizing Committee Member (OCM), 2nd International Conference on Advanced Physics and Quantum Physics (Advanced Physics Conference 2023), 02–04 October 2023, Vienna, Austria
Alireza Heidari, Organizing Committee Member (OCM), 2nd Annual Summit on Neuro Science and Neurological Disorders (Neuroscience 2023), 05–07 October 2023, Vienna, Austria
Alireza Heidari, Organizing Committee Member (OCM), International Experts Summit on Toxicology and Phamacology (IESTP 2023), 09–11 October 2023, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 5th International Conference on Proteomics, Genomics and Molecular Medicine (Proteomics Conference 2023), 09–11 October 2023, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), International Conference on Pharmaceutical and Pharma Industry (Pharmaceutics 2023), 16–18 October 2023, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Surgery and Anesthesia (Surgery Conference 2023), 16–18 October 2023, Paris, France
Alireza Heidari, Organizing Committee Member (OCM), Global Congress on Biomedical Engineering (BioMed–2023), 23–24 October 2023, Bangkok, Thailand
Alireza Heidari, Organizing Committee Member (OCM), Global Meet on Polymer Science and Composite Materials (PSCM2023), 23–25 October 2023, Dubai, UAE
Alireza Heidari, Technical Committee Member (TCM), 3rd International Conference on Industrial Automation, Robotics and Control Engineering (IARCE 2023), 27–30 October 2023, Chengdu, China
Alireza Heidari, Scientific Committee Member (SCM), 6th International Conference on Recent Trends in Multi–Disciplinary Research (ICRTMDR–23), 10–11 November 2023, Istanbul, Turkey
Alireza Heidari, Organizing Committee Member (OCM), Global Congress on Toxicology and Applied Pharmacology (GCTAP–2023), 13–15 November 2023, Rome, Italy
Alireza Heidari, Organizing Committee Member (OCM), 3rd International Conference on Surgery and Anesthesia (Surgery 2023), 23–24 November 2023, Dubai, UAE
Alireza Heidari, Plenary Speaker, Global Meet on Food Science and Nutrition Technology (FSNT2023), 23–25 November 2023, Nice, France
Alireza Heidari, Technical Program Committee Member (TPCM), 2023 International Conference on Mechanical, Aerospace and Electronic Systems (MAES 2023), 24–26 November 2023, Johannesburg, South Africa
Alireza Heidari, Organizing Committee Member (OCM), 4th International Conference on Clinical Trials and Case Reports (Clinical Trials 2023), 27–29 November 2023, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 12th International Conference on Neurological Disorders and Stroke (Stroke 2023), 07–09 December 2023, Dubai, UAE
Alireza Heidari, Organizing Committee Member (OCM), 2023 International Conference on Nanotechnology and Multifunctional Structures (ICNMS 2023), 28–29 December 2023, Wuhan, China
Alireza Heidari, Technical Program Committee Member (TPCM), The 15th International Conference on Mechanical and Intelligent Manufacturing Technologies (ICMIMT), 07–09 March 2024, Cape Town, South Africa
Alireza Heidari, Organizing Committee Member (OCM), 4th Global Summit and Expo on Magnetism and Magnetic Materials (GSEMMM2024), 21–23 March 2024, Lisbon, Portugal
Alireza Heidari, Organizing Committee Member (OCM), Global Summit on General & Internal Medicine (GSGIM2024), 22–24 April 2024, Osaka, Japan
Alireza Heidari, Scientific Committee Member (SCM), Golbal Conference on Medicinal Chemistry, Drug Discovery and Drug Design (GCMCDD2024), 15–17 May 2024, Munich, Germany
Alireza Heidari, Scientific Committee Member (SCM), Global Summit and Expo on Magnetism and Magnetic Materials (GSEMMM2024), 17–19 June 2024, Porto, Portugal
Alireza Heidari, International Scientific Advisory Board Member (ISABM), The 5th International Congress on Advanced Materials, Sciences and Engineering (AMSE– 2024), 23–26 July 2024, Opatija, Croatia
Alireza Heidari, Scientific Committee Member (SCM), Global Summit on Neurology and Neurological Disorders (Neuro2024), 22–24 August 2024, Kuala Lumpur, Malaysia
Alireza Heidari, Scientific Committee Member (SCM), Global Meet on Catalysis, Chemical Engineering and Technology (GMCATALYSIS2024), 02–04 September 2024, Dubai, UAE
Alireza Heidari, Scientific Committee Member (SCM), Global Summit and Expo on Materials Science and Nanoscience (GSEMSN2024), 16–18 September 2024, Prague, Czech Republic
Alireza Heidari, Organizing Committee Member (OCM), 3rd Global Summit and Expo on Toxicology and Applied Pharmacology (TOXI2024), 23–25 September 2024, Dubai, UAE

c) Book Published:

Alireza Heidari, “Solutions Manual for Physical Chemistry of Iran. Levine”, 1st Edition, Mobtakeran Company Press, Tehran, Iran, 2007
Alireza Heidari, “Principles of Modern Relativistic Quantum Mechanics”, 1st Edition, Karvar Company Press, Tehran, Iran, 2008
Alireza Heidari, “Principles and Methods of Using Chemical Abstracts”, 1st Edition, Karvar Company Press, Tehran, Iran, 2008
Alireza Heidari, “Fundamentals of Surface and Solid State Physical Chemistry”, 1st Edition, Karvar Company Press, Tehran, Iran, 2008
Alireza Heidari, “Molecular Physical Chemistry”, 1st Edition, Karvar Company Press, Tehran, Iran, 2009
Alireza Heidari, “Fundamentals of Quantum Chemistry and Molecular Spectroscopy”, 1st Edition, Karvar Company Press, Tehran, Iran, 2009
Alan K. Brisdon, “Inorganic Spectroscopic Methods”, 1st Edition, Oxford Chemistry Primers, Oxford University Press, 1998
Martin Cockett, Graham Dogget, “Math’s for Chemists (Volume 1): Numbers, Functions and Calculus”, 1st Edition, The Royal Society of Chemistry (RSC), 2003
Martin Cockett, Graham Dogget, “Maths for Chemists (Volume 2): Power Series, Complex Numbers and Linear Algebra”, 1st Edition, The Royal Society of Chemistry (RSC), 2003
H. Paschen, C. Coenen, T. Fleischer, R. Grünwald, D. Oertel, C. Revermann, “Nanotechnologie Chemie: Forschung, Entwicklung, Anwendung”, Erste Auflage, Springer, 2004
Alireza Heidari, “Vibrational Spectroscopy of Nucleic Acids”, Wahid Ali Khan (Editor), “Basic Biochemistry”, Austin Publishing Group (APG)/Austin Publications LLC, ISBN: 978–0–9971499–2–0, Pages 1–18, Jersey City, New Jersey, USA, 2016
Alireza Heidari, “Pros and Cons Controversy on Future Prospects of Point Fluorescence Spectroscopy, X–Ray Fluorescence (XRF) Spectroscopy, Cold Vapour Atomic Fluorescence (CVAF) Spectroscopy, Fluorescence Imaging and Fluorescence Endoscopy in Photodynamic Therapy (PDT) for Human Cancer Cells and Tissues Prevention, Diagnosis and Treatment”, Chapter 01, “Top 10 Contributions on Pharmaceutical Sciences”, Avid Science, Pages 2–29, Hyderabad, Telangana, India, 2018
Alireza Heidari, “Elimination of Cancer Cells Using Thin Layers of Cadmium Oxide (CdO)–DNA/RNA Sandwiched Complex Composite Plasmonic Nanostructureunder Synchrotron Radiation”, Importance & Applications of Nanotechnology, Austin Publishing Group (APG)/Austin Publications LLC, Vol. 1, Chapter 2, pp. 8–38, 2021
Alireza Heidari, “Advanced Applications of Nanotechnology in Cancer Detection and Therapy”, IGI Global, ISBN–10: 179980139X, ISBN–13: 978–1799801399, Hershey, Pennsylvania, USA, 2019
Alireza Heidari, “Advances in Medical and Health Research (Volume–1)”, Rubicon Publications, ISBN: 978–1–913482–47–3, London, UK, 2022
Alireza Heidari, “Advances in Medical and Health Research (Volume–2)”, Rubicon Publications, ISBN: 978–1804339–72–5, London, UK, 2023

Brief Introduction of Prof. Dr. Alireza Heidari

Make a Submission

submission-issue

quick

partnes

Current Issue